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Summary 
The evolvement of a complex endomembrane system, which is separating a variety of 
biochemical processes into distinct compartments, is a hallmark of eukaryotic cell 
development. Cellular homeostasis depends on the abilities of these lipid bilayer-enclosed 
organelles both to maintain distinct characteristics and to exchange materials. This is 
mainly achieved by a process called vesicular transport, which allows for a constant 
exchange of proteins, lipids and metabolites between different compartments. Lipid-
bilayer enclosed vesicles bud from the donor compartment, are transported to the target 
compartment and fuse with its surrounding membrane. The basic machineries involved in 
the process in budding and fusion have been intensely investigated in the last years. 
However, our knowledge about the processes, which confer target specificity and regulate 
intracellular membrane fusion, is still limited. Before fusion of two-compartments can 
occur, they have to specifically recognize and bind each other to allow for subsequent 
SNARE1-induced fusion to take place. This early step in the fusion reaction is called 
tethering and involves the action of tethering factors and Rab GTPases. 
In my research, I focused on the HOPS2 protein complex that is implicated to 
function in the tethering process at the yeast vacuole, the fungal equivalent of lysosomes. 
To investigate the molecular properties that confer the functionality of this large 
hexameric complex, I established a method that allowed for the purification of substantial 
amounts of HOPS and investigated the interactions taking place between different 
subunits. This work paved the ground for electron microscopy analysis of the whole 
complex, which is currently performed and which yielded first, preliminary data. 
Furthermore, it allowed for the identification of the novel CORVET3 tethering complex at 
the endosome, which has several subunits in common with the HOPS complex. I was 
able to show that chimeric complexes exist, harboring both HOPS- and CORVET-
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specific subunits. This finding suggests that both complexes are dynamic and can 
interconvert.  
During my studies on the subunits’ interactions, I identified stable subcomplexes 
of the HOPS complex, for one of which I could show that it exists in vivo. The existence 
of such subcomplexes implies a much more dynamic functioning of the HOPS subunits 
than previously anticipated. This notion is further strengthened by my studies on the 
functionality of different subunits and subcomplexes. Intriguingly, my results show that 
the Rab Guanyl nucleotide exchange factor Vam6, which is needed to activate the 
vacuolar Rab Ypt7 for subsequent fusion and which is a component of the HOPS 
complex, loses its ability to interact with Ypt7 upon incorporation into a subcomplex or 
the fully assembled HOPS complex. In contrast to this, the subunit Vps41, which I could 
identify as a Rab effector, is active as a single protein and as part of the complex, 
suggesting that it might sequentially recruit the subcomplexes to assemble into the holo 
complex at sites harboring active Ypt7.  
Another feature of Vps41 was addressed in my work. This protein was previously 
shown to be phosphorylated by the vacuolar casein kinase Yck3. I identified the 
phosphorylation sites in the Vps41 sequence, which allowed further studies on the effect 
of the phosphorylation on the functionality of the protein. In the phosphorylated state, the 
protein is displaced into the cytosol whereas it accumulates at endosomal-vacuolar fusion 
sites if phosphorylation is prevented. Intriguingly, we found that Ypt7 overexpression is 
able to partially rescue the loss of localization in the phosphomimetic mutant, indicating a 
cross-talk between these two layers of Vps41 regulation. 
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Zusammenfassung 
Die Entstehung eines komplexen Endomembransystems, in dem eine Vielzahl 
biochemischer Prozesse in spezielle Kompartimente aufgeteilt werden, ist ein prägendes 
Merkmal der Entwicklung eukaryotischer Zellen. Die Fähigkeiten dieser von einer Lipid-
Doppelschicht umgebenen Organellen sowohl ihre spezifischen Charakteristika zu 
erhalten, als auch Stoffe untereinander auszutauschen sind unabdingbar für die Erhaltung 
der zellulären Homöostase. Dies wird erreicht durch den sogenannten vesikulären 
Transport, der einen permanenten Austausch von Proteinen, Lipiden and Metaboliten 
zwischen verschiedenen Kompartimenten erlaubt. Membranumschlossene Vesikel 
knospen dabei vom Donorkompartiment ab, werden zum Zielkompartiment transportiert 
und fusionieren dort mit der Lipid-Membran. Die grundlegende Maschinerie, die für 
diese Prozesse verantwortlich zeichnet ist in den letzten Jahren intensiv erforscht und 
charakterisiert worden. Dennoch ist unser Wissen über die Prozesse, die die Spezifität der 
Fusionsprozesse vermitteln und diese regulieren nach wie vor sehr begrenzt. Bevor zwei 
membranumschlossene Kompartimente fusionieren können, müssen sie sich spezifisch 
erkennen und aneinander binden um die anschließende SNARE1-induzierte Fusion zu 
gestatten. Dieser frühe Schritt in der Fusionsreaktion wird als “Tethering” bezeichnet und 
umfasst die Wirkung von Tethering Faktoren und Rab GTPasen. 
 Wärend meiner Doktorarbeit beschäftigte ich mich hauptsächlich mit dem 
HOPS2 Protein Komplex, der beim Tethering an der Hefevakuole, dem Äquivalent der 
Lysosomen höherer Eukaryoten, seine Funktion ausübt. Um die Eigenschaften des 
Komplexes, die für seine Funktion wichtig sind, näher untersuchen zu können, etablierte 
ich eine Methode, die die Aufreinigung größerer Mengen des Komplexes erlaubt und 
untersuchte, welche Untereinheiten miteinander interagieren. Diese Arbeiten schafften 
die Voraussetzungen dafür, dass nun elektronenmikroskopische Untersuchungen des 
gesamten Komplexes durchgeführt werden können, welche bereits erste preliminäre 
Daten lieferten. Darüber hinaus erlaubten meine Arbeiten die Identifizierung des bis 
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dahin unbekannten, endosomalen CORVET1 Tethering Komplex, der einige 
Untereinheiten mit dem HOPS Komplex gemein hat. Ich konnte zeigen, dass chimäre 
Komplexe existieren, die sowohl HOPS- als auch CORVET-spezifische Untereinheiten 
enthalten. Diese Entdeckung lässt vermuten, dass beide Komplexe dynamische 
Strukturen darstellen und ineinander umwandelbar sind.  
 Während meiner Studien zu den Interaktionen zwischen einzelnen 
Untereinheiten, entdeckte ich, dass HOPS aus stabilen Subkomplexen aufgebaut ist und 
ich konnte für einen von diesen bereits zeigen, dass er in vivo vorkommt. Die Existenz 
dieser Subkomplexe impliziert eine wesentlich dynamischere Funktionsweise des 
vakuolären Tetherings, als bisher vermutet. Dieser Eindruck wird weiterhin unterstützt 
durch meine Studien zur Funktionalität verschiedener Untereinheiten und Subkomplexe. 
Interessanterweise zeigen meine Ergebnisse, dass der Rab GEF Vam6, der zur 
Aktivierung des vakuolären Rab Proteins Ypt7 benötigt wird und ein Bestandteil des 
HOPS Komplexes ist, seine Fähigkeit mit Ypt7 zu interagieren verliert, sobald er in einen 
Subkomplex oder den HOS Komplex inkorporiert wird. Im Gegensatz dazu funktioniert 
die HOPS Komponente Vps41, die ich als Rab Effektor identifizieren konnte, sowohl als 
einzelnes Protein als auch als Bestandteil des HOPS Komplexes. Diese Ergebnisse deuten 
darauf hin, dass Vps41 dazu dienen könnte, die einzelnen Subkomplexe an Stellen mit 
aktiviertem Ypt7 zu rekrutieren und im Verlaufe dessen, der gesamte HOPS Komplex 
assembliert wird. 
 Eine weitere spezifische Eigenschaft der HOPS Untereinheit Vps41 wurde in 
meiner Arbeit näher charakterisiert. Frühere Arbeiten in unserem Labor haben gezeigt, 
dass dieses Protein von der vakuolären Casein Kinase Yck3 phosphoryliert wird. Mir ist 
es gelungen, die Phosphorylierungsstellen in der Vps41 Sequenz zu identifizieren. Dies 
erlaubte die Durchführung weiterer Studien zu dem Effekt der Phosphorylierung auf die 
Funktionalität des Proteins. Im phosphorylierten Zustand verliert Vps41 teilweise seine 
perivakuoläre Lokalisierung und liegt vornehmlich zytosolisch vor. Demgegenüber 
akkumuliert das nicht-phosphorylierte Protein zusammen mit anderen HOPS 
Untereinheiten an endosomal-vakuolären Fusionsstellen. In Übereinstimmung mit 
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meinen oben genannten Ergebnissen konnte gezeigt werden, dass die Überexpression von 
Ypt7 die zytosolische Lokalisierung der phosphomimetischen Mutante teilweise 
rückgängig machen konnte. Dieses Ergebnis impliziert, dass über Yck3-vermittelte 
Phosphorylierung und die Interaktion mit aktiviertem Ypt7 die Lokalisierung und 
Funktionalität von Vps41 auf zwei Ebenen reguliert wird. 
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1 Introduction 
Ever since evolution led to the development of intracellular membranes, living cells 
became able to efficiently separate metabolic and physiological entities, a feature their 
evolutionary predecessors where incapable of. A complex intracellular endomembrane 
network is a distinct property of all eukaryotic cells (Whittaker and Margulis, 1978; 
Woese et al., 1990). The DNA of eukaryotic cells resides in the most prominent 
membrane-enclosed compartment, the nucleus. Translation of proteins destined for 
organelles or the extracellular medium are translated on the rough endoplasmic reticulum 
and routed by vesicular transport to the Golgi apparatus. Inside the Golgi, proteins are 
further processed and modified before they get sorted to the plasma membrane, the 
endosomal compartment or the vacuole/lysosome. Next to mitochondria, the key players 
in the cellular energy metabolism, and chloroplasts in plant cells and eukaryotic algae, the 
above-mentioned organelles constitute the core components of the eukaryotic 
endomembrane system. 
1.1 The Eukaryotic Endomembrane System 
The boundary membranes of all intracellular organelles as well as the eukaryotic cell 
itself are comprised of lipid bilayers. A variety of proteins are embedded into or 
associated to the different membranes, both as structural as well as functional entities. At 
physiological temperature, lipid bilayers are dynamic structures and allow for lateral 
diffusion of lipids and proteins. The main lipid components of eukaryotic lipid bilayers 
are glycerolipids, sphingolipids and sterol derivatives. Different organelles’ membranes 
harbor distinct lipid and protein compositions, which can diverge between the two 
membrane leaflets, allowing for separate functionalities on each side of the bilayer 
(Holthuis et al., 2003). Next to the distinct features of all organelles’ membranes, their 
bilayer-enclosed lumina encompass different biochemical activities that are needed for 
synthesis and modification or breakdown of proteins, lipids and carbohydrates. By being 
performed in a highly ordered and regulated manner, these biologically essential 
functions allow for sustaining viability and progeny of the cell. 
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1.1.1 Intracellular Organelles  
The genetic material of eukaryotes is kept separately from the cytosol in the nucleus, 
where replication as well as transcription of the DNA is taking place. The nuclear 
envelope is composed of a double membrane, which is continuously connected with the 
endoplasmic reticulum (ER). After the messenger-RNA is exported through the nuclear 
pores, translation of the RNA transcripts is carried out by ribosomes. Only in the case of 
translation of transmembrane proteins or proteins destined for the secretory pathway, the 
emerging amino acid chain is specifically recognized by the Signal Recognition Particle 
(SRP) ribonucleoprotein complex. The SRP binds to the SRP receptor on the ER 
membrane and subsequently hands over the ribosome to the translocon, which builds up a 
pore-like structure in the ER membrane and allows for the translocation of the nascent 
polypeptide chain across the ER membrane (Deshaies et al., 1991; Walter and Blobel, 
1980). Inside the ER lumen, folding of the polypeptide chain takes place. Multiple 
chaperones facilitate correct folding, and disulphide-bond formation allows for 
stabilization of the tertiary protein structure. However, if polypeptides are misfolded and 
expose hydrophobic amino acid stretches that are normally secluded inside the protein’s 
structure, aggregation can take place and subsequent impairment of the ER integrity 
could occur. To counteract these effects, eukaryotic cells employ the unfolded protein 
response (UPR) system. If the UPR is activated upon accumulation of misfolded proteins, 
production of chaperones is upregulated and the ER associated degradation pathway 
(ERAD) is activated, which leads to ubiquitination and subsequent proteasomal 
degradation (Vembar and Brodsky, 2008). If by these means, further misfolding cannot 
be prohibited and the cellular integrity is endangered, apoptotic cell death can be initiated 
by the UPR. In contrast to this, correctly folded proteins can be further modified in the 
ER by O- and N-glycosylation and are subsequently transported to the Golgi apparatus 
(Golgi) by COPII vesicular transport. 
 Other than the ER, the Golgi is not composed of a continuous membrane system 
but of several separate cisternae. In higher eukaryotes, these cisternae are closely located 
next to each other, thereby forming a stacked higher order structure. The Golgi is a 
polarized organelle, meaning that different cisternae harbor distinct biochemical 
properties. The part of the Golgi, which is receiving cargo from the ER and is often 
facing the ER, is referred to as the cis-Golgi. The part, which is distal to the ER and 
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receives cargo after it has passed all other intermediate Golgi compartments, is referred to 
as the trans-Golgi. Since cis- and trans-Golgi are sites of specifically rapid vesicular 
turnover, these parts form bigger and more complex cisternae, called the cis- and the 
trans-Golgi-network (CGN and TGN, respectively) (see Fig. 1.1). Trafficking between 
the Golgi cisternae is taking place by anterograde and retrograde transport, which is 
mediated by coat protein complex II and I (COPII and COPI) vesicles, respectively. 
Furthermore, ER resident proteins, which escaped to the CGN are transported back as 
well by means of COPI vesicular transport. 
Proteins that travel from the ER to the Golgi are prone to many different 
modifications. Further glycosylation takes place and certain proteins are proteolytically 
cleaved to remove signal peptides. These alterations can be observed in some cases by 
mobility shift in an electrophoretic chromatography setup and are often referred to as 
“maturation”. Next to the execution of modifications, the Golgi resembles the main 
Figure 1.1 | Overview of the endomembrane system in eukaryotic cells.  Organelles found in eukaryotic 
cells and of main interest for this study are schematically depicted. Note that distribution and shape of 
organelles can differ between species. EE=Early Endosome, LE=Late Endosome, MVB=Multi Vesicular 
Body, ER=Endoplasmic Reticulum. Figure adapted from Ostrowicz et al., 2008. 
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sorting station of the cell, leading to protein-specific transport to the plasma membrane, 
the endosomal compartment, the lysosome/vacuole, or back to the ER.  
The endosomal compartment confers a similar sorting function as the Golgi. 
Upon endocytosis, proteins from the extracellular space as well as integral, plasma 
membrane (PM) resident proteins are transferred to the cytosol by endocytic vesicles that 
pinch off from the PM. These endocytic vesicles can either homotypically fuse to form an 
early endosomal compartment or fuse to pre-existing early endosomes. Proteins destined 
for degradation are retained in the endosome for degradation in the lysosome/vacuole. 
Due to the action of proton-pumps, the endosomal lumen is mildly acidified. Thus, 
endocytosed transmembrane receptors can undergo conformational changes that lead to 
the release of their substrate, which is retained in the endosome, while the receptor is 
recycled back to the plasma membrane. Similarly, biosynthetic cargo like the 
carboxypeptidase Y (CPY) is uni-directionally transferred from the TGN to the early 
endosome with the help of receptors. Subsequently, the cargo proteins dissociate off their 
receptors, which are efficiently transported back via vesicular transport (see Fig. 1.1).  
The targeting of endocytosed transmembrane proteins to the vacuolar lumen 
eventually leads to their degradation. This process is initiated by the addition of a single 
ubiquitin moiety to or Lys-63-linked oligoubiquitination of the cytosolic part of the 
protein destined for degradation. Upon maturation of endosomes to the late endosomal 
compartment, the ubiquitin carrying proteins are further enriched on the endosomal 
membrane. This ubiquitin-enriched membrane is recognized by a subset of cytosolic 
proteins that can transiently associate with the endosomal membrane, the so-called 
Endosomal Complex Required for Transport (ESCRT) proteins. Four distinct ESCRT 
complexes are known to bind to the endosomal membrane and sequentially recruit each 
other in a well-defined order (Teis et al., 2008). The ESCRT-0 complex initiates this 
process by recognizing ubiquitinated cargo and phosphatidylinositol-3-phosphate, a lipid 
that is typically enriched on endosomal membranes. ESCRT-I and II act downstream of 
ESCRT-0 and are believed to further enrich or “trap” the ubiquitinated proteins. ESCRT-
III finally leads to invagination of the endosomal membrane away from the cytosol into 
intraluminal vesicles, thereby forming Multivesicular Bodies (MVBs) (Fig. 1.2) (Hurley 
and Emr, 2006). Interestingly, recycling of cellular components is so elaborate that just 
before the invagination event, the ubiquitin is proteolytically cleaved from the 
invaginated cargo and is therefore made available for further endocytotic events (Amerik 
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et al., 2000). Whether MVBs as very late endosomes heterotypically fuse with the 
vacuole/lysosomes or must further mature to become indistinguishable from 
vacuole/lysosomes and finally homotypically fuse with this compartment, is currently 
under debate. However, there is strong evidence, that the latter is predominantly taking 
place (Peplowska et al., 2007; Rink et al., 2005).  
The yeast vacuole corresponds to the lysosomal compartment of higher 
eukaryotes as a terminal organelle, responsible for the degradation and recycling of 
macromolecules. Moreover, it plays an important role as a storage compartment for 
amino acids and ions. It is therefore involved in detoxification, and pH- and ion-
homeostasis of the cell. To maintain functionality of the vacuole, it constantly receives 
protein cargo from the biosynthetic pathway, which is transported via different routes 
from the Golgi either via the endosome by the CPY-pathway or directly from the Golgi 
by the AP3-pathway (Ostrowicz et al., 2008). These pathways are described in more 
detail in the next sections. Most of the vacuolar resident proteins are degradative enzymes 
like proteases, lipases, nucleases, and phosphatases needed for breakdown of various 
Figure 1.2 | Formation of multi vesicular bodies in yeast.  Successive recruitment of ESCRT complexes –I, 
–II, and –III leads to enrichment of ubiquitinated cargo, deubiquitination by Doa4 and invagination of the 
endosomal membrane. The Vps4 AAA ATPase is required for ESCRT-III complex disassembly and therefore 
allows for the re-cycling of its subunits. Figure from Hurley and Emr, 2006. 
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substrates. Many of these enzymes reach the vacuole in an inactive state and are either 
activated by proteolytic cleavage or by the low vacuolar pH of down to 4.5. The low pH 
of the vacuolar lumen, which facilitates numerous acid catalyzed hydrolysis breakdown 
reactions, is primarily maintained by the vacuolar (“V”)-ATPase, which couples the 
hydrolysis of ATP to directed proton transport across the vacuolar membrane. Next to its 
contribution to the numerous hydrolysis reactions taking place in the vacuolar lumen, the 
proton gradient is also used by various active transporters. These carry ions from the 
cytosol to the vacuolar lumen, therefore supporting the ion homeostasis of the cell. 
1.1.1.1 Transport Pathways involving the vacuole
*
 
The yeast vacuole, which resembles the lysosome of higher eukaryotes, is 
positioned at a crucial point of the eukaryotic endomembrane system. The two major 
trafficking pathways in the cell, the endocytic and the biosynthetic/secretory pathway 
target cargo to the vacuole/lysosome (Fig. 1.3). The metabolic function of the 
vacuole/lysosome has often been referred to as the cell’s “stomach” or “sink”. Nowadays, 
and to shed a more realistic light on this organelle, one would rather call it the major 
recycling facility of the cell. Its acidic pH is a prerequisite for the activity of the 
numerous hydrolases, i.e., nucleases, phosphatases, lipases and proteases within the 
vacuolar lumen, and the low molecular weight degradation products of these enzymes’ 
catabolic activities are released into the cytosol for further use. Moreover, lysosomes are 
critical during starvation and for the degradation of cell surface receptors, thus allowing 
cells to respond to extracellular signals and adjust their response. Research on vacuole 
biogenesis and function was strongly promoted by several elegant genetic screens, which 
led to the identification of proteins involved in endocytosis (End), biosynthetic transport 
(Vps, Pep), vacuole inheritance (Vac), and vacuole morphology (Vam) in yeast (Bowers 
and Stevens, 2005). In many identified mutants, vacuole morphology is strongly 
perturbed. A morphology?based classification distinguishes normal (class A), partly 
(class B) and highly (class C) fragmented vacuoles from large (class D) vacuoles, and 
those having an enriched endosomal compartment (class E). The subsequent 
characterization of these genes unraveled the underlying machinery of a number of 
                                                      
* extract from Ostrowicz et al., 2008, written by the author of this thesis 
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trafficking pathways that are critical for vacuole biogenesis, and in the case of the VAM 
genes, for vacuole fusion (Wada et al., 1992). Below, these trafficking pathways are 
briefly described. The vacuolar carboxypeptidase Y (CPY/Prc1) travels from the 
trans?Golgi?Network (TGN) to the late endosome, from where it is subsequently 
delivered to the vacuole (Rothman et al., 1989; Stevens et al., 1982). At the TGN, it is 
recognized by the receptor protein Vps10 (Marcusson et al., 1994), concentrated and 
packed into vesicles that pinch off from the TGN in an AP?1/clathrin?dependent 
manner. After fusion with the late endosomal compartment, Prc1 dissociates from its 
receptor and is then transported to the vacuole upon endosomal maturation. Vps10 is 
subsequently recycled back to the TGN with the help of the retromer complex (Seaman, 
2005). Various other hydrolases have additionally been shown to interact with Vps10 and 
therefore follow the same route to the vacuole (Cooper and Stevens, 1996; Jørgensen et 
al., 1999). Consequently, this generic pathway has been termed the CPY?pathway after 
its most prominent cargo.  
Figure 1.3 | Transport pathways leading to the vacuole.  The vacuole receives cargo from a number of 
different routes, including the biosynthetic pathway, the endocytic pathway and autophagy. The cytoplasm 
to vacuole targeting (cvt-) pathway is not depicted, since the required machinery has a substantial overlap 
with the (macro-)autophagy machinery. Figure from Ostrowicz et al., 2008. 
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However, a small subgroup of vacuolar resident proteins, namely the PHO8 gene 
product alkaline phosphatase (ALP), the soluble N-ethylmaleimide sensitive protein 
receptors (SNAREs) Vam3 and Nyv1 and the vacuolar casein kinase Yck3, which is 
palmitoylated at its C terminus, travel to the vacuole in a more direct trafficking event 
omitting the endosome (Darsow et al., 1998; Reggiori and Pelham, 2002; Sun et al., 
2004; Wen et al., 2006). This pathway was termed the ALP? or AP?3?pathway after the 
adaptor complex, which is involved in the generation of vesicles at the TGN in a 
clathrin?independent fashion (Cowles et al., 1997a; Rehling et al., 1999; Stepp et al., 
1997; Sun et al., 2004). Additional pathways are linked to the vacuole. The cytoplasm to 
vacuole targeting (Cvt) pathway and macroautophagy use a similar set of components to 
transport proteins to the vacuole (Klionsky et al., 1992; Klionsky, 2005; Scott et al., 
1997; Scott et al., 1996; Scott et al., 2000). Whereas the Cvt pathway is a biosynthetic 
route to direct aminopeptidase I (Ape1) to the vacuole lumen, macroautophagy is a 
catabolic pathway, which plays a crucial role for cell survival upon starvation. In both 
cases, a double membrane of unknown origin engulfs organelles and cytosolic material 
(macroautophagy) or oligomeric Ape1 (Cvt pathway) and targets them directly to the 
yeast vacuole (Klionsky, 2005).  
Considering the number of trafficking pathways leading to the vacuole, it is not 
surprising that the vacuole is a highly dynamic organelle (Weisman, 2006). During cell 
division, the vacuole fragments partially, producing vesicular and tubular structures, 
which are transported into the emerging bud. In order to control the overall shape of 
the vacuolar organelle, inherited vacuolar vesicles fuse later during cell division, 
maintaining a low copy number for this organelle (Conradt et al., 1992; Weisman et 
al., 1987; Weisman and Wickner, 1988). A number of proteins involved in 
inheritance have been identified in the past, including the vacuolar protein Vac8, the 
actin?binding Myo2 protein and its adaptor, Vac17 (Weisman, 2006). Moreover, the 
dynamin?homolog Vps1 has been implicated in vacuole fission (Baars et al., 2007; 
Peters et al., 2004). Vacuole fragmentation and fusion is also connected to 
osmoregulation, and to the synthesis and turnover of 
phosphatidylinositol?(3,5)?bisphosphate (PI(3,5)P2) (Bonangelino et al., 1997; 
Bonangelino et al., 2002; Dove et al., 1997; Schott et al., 1999). Nevertheless, a 
clear concept of vacuole fission and fragmentation is still missing.
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1.2 Membrane Trafficking 
As outlined above, all intracellular organelles communicate to varying extents by 
exchanging proteins and lipids. Vesicles are employed as carriers in a variety of 
constitutive processes such as transport between the ER and the Golgi, as well as all 
Adaptor Protein (AP) associated transport steps, which are necessary for endo- and 
exocytosis, Golgi-to-endosome-, and Golgi-to-vacuole cargo transfer. In all of these 
cases, a distinct portion of the donor membrane is being pinched off during vesicle 
budding (Fig. 1.4 a). This process depends on the direct recognition of cargo by specific 
coat-forming proteins (in the case of COPI and –II transport) or AP complexes, which 
mediate interaction with the respective coat proteins. The nascent vesicles are 
subsequently enclosed by the coat proteins, which thereby facilitate the budding process. 
After complete separation from the donor membrane, vesicles are transported along the 
cytoskeleton to the target organelle.  
Figure 1.4 | General principle of vesicular transport. Transport vesicles carrying cargo proteins bud off 
from the donor membrane and move by active cytoskeletal transport and by diffusion to their target 
membrane. First membrane contact is initiated during tethering, which promotes SNARE trans-complex 
assembly and subsequent membrane fusion. Figure adapted from Behnia and Munro, 2005.  
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To achieve fusion of the vesicular lipid bilayer with the organelle’s membrane, 
several steps have to occur in a defined order. First, vesicle uncoating occurs. Second, a 
first step of recognition between vesicle and target compartment has to be initiated to 
ensure specificity of the subsequent fusion event. During this step, usually referred to as 
“tethering”, the first physical interaction between the vesicle and its target membrane is 
established. Tethering, which is mediated by the concerted action of tethering factors and 
Rab (Ras-like in rat brain)-GTPases is a reversible process (Fig. 1.4 c). It is only after 
successful tethering that apposing membranes are brought into close enough contact to 
allow for interaction of cognate SNARE proteins that constitute the core machinery of 
membrane fusion. Partial assembly of the trans-SNARE complex leads to irreversible 
docking of the opposing membranes. Subsequent further assembly of the zipper-like trans 
complex ultimately leads to fusion and content mixing of the two compartments. 
1.2.1 Vesicle Formation 
Intracellular vesicles serve as the main carrier machinery in soluble and transmembrane 
protein as well as lipid transport between organelles. One remarkable example for 
vigorous production of vesicles is the TGN. As previously described, it serves as a 
sorting hub for a number of proteins either destined for the PM (exocytic pathway), the 
endosome (CPY pathway) or the vacuole (AP-3 pathway). How is specific recruitment of 
the correct cargo to these three different pathways achieved? Before the vesicle is shaped 
by the action of coat proteins, cargo proteins are specifically enriched in dedicated areas 
of the donor organelle membrane. Depending on their trafficking target, transmembrane 
proteins contain short, specific amino acid sequences in their cytoplasmic tail.  Soluble 
proteins located in the lumen of organelles depend on the recognition by transmembrane 
receptors, which contain similar signal sequences in their cytoplasmic tails. Generally, 
these cytoplasmic signals are then recognized by soluble adaptor proteins, which are in 
turn recruited to the organellar membrane. It appears that mutual recruitment of 
cargo/cargo receptors and adaptor proteins leads to enrichment of cargo harboring the 
adaptor protein’s specific signal sequence. Finally, next to cargo binding, the adaptor 
complexes are able to specifically interact with coat proteins to fulfill their function as 
adaptors. By recruiting coat proteins and other accessory proteins, the donor membrane is 
substantially remodeled and brought into the vesicular shape. The final step of membrane 
abscission has been reported to depend on the action of dynamin or related proteins for 
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example in clathrin-mediated endocytosis. In COPI- and –II-dependent transport, current 
evidence is suggesting the involvement of the respective initiating GTPases Arf1 and 
Sar1 in the final scission process (Beck et al., 2008; Lee et al., 2005).  
1.2.1.1 Clathrin mediated vesicle formation 
One of the first coat proteins to be identified in 
the process of vesicle formation was Clathrin. 
Clathrin-coated-pits as the precursor state of 
Clathrin-coated vesicles (CCVs) were easily 
observed in electron microscopic (EM) 
visualizations of the intracellular side of the 
plasma membrane (Fig. 1.5) (Kanaseki and 
Kadota, 1969; ROTH and PORTER, 1964). 
Purified vesicles allowed for further 
characterization of the observed structures and 
finally led to the identification of one of the 
main proteinaceous factors involved in their 
formation (Pearse, 1976). Clathrin coats are 
assemblies of single Clathrin entities that each 
contain three clathrin heavy and three clathrin 
light chains, assembled into a typical triskelion or three legged structure (Kirchhausen 
and Harrison, 1981). Before coat assembly can occur, Adaptor Protein (AP) complexes 
are recruited to the donor membrane and specifically recognize Tyrosine-based YXX?- 
and dileucine D/EXXXLL-motifs on the cytoplasmic tails of cargo proteins. At the TGN, 
vesicles carry the AP-1 adaptor protein complex, whereas during clathrin-mediated 
endocytosis, clathrin is recruited to the plasma membrane by AP-2 complexes. 
Furthermore, Clathrin has recently been shown to form vesicles at the TGN in 
dependence of newly identified single-polypeptide GGA proteins (Costaguta et al., 2001; 
Hirst et al., 2001). Next to AP complexes, clathrin depends on a number of additional 
accessory proteins that support the formation of CCVs (Fig. 1.6).  
Beside the AP-1 and -2 complexes, two additional homologous adaptor protein 
complexes, namely the AP-3 and AP-4 complexes, were described (Simpson et al., 1996). 
Figure 1.5 | Clathrin coat assembly aids 
in formation of endocytic vesicles. EM 
picture of the inner plasma membrane of 
chicken fibroblasts. Figure adapted from 
Heuser and Anderson, 1989. 
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Whereas AP-3 is conserved from yeast to men, AP-4 is not present in yeast, fruit flies or 
nematodes. Both complexes are acting at the level of the TGN and have been reported to 
also act on endosomes in mammalian cells. The involvement of clathrin in the formation 
of vesicles in dependence of AP-3 and AP-4 remains controversial, although the AP-3 
dependent ALP-pathway in yeast has been shown to be clathrin independent (Seeger and 
Payne, 1992; Vowels and Payne, 1998). Instead, a component of the vacuolar HOPS 
tethering complex, Vps41, appears to be involved in coat assembly and vesicle formation 
(Darsow et al., 2001; Rehling et al., 1999). 
1.2.1.2 AP-3 dependent vesicle formation 
In mammalian cells, the term Adaptor Protein 3 (AP-3) was used for two different 
adaptors involved in vesicle formation in the past. Originally, the single polypeptide 
clathrin adaptor AP 180/NP185 (Ahle and Ungewickell, 1986; Kohtz and Puszkin, 1988) 
was termed this way to stress its similarity with the AP-1 and -2 adaptors in that it binds 
Figure 1.6 | Adaptor protein complex dependent formation of Clathrin coated vesicles.  Several 
accessory factors that are known to be needed during CCV formation are depicted. Figure from Kirchhausen, 
2000. 
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clathrin to form a coat 
(Murphy et al., 1991). In 
contrast to this similarity, AP 
180 does not share structural 
or organizational features with 
the two previously identified 
APs, since it is not composed 
of four different proteins that 
assemble into a higher ordered 
structure to confer both cargo 
as well as clathrin specificity. 
Due to this disparity of 
features, the same name was 
later chosen by Robinson and 
colleagues (Simpson et al., 
1997) for a novel adaptor 
protein complex that exhibited 
clear structural and functional 
homology with the AP-1 and -
2 complexes. However, it was reported that the novel adaptor complex does not depend 
on clathrin in the formation of vesicles, a feature that made it unique among the classical 
APs. Although clathrin-independence was claimed for the AP-3-dependent pathway in 
mammalian cells, several publications still reported on a role of this coat protein during 
vesicle formation in this pathway (Dell'Angelica et al., 1998; Drake et al., 2000). As 
outlined above, the functioning of the AP-3 adaptor complex in the formation of vesicles 
remained obscure in mammalian cells. However, studies on the AP-3 complex in yeast 
yielded interesting insights into a possible alternative of AP-3 coat formation (Darsow et 
al., 2001; Rehling et al., 1999). Due to the robustness of the model system 
Saccharomyces cerevisiae, it was simple to probe for clathrin independence of the AP-3 
pathway in yeast. A clathrin deletion mutant is viable in S. cerevisiae and studies of 
Seeger and Payne (Seeger and Payne, 1992) showed that alkaline phosphatase (ALP), the 
product of the PHO8 gene, was transported to the vacuole unlike other biosynthetic cargo 
with wild type kinetics in cells lacking a functional clathrin heavy chain. In several 
following studies, the class B VPS protein Vps41 was identified as a required factor for a 
Figure 1.7 | Possible mode of function of the AP-3 pathway. 
At the late Golgi, proteins harboring specific di-leucine(-like) 
targeting motifs are recognized by the AP-3 adaptor complex. 
The HOPS subunit Vps41 binds to the AP-3 via its N-terminus 
and was proposed to fulfill a coat-like function. Figure from 
Rehling et al., 1999. 
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functional AP-3 pathway in general (Cowles et al., 1997b) and, more specifically, by 
directly interacting with the AP-3 subunit Apl5 at the level of vesicle formation (Darsow 
et al., 2001; Rehling et al., 1999) (Fig. 1.7). Interestingly, Vps41 was also identified as a 
subunit of the hexameric HOPS tethering complex at the vacuole (Cowles et al., 1997b; 
Nakamura et al., 1997; Price et al., 2000a; Price et al., 2000b; Seals et al., 2000).  
Compared to the generic CPY-pathway from the TGN to the vacuole, which 
utilizes AP-1 vesicles, few proteins have yet been identified as AP-3 cargo. The vacuolar 
transmembrane phosphatase ALP, the vacuolar SNAREs Vam3 and Nyv1 as well as the 
C-terminally palmitoylated Casein Kinase 3 Yck3 are transported directly from the TGN 
to the vacuole without passing the endosomal compartment. ALP harbors a dileucine-like 
LV motif as a recognition signal for the AP-3 complex (Vowels and Payne, 1998), 
whereas Vam3 contains a classical dileucine motif (Darsow et al., 1998). Nyv1 is sorted 
via the AP-3 pathway in dependence of an YXX?-like motif in its longin-domain (Wen 
et al., 2006) and Yck3 was the first yeast cargo protein identified to contain a classical 
YXX?-motif (Sun et al., 2004). 
1.2.2 Vesicle targeting 
For transport of budded vesicles 
from the donor to the target 
compartment, motor-protein 
driven movement along actin 
filaments or microtubules is 
typically employed. In the case of 
actin filament based transport, 
myosin proteins serve as motors 
whereas dyneins and kinesins are 
associated with movement on 
microtubules (Pruyne et al., 1998; 
Ross et al., 2008). These motor 
proteins connect to vesicles and 
compartments by interacting with 
Rab GTPases, a class of proteins 
Figure 1.8 | Distribution of different fibers and modes of 
vesicle transport in the cell. Actin-dependent motor proteins 
aid in peripheral transport events e.g. after endocytosis. 
Vesicles can then be handed over to microtubule-dependent 
motor proteins. Figure adapted from Ross et al., 2008. 
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that is as well involved in the tethering process upstream of membrane fusion (Hammer 
and Wu, 2002; Matanis et al., 2002; Schott et al., 1999). A switch between the associated 
kind of fiber and, consequently, the motor protein has been observed for example for 
endocytic vesicles that initially employ the cortical actin cytoskeleton during and shortly 
after endocytosis. For transport away from the cell cortex into the interior of the cell, 
myosin has to be exchanged for dynein so that movement along the centrically organized 
microtubules can occur (Fig. 1.8). How such exchanges are organized and which factors 
define, which motor protein dominantly acts on vesicles that harbor several different 
motor protein binding sites, remains to be elucidated. It is currently under debate if 
transport along cytoskeletal structures is a highly coordinated process or if a constant “tug 
of war” between different motor proteins is taking place (Ross et al., 2008).  
1.2.3 Membrane Tethering 
The transport of vesicles along the cytoskeleton is a process needed for targeting to the 
appropriate region inside the cell. However, before a subsequent fusion event with the 
correct target compartment can occur, the membranes destined for fusion have to 
specifically recognize each other. This step is critical to maintain organelle identity and 
therefore cellular homeostasis. It has been postulated in the past that SNARE proteins, 
which constitute the core machinery in intracellular membrane fusion, confer membrane 
specificity, but more recent work revealed that other factors are needed for this process 
upstream of SNARE function. Tethering of organelles, i.e. the reversible binding of 
matching membrane surfaces, appears to depend on the action of small Rab GTPases and 
tethering factors. For both of these groups of fusion factors, an increasing number has 
been identified in the past and I will present data in this study that allowed for the 
identification of a novel tethering complex a the endosome (see section 3.3). The 
diversity of Rab GTPases and tethering factors in eukaryotic cells allows for each 
organelle to harbor its individual set of these fusion factors, thereby mediating specificity 
in intracellular fusion events. In section 1.3, I will provide a detailed overview about 
tethering factors and Rab GTPases. 
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1.2.4 Membrane Fusion 
The fusion of lipid bilayers in an aqueous environment is generally a thermodynamically 
unfavored process (Chernomordik and Kozlov, 2003). Although the rate of fusion of 
artificially produced liposomes can be increased chemically, the observed fusion rates are 
usually both kinetically and quantitatively low and do not compare to the speed and 
number of intracellular lipid bilayer fusion events. Taking into account the high density 
of transmembrane and membrane associated proteins, it becomes evident that fusion of 
intracellular compartments must rely on the concerted action of a highly organized 
protein machinery. Compartments destined for fusion need to be specifically brought into 
and retained in close proximity. For bilayer fusion to occur, apposing membranes have to 
be pulled together and eventually strongly deformed so that first the outer lipid layers can 
merge into a fusion stalk which is subsequently leading to a state called “hemifusion” 
(Fig. 1.9) (Chernomordik and Kozlov, 2003). It is now generally accepted that SNARE 
protein complex assembly is the minimal requirement for intracellular membrane bilayer 
fusion and I will discuss this process in more detail in section 1.5. 
Several different physical models for the fusion of two membranes exist, and not all favor 
the existence of a hemifusion state. However, for vacuoles derived from S. cerevisiae this 
intermediate state of lipid bilayer fusion can be observed in vitro, if fusion speed is 
sufficiently reduced (Reese et al., 2005). Under physiological conditions, subsequent 
fusion of the second lipid layer is presumably taking place immediately after hemifusion. 
It is still under debate if this process requires additional downstream factors (Reese et al., 
2005) or rather depends on the ability of SNARE transmembrane domains to self-interact 
Figure 1.9 | Stages of lipid bilayer fusion. After first contact is established, a membrane protrusion helps 
minimizing the inter-membrane repulsion caused by the aqueous environment. After  formation of a fusion 
stalk, the site of hemifusion can expand to a hemifusion diaphragm and subsequently to the formation of a 
fusion pore. Figure adapted from Chernomordik and Kozlov, 2008. 
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and oligomerize (Hofmann et al., 2006). However, fusion of artificial liposomes 
harboring SNAREs on their surface have been shown to be fusion competent, although 
efficiency and speed of fusion do not compare to biological systems (Nickel et al., 1999; 
Weber et al., 1998). 
1.3 The Tethering machinery 
1.3.1 Rab GTPases 
Rab proteins are small monomeric GTPases that belong to the Ras superfamily. In yeast, 
eleven members of the Rab family have been identified, whereas multicellular organisms 
harbor a higher number of different Rabs, and many of these are believed to function in a 
tissue-specific manner (Fukuda, 2008). Most of the members of the Ras superfamily, like 
Rho, Ran or Sar/Arf GTPases, appear to be key regulators in a variety of intracellular 
events like cell morphogenesis and cytokinesis, nuclear transport, and vesicle formation. 
Rab proteins have been identified to regulate membrane trafficking and, more 
specifically, intracellular membrane fusion events. Like other GTPases, Rab proteins 
function as molecular switches. This is achieved by cycling between an active and 
inactive state, which are defined by the nucleotide that is bound to the protein. It is the 
nucleotide state, which also defines the localization of the Rab protein. Membrane 
anchoring is achieved by a double geranylgeranylation at the C-terminus, a modification, 
which is carried out by a cytosolic geranylgeranyltransferase. Rab escort proteins (REPs) 
bind to yet unprenylated Rab proteins, present them to the modifying enzyme and aid in 
the membrane targeting after geranylgeranylation has occurred. Next to REPs that are 
involved during the biogenesis of Rab GTPases, another kind of Rab binding protein has 
been described, the guanine nucleotide dissociation inhibitors (GDI) (Pfeffer et al., 1995; 
Takai et al., 1992). In yeast, only one Rab-GDI (Gdi1) has been identified (Garrett et al., 
1994). Due to the strong hydrophobicity of the geranylgeranyl moiety, Rabs themselves 
are unable to leave the membrane. GDI only binds to the inactive, GDP-bound form of 
the Rab protein and at the same time mask its prenyl anchor, therefore allowing the 
protein to dissociate into the cytosol (Fig. 1.10). To prevent random re-association of 
Rabs onto membranes, they are believed to be recruited by GDI-displacement factors 
(GDFs) (Behnia and Munro, 2005). However, until today only one example of a protein 
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harboring GDF activity has been described (Sivars et al., 2003) and it is currently under 
debate, if this activity is not possibly mediated by another group of Rab interactors, the 
guanyl nucleotide exchange factors (GEFs). GEF activity was described for a number of 
unrelated proteins and it seems that several different approaches for this intermolecular 
activity have developed during evolution (Bos et al., 2007). This fact strongly 
complicates the search for yet unidentified GEFs, or a clear characterization due to 
sequence or even structural similarities. GEFs specifically recognize Rab proteins and 
alter the nucleotide-binding pocket, thereby facilitating the removal of the bound 
nucleotide. As the next step, the GTPase is loaded again with guanly nucleotide due to its 
high affinity for this compound. Interestingly, both GDP and GTP are believed to bind 
equally well to the unloaded Rab and it is only the about ten-fold higher concentration of 
GTP in the cell which leads to an activation in the majority of nucleotide exchange 
reactions (Vetter and Wittinghofer, 2001). The GTP-bound Rab is in its active state and 
remains bound to its specific compartment until GTP hydrolysis occurs, rendering the 
protein a target for the GDI. The binding of GTP to the Rab protein leads to a 
conformational change of the protein, where the two switch domains are bend at flexible 
hinge regions due to charge-interactions with the ?-phosphate group of the GTP (Vetter 
and Wittinghofer, 2001). It is this activated conformation that is recognized by the Rab 
GTPase effector proteins, which are typically tethering factors or part of a tethering 
Figure 1.10 | Rabs cycle dynamically between cytosol and target membrane. The GDP-bound, inactive 
Rab protein is extracted from membranes by action of GDI, which binds the Rab and shields the prenyl 
anchor. GDFs are believed to recruit Rab proteins from the Rab-GDI complex and favor membrane 
association. Nucleotide exchange occurs with the help of a GEF and the GTP-bound Rab can then bind its 
effector. GTP hydrolysis is stimulated by a GAP, leading to a GDP-bound, inactive Rab. Adapted from 
Behnia and Munro, 2005. 
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complex that mediate the signaling of the active Rab protein to the downstream event of 
tethering (Fig. 1.10) (Behnia and Munro, 2005).  
Since Rab proteins are comparably inefficient GTP hydrolyzing enzymes, they 
can stay in the GTP-bound, activated state for a long time. However, their intrinsic 
GTPase activity can be enhanced manifold by GTPase activating proteins (GAPs). These 
proteins complement the enzymatic active site of the Rab proteins. It has been reported 
that a Rab GAP contributes a glutamine residue, which orients the water molecule, which 
is needed for the hydrolysis reaction, whereas an arginine residue stabilizes the transition 
state by neutralizing negative charge at the ?-phosphate (Bos et al., 2007).  
Compared to the protein classes of GEFs, GAPs and Rab effector proteins, GDFs 
are yet poorly characterized, in fact only one GDF has been identified in yeast (Sivars et 
al., 2003). It is puzzling, why it should be so difficult to identify a protein with a 
relatively clear expected phenotype for example upon deletion. If GDFs act specifically, a 
knockout should lead to a mis-localization of the total pool of affected Rab to the cytosol, 
since the protein could not be recovered from there after it was inactivated and extracted 
from the membrane by GDI (compare Fig. 1.10). Recently, Ralph Isberg and co-workers 
showed that the SidM protein of the intracellular pathogen Legionella pneumophila can 
act both as a GDF as well as a GEF protein for the human Rab1 protein (Machner and 
Isberg, 2007). In infected cells, it is efficiently recruited to the pathogen-containing 
replication vacuole by the SidM protein, which thereby allows the pathogen to hijack the 
intracellular trafficking machinery. Although SidM is a bacterial protein not involved in 
intrinsic trafficking events, it could serve as an example, which tells us that efficient 
localization and activation of a Rab protein mediated by a single factor is a functional 
approach. Hence, it appears likely that GEF proteins might as well act as GDFs therefore 
linking membrane recruitment to an immediate activation of the respective Rab protein. 
In this concept, Rab localization efficiency is increased due to a decreased risk of 
repeated membrane dissociation. Moreover, the specific recruitment of only one Rab 
protein to a defined compartment would in such a case only depend on one other factor 
that would have to localize independently. 
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1.3.2 Tethering Factors 
The general mechanism of intracellular membrane tethering is defined by a process of 
reversible binding of apposite compartments destined for fusion, which involves tethering 
factors and in most cases members of the Rab GTPase family. Tethering occurs prior to 
the docking step, when trans-SNARE complexes start forming. In fact, tethering appears 
to be a prerequisite for efficient docking and proteins involved in tethering have been 
shown to bind SNAREs and are believed to facilitate binding of cognate SNAREs 
(Whyte and Munro, 2002).  
To complicate matters, tethering events at different compartments were reported 
to involve a set of similarly functioning proteins such as Rabs, GEFs, and tethers, but the 
order of events and the precise functioning of these factors appear to substantially differ 
between organelles. In general, two classes of tethering factors have been described: long 
coiled-coil single polypeptide tethers that can form homodimers and large multi-subunit 
protein complexes. Among the first group are the early endosomal antigen 1 (EEA1) and 
p115 in mammalian cells and Uso1, a p115 homolog in yeast. EEA1 is implicated in 
homotypic tethering between early endosomes or endocytic vesicles. The C-terminal part 
of EEA1 contains a FYVE domain, which binds to phosphatidylinositol-3-posphate 
(PI(3)P) in the endosomal membrane bilayer. The rod-shaped homodimer sticks out into 
the cytosol and presents its N-terminus, which is able to specifically recognize and bind 
the endosomal Rab5, the mammalian Vps21 homolog.  
The second class of tethering factors, the multi-subunit protein complexes, is 
characterized by a high degree of diversity among its members. It has to be noted, though, 
that all of the tethering complexes described here share a substantial conservation 
between species and some have been characterized in parallel for the mammalian system 
as well as in yeast. Other than for SNAREs and Rab proteins, most of these different 
complexes do not appear to be closely related, although some share similarity on a level 
of secondary structure (Whyte and Munro, 2002), implying a convergent development 
rather than a common ancestor (Koumandou et al., 2007). However, most tethering 
complexes were shown to interact with SNAREs and a specific Rab GTPase, either as a 
GEF, an effector or both (Kümmel and Heinemann, 2008; Whyte and Munro, 2002). The 
COG complex is needed for tethering events at the Golgi, the GARP complex acts in 
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endosome-Golgi transport, the TRAPP complexes are required for the biogenesis of the 
Golgi, the exocyst tethers vesicles destined for exocytosis, and the HOPS complex 
operates in the late endocytic pathway together with the novel CORVET complex and 
during homotypic vacuole fusion (Fig. 1.11). The Dsl-complex, which functions between 
the Golgi and the ER, is the only tethering complex described so far that is lacking a Rab 
binding partner. Interestingly, the Dsl complex consists of only three subunits, a small 
number compared to most other tethering complexes, and appears to interact notably tight 
with SNARE proteins, which might confer membrane specificity in this one special case 
Figure 1.11 | Rabs and tethering factors in eukaryotic cells. Yeast Rab GTPase homologs are in italics. 
See figure legend for further details. Figure adapted from Markgraf et al., 2007. 
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(Tripathi et al., 2009). In the following sections, I will present an overview of selected 
tethering complexes and their proposed mode of function. 
1.3.2.1 The TRAPP complexes 
Two of the best-characterized complexes involved in intracellular membrane tethering are 
the transport protein particle (TRAPP) complexes. Ten TRAPP subunits have been 
identified in yeast and the six smallest (Bet3, Bet5, Trs20, Trs23, Trs31 and Trs33) and 
one additional subunit of higher molecular weight (Trs85) form the TRAPP I complex, 
which has a role in ER to Golgi transport. Three additional subunits (Trs120, trs130 and 
Trs65) are added to TRAPP I to form the TRAPP II complex that is involved in 
trafficking at the later Golgi compartments (Sacher et al., 2008). Several studies dealing 
with the structural characterization of theses complexes yielded a very detailed picture of 
the subunits’ assembly (Fig. 1.12) (Cai et al., 2008; Kim et al., 2006; Sacher et al., 2008). 
It appears that the core subunits of both TRAPP I and II form an elongated, rod-shaped 
structure (Fig. 1.12 B) (Kim et al., 2006). However, the functioning of the two complexes 
Figure 1.12 | Architecture and structure of the TRAPP I complex. Interactions between different 
subunits are depicted in A. Note that Ypt1 GEF activity relies on the assembly of four subunits. EM 
analysis of the yeast TRAPP I complex reveals its rod-shaped structure B, upper panel. Overlay of 
the crystal structure of human TRAPP subunits on the yeast TRAPP I EM structure B, lower panel. 
Sedlin is the mammalian ortholog of yeast Trs20. Figure adapted from Kim et al., 2006. 
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remains controversial. TRAPP I and II have been reported to harbor several interaction 
sites. The assembled TRAPP I complex was reported to exhibit GEF activity towards the 
Rab Ypt1. Interestingly, the active site is composed of the four TRAPP subunits, which 
are essential for cell viability (Fig. 1.12 A) (Kim et al., 2006). It appears straightforward 
that TRAPP II, which harbors the same four subunits, also acts as a Ypt1 GEF and this 
activity has been recently reported by the group of Susan Ferro-Novick (Cai et al., 2008). 
Nevertheless, these findings are in contrast to a previous study (Morozova et al., 2006), 
which reported on a switch of specificities of the GEF region in the complexes from Ypt1 
to the Rabs Ypt31 and Ypt32, which act at later Golgi compartments, upon binding of the 
TRAPP II specific subunits. How these differing results can be explained remains 
controversial and before this specific question is addressed in an independent study, 
clarity will most likely not be achieved. An alternative explanation for the functioning of 
the three additional subunits in TRAPP II was proposed in the same study that found 
Ypt1 GEF activity in both complexes. TRAPP I and II had already been described to 
specifically bind to COPII and COPI vesicles via Sec23 and an unknown coat subunit, 
respectively (Cai et al., 2007b; Cai et al., 2005; Sacher et al., 2001). It was therefore 
proposed that transformation of TRAPP I to II does not alter its GEF specificity, but 
changes the mode of interaction with transport vesicles from COPII tethering at the early 
Golgi to COPI tethering at the intermediate and late Golgi. The functioning of the 
TRAPP I complex as tethering complex was proposed to be cooperating with the Golgi 
specific long tether and Ypt1 effector Uso1/p115, which is supposed to act as a long-
range tether. After binding to the Ypt1-GTP positive vesicle, inactivation of Ypt1 could 
occur, leading to a conformational change in Uso1/p115, thereby bringing vesicles into 
closer proximity to the TRAPP complexes that then serve as GEFs for Ypt1 and re-
activate the Rab, which initiates downstream events (maybe involving the COG complex, 
see below) that subsequently lead to fusion (Kim et al., 2006). However, no Ypt1 GEF 
acting upstream of TRAPP I was identified yet, a fact that is challenging this model. 
Clear biochemical evidence for such a two-step tethering event is largely missing, but it 
has been implicated in other studies of Golgi resident tethering factors (see below) 
As pointed out above, solving a tethering complex’s molecular structure can yield 
intriguing insights into its functionality, but cannot answer all the questions. In the case 
of the TRAPP complexes, which are examples for well-characterized complexes, it 
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becomes apparent that we are far from understanding the process of tethering to detail 
and that new questions arise with every new finding. 
1.3.2.2 The COG complex 
Next to the TRAPP complexes, a hetero-oligomeric complex composed of eight subunits 
has been identified to function at the Golgi apparatus with no preference for the cis- or 
trans- compartments. The conserved oligomeric Golgi (COG) complex is an effector of 
Ypt1-GTP, therefore functionally linking it to the Ypt1-GEF activity of the TRAPP 
complexes. It appears that the COG 
complex is specifically regulating 
intra-Golgi transport for example of 
Golgi-resident, intraluminal 
enzymes, since glycosylation of 
proteins is affected in COG mutants, 
but neither transport through the 
secretory pathway nor endocytic 
cycling of cargo appear to be 
profoundly disrupted (Ungar et al., 
2002). Indeed, genetic interactions 
between COG subunits and coat 
proteins of COPI vesicles, which are 
the main retrograde transport carriers 
at the Golgi, have been reported 
(Kim et al., 2001; Ram et al., 2002). 
Moreover, the COG complex appears to interact with some but not all of the SNAREs 
implicated in trafficking to or from the cis-Golgi (Suvorova et al., 2002). In contrast to 
the TRAPP complexes, no GEF activity has been reported on COG subunits. It therefore 
appears likely that the Golgi-resident TRAPP complexes serve as Ypt1 GEFs thereby 
producing the activated Rab pool, which is then interacting with the COG tethering 
complex as their effector. Interestingly, also the COG complex has been found to interact 
with the COPI coat and with Golgi SNARE proteins, similar to the TRAPP complexes 
(compare section 1.3.2.1) (Suvorova et al., 2002). Therefore, it was suggested by 
Vladimir Lupashin and co-workers that the COG complex might have an additional 
Figure 1.13 | Structure of the COG complex. EM 
analysis of purified and fixed COG complex A The two-
lobed structure observed in A reflects the findings about 
the subunits’ interactions depicted in B. Figure adapted 
from Ungar et al., 2006. 
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function during vesicle formation, a model that has been also developed for the GARP 
complex, which will be presented in the next section. 
 The COG complex has been structurally characterized by electron microscopy 
(Fig. 1.13) The complex harbors two connected lobes, a structure that is strikingly 
different to the structure of the TRAPP core complex that was outlined above (Kim et al., 
2006; Ungar et al., 2002). 
1.3.2.3 The GARP complex 
The Golgi associated retrograde protein (GARP)/VFT (Vps fifty three) complex is 
composed of four proteins (Vps51, Vps52, Vps53 and Vps54) and three of these were 
initially identified as Class B proteins in a VPS-screen for defective vacuole protein 
sorting (Conibear and Stevens, 2000). Deletion of single or several subunits yields the 
same phenotype with inefficient CPY-pathway transport and missorting of Golgi resident 
proteins to the vacuole, consistent with the complex’ functioning in retrieval of Golgi 
resident proteins from endosomes (Conibear and Stevens, 2000). Furthermore, the 
complex interacts with the GTP-form of the late Golgi Rab Ypt6/Rab6 and the SNARE 
Tlg1 that has also been implicated in this trafficking step (Conibear et al., 2003; 
Siniossoglou and Pelham, 2001; Siniossoglou and Pelham, 2002). The Ypt6 GEF 
heterodimer Ric1-Rgp1 appears to act independently of the GARP complex 
(Siniossoglou et al., 2000). Interestingly, the interaction with the SNARE Tlg1 depends 
on the smallest subunit of the complex (Vps51), which is not essential for assembly of the 
rest of the subunits (Fig. 1.14 A) (Siniossoglou and Pelham, 2002). Since the Ypt6 
binding site is located in a different subunit (Vps52) that is part of the core complex, 
Pelham and co-workers suggest that Vps51 alone could bind to Tlg1 on recycling vesicles 
and that tethering is mediated by its interaction with the trans-Golgi resident GARP core 
complex (or the other way around, as implicated by Tom Stevens and co-workers, as in 
Fig. 1.14 A) and subsequent assembly into the full complex (Conibear et al., 2003; 
Siniossoglou and Pelham, 2002). A more recent study supports the idea of GARP subunit 
binding to endosomal structures upstream of the trans-Golgi, but suggests a different 
mode of action. Elizabeth Conibear and co-workers could show that a C-terminal domain 
of the core subunit Vps54 mediates localization to the early endosome and their results 
suggest that Vps54 is involved in the formation of retrograde vesicles at this compartment 
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(Fig. 1.14 B). The deletion of this region (Vps54-N, see Fig. 1.14 B II.) did not impair 
overall complex assembly and yielded no obvious effect on retrograde transport from late 
endosomes, but had an effect as soon as functioning of the retromer was impaired, a 
protein complex that is needed for late endosomal retrieval pathways (Quenneville et al., 
2006). The group proposes a model in which the GARP complex is recruited to 
retrograde vesicles at the site of their formation and even plays a role in cargo sorting or 
vesicle budding. This hypothesis is substantiated by a study from Howard Riezman and 
colleagues, who have previously shown that COG complex subunits not only interact 
with the COPI coat but seem to be needed for proper cargo sorting at the site of vesicle 
formation at the ER (Morsomme and Riezman, 2002). In both of these studies, single 
subunits of tethering complexes have been shown to interact with factors involved in 
vesicle formation. Therefore, Conibear argues that this is clear evidence that vesicles 
destined for a specific organelle do not only need Rab GTPases as tethering effectors on 
Figure 1.14 | Two models of GARP functioning in endosome-Golgi tethering. A The Tlg1-
binding subunit Vps51 could independently localize and assemble into the GARP complex at site of 
tethering with the preassembled core complex. B I Alternatively, fully assembled GARP complex is 
needed on both membranes for proper tethering. B I. and II. GARP seems to harbor two distinct 
interaction sites for early and late endosomal retrograde vesicles. Figures adapted from Conibear et 
al., 2003; and Quenneville et al., 2006. 
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their membrane but also need to harbor the corresponding tethering complex, to allow for 
a homotypic tethering event between vesicle and target compartment. This intriguing 
hypothesis could explain why several tethering complex’s subunits have been described 
to interact with coat proteins although it is believed that coat disassembly efficiently 
occurs prior to tethering, making it unlikely that this interaction plays a role directly 
during tethering. However, the data leave enough space for the alternative hypothesis of 
tethering complex assembly during tethering as proposed by Hugh Pelham for the GARP 
complex and as has been observed in the case of the exocyst complex (see next section). 
1.3.2.4 The exocyst complex 
The majority of subunits of the exocyst complex has been identified in a screen for 
temperature sensitive mutants that fail to secret proteins (TerBush et al., 1996). The fully 
assembled complex consists of eight subunits, which appear to be conserved from yeast 
to man, a typical feature of tethering complexes. The exocyst is mainly found at the 
plasma membrane, at sites of pronounced exocytosis for example the bud tip in S. 
cerevisiae due to expansion of the cell wall. Consequently, several studies in other model 
systems also imply a functioning of the exocyst in membrane and protein retrieval from 
recycling endosomes and in cytokinesis, where secretion is enhanced at the midbody 
(Gromley et al., 2005; Prigent, 2003). Interestingly, members of the exocyst have been 
observed to reach the site of exocytosis via different routes and assemble into the full 
complex during exocytic vesicle tethering (Boyd et al., 2004; Finger et al., 1998). Two 
subunits (Sec3 and Exo70) appear to be directly recruited to sites of exocytosis by the 
Cdc42, Rho1, and Rho3 GTPases, which are regulators of cell polarity (Fig. 1.15 A). The 
six other subunits are attached to exocytic vesicles, which are targeted via Actin cables to 
the plasma membrane (Boyd et al., 2004; Finger et al., 1998). This model was challenged 
by a recent study, which doubts that Sec3 is localized independent of exocytic vesicles, 
based on immunofluorescence experiments compared to GFP-tagged proteins in the 
original work (Finger et al., 1998; Roumanie et al., 2005). However, the idea of a spatial 
landmark for exocytic vesicles at the plasma membrane made of Sec3 and Exo70 
remained widely accepted. Furthermore, the exocyst subunit Sec6 appears to interact with 
the plasma membrane SNARE Sec9, another common feature among tethering 
complexes (Sivaram et al., 2005). The interaction of a subset of exocyst subunits with 
Rho-GTPases is a rather unique characteristic, but it is apparent that tethering of vesicles, 
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which act in a number of cell cycle 
dependent, spatially restricted 
processes, has to be controlled by 
GTPases that connect to these layers 
of intracellular controlling.  
 The membrane recruitment 
of the vesicular exocyst subcomplex 
has also been studied to some 
extent. Data from the lab of Peter 
Novick showed that the exocyst 
recruiting Rab GTPase Sec4 is 
activated by a protein (Sec2) (Fig. 
1.15 A), which is recruited to 
membranes by interacting with the 
trans-Golgi resident, activated form 
of the Rab Ypt32 (Ortiz et al., 2002) 
(compare section 1.3.2.1). The 
authors of that study therefore 
suggest that it might be a common 
theme that such Rab cascades 
determine functioning and 
directionality of intracellular 
trafficking events (Markgraf et al., 
2007). Further evidence for this 
mechanism was provided more 
recently by a study in which 
interaction of Sec2 with the exocyst 
subunit Sec15, the direct Sec2-GTP 
effector was shown to disrupt Ypt32-Sec2 interactions after recruitment of Sec15 by 
activated Sec4 (Medkova et al., 2006). However, whether the GEF activity of Sec2 was 
altered subsequently of Sec15/exocyst binding, was not assessed. Taken together, the 
exocyst is recruited by a Rab after its activation by a transiently interacting GEF, which 
gets initially recruited by an upstream Rab GTPase, an intriguing mechanism that 
Figure 1.15 | The Exocyst tethering complex assembles 
at sites of secretion. A Sec3 and to some part, Exo70 are 
believed to localize to sites of exocytosis due to Rho-
GTPase binding, whereas the other subunits preassemble 
and travel via exocytic vesicles before complex assembly 
occurs during tethering. B EM analysis of assembled and 
fixed exocyst complex (right) and model of interactions 
during complex assembly (left). Note that the subunits are 
believed to form rod-shaped structures. Figure adapted 
from Munson and Novick, 2006. 
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elegantly includes the proposed upstream activity of the TRAPP II complex (compare 
section 1.3.2.1).  
 The exocyst is structurally characterized to some extent (Fig. 1.15 B). EM studies 
revealed a rod shaped structure with two juxtaposed extensions that are believed to 
represent the GTPase binding sites. The crystal structure of some exocyst subunits was 
solved and it appears that they predominantly form elongated ?-helical bundle structures, 
which were proposed to pack against one another along their length to form a structure 
that could fit the EM data (Munson and Novick, 2006).  
1.3.2.5 The HOPS tethering complex
*
 
Tethering events at the vacuole/lysosome are mediated by the C-Vps/HOPS (homotypic 
fusion and vacuole protein sorting) protein complex, which is well conserved among 
species. In yeast, this complex consists of six subunits ranging from 79 to 123 kDa in 
size. Four of its subunits belong to the class C gene family, which result in the most 
fragmented vacuole phenotype if deleted Raymond, 1992 p03219; Robinson, 1991 
p04163; Preston, 1992 p04164}, whereas the two additional subunits, Vps41/Vam2 and 
Vps39/Vam6, are class B genes (Fig. 1.16) (Nakamura et al., 1997). The HOPS complex 
was characterized as a 700 kDa hetero-oligomeric complex that binds the vacuolar Rab 
GTPase Ypt7 in its GTP form (Peplowska et al., 2007; Seals et al., 2000; Wurmser et al., 
2000), this study.  
All six HOPS proteins have been characterized in some detail, even though their 
precise function still needs further clarification. Vps11/Pep5 and Vps18/Pep3 both 
contain C-terminal RING-H2 domains. Mutations in the RING domain of Vps18 lead to 
vacuole fragmentation and missorting of proteins to the vacuole (Rieder and Emr, 1997), 
indicating an essential role of these domains in complex assembly or protein function. 
RING domains are present in ubiquitin ligase proteins, and the mammalian Vps18 protein 
has indeed been shown to promote ubiquitination (Yogosawa et al., 2006). In contrast to 
the tethering complexes introduced above, the HOPS complex harbors a subunit that 
belongs to the Sec1/Munc18 (SM)-protein family (Vps33). Members of this protein 
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family bind SNAREs and are believed to act as chaperones for unassembled SNAREs 
and to promote efficient trans-SNARE-complex assembly (Dulubova et al., 2003; Rizo 
and Südhof, 2002; Scott et al., 2004; Shen et al., 2007). Indeed, a recent study from the 
group of Bill Wickner provided evidence for a SNARE-complex proofreading function of 
the HOPS complex (Starai et al., 2008). They observed that SNARE complexes including 
mutated SNAREs led to fusion in the in vitro vacuole fusion assay, but were blocked 
upon HOPS addition. Interestingly, this observation was only observed if complete HOPS 
was added and not in the case of Vps33 addition (Starai et al., 2008). Moreover, Vps33 
contains an ATP binding site (Banta et al., 1990; Gerhardt et al., 1998). The subunit 
Vps16 remains the least characterized HOPS subunit, lacking clearly characterized 
motifs.  
The Class B protein Vps41 has several N-terminal WD-40 domains, which are 
most likely part of a large ?-propeller structure (Fig. 1.16) (McMahon and Mills, 2004). 
In addition to its role in vacuole fusion, the protein is required for the formation of AP-3 
vesicles at the late Golgi (compare section 1.2.1.2). In this context, Vps41 has been 
discussed as a coat protein because specific mutants abolish AP-3 vesicle generation, a 
feature that was also observed for other tethering complexes’ subunits (compare sections 
1.3.2.1, 1.3.2.2 and 1.3.2.3) (Darsow et al., 2001; Rehling et al., 1999). The other Class B 
Figure 1.16 | Schematic overview of the HOPS/CORVET complex subunits. Note the similarity of 
secondary structure arrangement, despite very limited sequence similarity. Depicted domains were identified 
using the SMART sequence analysis tool (http://smart.embl-heidelberg.de/). The Class D genes Vps3 and 
Vps8 are subunits of the homologous CORVET tethering complex, which was identified in this thesis’ work 
and are depicted for comparison. 
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subunit Vam6 was shown to exhibit guanyl-nucleotide exchange factor activity (GEF) for 
Ypt7 (Wurmser et al., 2000). Interestingly, all HOPS subunits (with the exception of 
Vps33) seem to share a common domain structure with the N-terminus being rich in ?-
sheets and a predominantly ?-helical C-terminus, consistent with the idea of a common 
ancestor or convergent evolution (Koumandou et al., 2007). Furthermore, Vps41 and 
Vps18 share a limited sequence similarity with the clathrin heavy chain and are harboring 
a CLH (clathrin heavy chain repeat homology) domain inside their ?-helical C-terminal 
region. This repeat was shown to mediate interactions between clathrin heavy chains 
during coat assembly (Ybe et al., 1999). In silico analysis revealed that although sequence 
similarity of the HOPS subunits is low, it appears likely that all of them (despite Vps33) 
share an N-terminal ?-propeller and an adjacent ?-solenoid structure (Fig. 1.16) 
(http://bioinf.cs.ucl.ac.uk/psipred/). This kind of arrangement of ?-sheets and ?-helices 
has also been observed for protein coats like clathrin, COPI and II, and nuclear pore 
complex proteins (Devos et al., 2004). 
The mechanism of HOPS function on vacuoles is not resolved. Based on the GEF 
activity of Vam6, it was believed that HOPS activates Ypt7 at the vacuole and binds to it 
in the GTP-bound form, a model that is challenged by data from this study (see section 
3.5). Indeed, binding of HOPS to the membrane is reduced in the absence of Ypt7 (Price 
et al., 2000a), but it has not been tested whether the identified affinity of HOPS for 
phospholipids (Stroupe et al., 2006) accounts for the residual association of HOPS with 
vacuoles. Potentially, it is a combination of several interactions, including its binding to 
SNAREs (Dulubova et al., 2001; Laage and Ungermann, 2001; Sato et al., 2000; Stroupe 
et al., 2006). HOPS is thought to act as a tether, which spans the distance between 
vesicles and the vacuole or two vacuoles during homotypic fusion. During this event, first 
contact between vacuoles seems to be reversible (Ungermann et al., 1998b). Because 
Ypt7 appears to be required on both vacuoles (Mayer and Wickner, 1997), and HOPS 
binds to Ypt7-GTP (Seals et al., 2000), tethering could occur by transient dimerization of 
HOPS. It is also possible that HOPS is binding asymmetrically to SNAREs and Ypt7, and 
the symmetric requirement of Ypt7 would not be exclusively related to HOPS function. 
In a recent study from the Wickner lab, it was shown, that high concentration of SNAREs 
due to overproduction on the vacuolar membrane can circumvent the need for Ypt7 
(Starai et al., 2007). The authors conclude that the Rab might have a regulatory role by 
enriching SNAREs, HOPS and regulatory lipids at the site of fusion, the so-called vertex-
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enrichment. It should be noted that it was shown previously that HOPS, SNAREs and 
Ypt7 accumulate in an interdependent manner at the vacuole docking site (or the vertex 
ring) (Wang et al., 2003b), indicating a strong crosstalk among, and potentially, 
multimerization of, these proteins. However, like for in vitro fusion of liposomes, which 
are bearing only SNARE proteins on their surface, the presented system of overproduced 
SNAREs only provides another evidence that these proteins constitute the core fusion 
machinery and that Rabs and tethering complexes are needed to mediate specificity and 
increase efficiency of the fusion reaction.  
Regulation of the HOPS complex function occurs on several levels. During the 
fusion reaction, HOPS is released from vacuoles (Price et al., 2000a), which might 
explain the ATP-dependent dynamics of Vps33 observed in vivo and in vitro (Gerhardt et 
al., 1998). Moreover, the membrane association of the HOPS complex is regulated by the 
vacuolar casein kinase Yck3 (LaGrassa and Ungermann, 2005). Yck3 phosphorylates the 
HOPS subunit Vps41 on the vacuolar membrane, which attenuates fusion in wild type 
conditions. Yck3 knockout leads to a strong accumulation of Vps41 at vacuole contact 
sites, whereas overexpression of the kinase strongly reduces fusion and these phenotypes 
can now be recapitulated using Vps41 mutants (Cabrera et al., 2009), this study. The data 
obtained in these studies allowed further characterization of the mode of function of 
Vps41 phosphorylation and yielded intriguing insights into a possibly general scheme of 
controlling membrane localization of factors not only involved in membrane tethering 
(see section 3.1). 
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1.4 The yeast vacuole as a model system for intracellular 
membrane fusion
*
 
Analysis of vacuole fusion was greatly facilitated by the invention of an in vitro fusion 
assay (Conradt et al., 1992; Haas et al., 1994). For this assay, vacuoles from two yeast 
strains with a different genetic background are employed. One of these strains lacks the 
major phosphatase Pho8, which usually serves as a degradative enzyme cleaving 
phosphoester bonds in the lumen of the vacuole. The other strain lacks the major vacuolar 
protease Pep4, which is needed for the activation of other hydrolases, including Pho8; it 
therefore accumulates inactive pro?Pho8. Upon mixing of the vacuoles purified from the 
two strains in a fusion reaction, the vacuoles fuse, and Pep4 removes the pro-peptide 
from Pho8. Fusion activity can then be measured using p?nitrophenylphosphate as a 
Pho8 substrate, which becomes yellow upon dephosphorylation. Thus, the amount of 
generated p?nitrophenol can be directly linked to the rate of fusion between the two pools 
of vacuoles. The advantages of this in vitro fusion assay are manifold: It is relatively easy 
to perform and basically every strain with the depicted background can be assayed for 
fusion activity, allowing for the efficient screening of fusion relevant open reading frames 
(ORFs). Furthermore, chemical compounds and proteins such as antibodies and fusion 
factors can simply be added to the reaction to investigate their influence on the fusion 
rate. However, since the assay employs biological reaction partners certain shortcomings 
are unavoidable: Mutants with altered vacuole morphology may have vacuoles deficient 
in Pho8 or Pep4, since both marker proteins have to be sorted to the vacuole, and some 
endosomal proteins affect vacuole morphology (Peplowska et al., 2007; Raymond et al., 
1992). Inhibitors applied in the assay may inhibit Pho8 or Pep4 activity rather than the 
targeted fusion factor (Jun and Wickner, 2007; Merz and Wickner, 2004a). Usually, the 
latter is controlled by lysing vacuoles prior to fusion in the presence of the inhibitor, such 
that Pep4?dependent activation of Pho8 can be measured independent of fusion. An 
alternative content mixing assay has been presented recently. For this assay, two 
segments of ??lactamase were fused to the transcription factors Fos or Jun and targeted 
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to the vacuole, where the formation of the Fos?Jun complex reconstitutes ??lactamase 
activity (Jun and Wickner, 2007). This assay shows the same kinetic properties as the 
Pho8?based assay, but ??lactamase activity seems to be less sensitive to inhibitors 
directed against fusion factors. In addition, lipid mixing assays have been developed, 
which allow a resolution of lipid and content mixing (Jun and Wickner, 2007; Reese et 
al., 2005). In some studies, the in vitro fusion assays have been complemented by the 
visual examination of vacuole fusion under the fluorescence microscope (Jun and 
Wickner, 2007; Mayer and Wickner, 1997; Merz and Wickner, 2004b; Reese et al., 2005; 
Wang et al., 2002b). Fused vacuoles increase in volume and populations can then be 
analyzed. In vivo vacuole fusion during osmotic stress is used as an additional measure. If 
exposed to hyperosmotic stress, vacuoles fragment, but fuse again, if the cells are 
subsequently placed into low osmotic medium afterwards (Bonangelino et al., 2002; 
Wang et al., 2001b). Neither alternative assay can be easily manipulated nor permit a 
kinetic analysis of the fusion reaction, but they may be valuable to complement the 
content and lipid mixing assay. In the following sections, I will discuss the present 
knowledge on vacuole fusion factors and give insight into the fusion mechanism and its 
regulation. 
1.4.1 Stages of vacuole fusion
*
 
A series of events occurs prior to lipid bilayer mixing (Fig. 1.17). It is still under debate if 
distinct steps follow a defined order or if the fusion rather arises through cooperative 
action of fusion factors involved in different steps of the reaction (Jun et al., 2006). It 
seems plausible that fusion occurs at least partly in a consecutive order of events, since 
inhibitors to intermediate steps will block the subsequent fusion reaction (Conradt et al., 
1994; Haas et al., 1994). As observed in the in vitro vacuole fusion assay, these steps are 
termed priming, tethering, docking and fusion/bilayer mixing (Wickner, 2002) and will 
be introduced below. 
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1.4.1.1 Priming
*
 
In the ATP-dependent priming reaction, vacuoles are prepared for the first contact and 
subsequent fusion. A number of fusion factors that reside on the vacuole in an inactive 
state are now activated in an ATP dependent manner (Haas and Wickner, 1996; Mayer 
and Wickner, 1997; Mayer et al., 1996; Price et al., 2000a; Ungermann et al., 1998a; 
Ungermann and Wickner, 1998). The NSF-homolog Sec18, an AAA ATPase, 
disassembles cis-SNARE complexes with the help of its co-factor Sec17 (Fig. 1.17), 
which is released from vacuoles during the priming reaction (Mayer et al., 1996). In this 
reaction, the soluble SNARE Vam7 dissociates from the complex but stays partially 
bound to the vacuole membrane (Boeddinghaus et al., 2002; Ungermann and Wickner, 
1998). In addition, the dynamin-like Vps1 protein, which binds to Vam3 on vacuoles, is 
released from this site (Peters et al., 2004). After disassembly, SNAREs are in an active, 
fusion-competent state. A couple of additional reactions like palmitoylation of the Vac8 
fusion factor and Vam10 function have also been connected to priming (Kato and 
Wickner, 2003; Veit et al., 2001). 
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Figure 1.17 | Stages of in vitro vacuole fusion.  The key players of vacuole fusion are depicted below the 
cartoon. Several additional accessory factors that are implicated in this process are omitted for reasons of 
clarity. Figure adapted from Ostrowicz et al., 2008. 
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1.4.1.2 Tethering
*
 
Tethering - the reversible but distinct contact between vacuoles - is dependent on the fully 
assembled HOPS tethering complex and the small Rab GTPase Ypt7, present in its GTP-
form on both membranes (Mayer and Wickner, 1997; Ungermann et al., 1998b). The 
HOPS complex is a large hexameric protein complex, consisting of the four C-Vps 
proteins (Vps11, 16, 18, 33), Vps41, and Vam6 (Seals et al., 2000; Wurmser et al., 2000). 
The complex has a molecular mass of approximately 700 kDa, and may be present in an 
even larger complex on membranes (Price et al., 2000a). Compared to the much smaller 
SNARE complex, the large size of the HOPS complex is believed to enable it to reach 
over much bigger distances, which predestines it for mediating first contacts between 
vacuoles (Fig. 1.17) (Cai et al., 2007a). At present it is not clear, if the bridging by one 
HOPS complex is sufficient for efficient vacuole tethering or whether the HOPS complex 
dimerizes during tethering. A major problem in addressing the tethering stage in the 
vacuole fusion assay is to dissect tethered from docked vacuoles, which already contain 
trans-SNARE complexes. 
1.4.1.3 Docking and fusion
*
 
During docking, unpaired SNAREs that were made available during vacuole priming 
assemble into trans-complexes between opposing membranes. According to several 
studies, it seems that the Q-SNAREs Vam3, Vam7 and Vti1 on one membrane pair with 
the R-SNARE Nyv1 from the other membrane (Fig. 1.17) (Collins and Wickner, 2007; 
Dietrich et al., 2005; Fratti et al., 2007; Ungermann et al., 1998b). This arrangement is 
sufficient to drive liposome fusion using purified SNAREs (Fukuda et al., 2000). The 
proteins form a zipper-like complex, which propagates from the N-terminal, cytoplasmic 
side to the transmembrane proximal part of the SNARE domain (Fasshauer et al., 1999; 
Fasshauer et al., 1997a; Fasshauer et al., 1997b). Most likely, assembly of the complex 
creates sufficient physical constraints on the vacuolar membrane to drive lipid bilayer 
mixing (Jahn and Scheller, 2006; McNew et al., 2000; Pobbati et al., 2006; Weber et al., 
1998). It should be noted that the liposome fusion assay, which has been employed to 
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demonstrate SNARE-dependent fusion in vitro, is dependent on the vesicle preparation 
and SNARE density on the liposome (Chen et al., 2006; Dennison et al., 2006). It 
therefore seems likely that additional factors promote SNARE-mediated fusion in vivo. 
Furthermore, inhibitors and mutants that allow SNARE pairing but block lipid mixing 
have been described in the literature (Bayer et al., 2003; Collins and Wickner, 2007; Jun 
and Wickner, 2007; Reese et al., 2005). It is presently unclear how vacuole fusion is 
triggered once the fusion process is initiated. 
 A number of factors such as the HOPS complex, the SNAREs, and Ypt7 
specifically enrich on a structure surrounding the future fusion site (Wang et al., 2003b; 
Wang et al., 2002b). The formation of the vertex-ring (compare section 1.3.2.5) leads to a 
flattening of the vacuole boundaries and therefore enlarges the contact zone between the 
fusion-destined vacuoles. Fusion of vacuoles was shown to leave membrane fragments 
within the organelle, which leads to the formation of intraluminal membranes (Wang et 
al., 2002b). The concerted enrichment of several factors at the fusion site may support the 
SNARE-driven fusion process. In vivo, such enrichment has, for example, been shown 
for the HOPS subunit Vps41, the docking factor Ccz1 and for the Vac8 fusion factor 
(LaGrassa and Ungermann, 2005; Tang et al., 2006; Wang et al., 2003a; Wang et al., 
2002a). 
1.5 SNARE function in vacuole fusion
*
 
SNAREs are membrane-anchored proteins that share a conserved coiled-coil domain 
adjacent to their transmembrane domain, which is required for regulated fusion of lipid 
bilayers. They are classified as either Q- or R-SNAREs, depending on whether they 
contain a glutamine or arginine residue at a conserved position within their SNARE 
domain (Fig. 1.18 B) (Fasshauer et al., 1998; Weimbs et al., 1997). According to their 
localization, they are also referred to as vesicle (v)- and target (t)-SNAREs (Rothman, 
1994). Most R-SNAREs are acting as v-SNAREs, while most Q-SNAREs form t-SNARE 
complexes. The fusion-competent assembly of SNAREs from opposing membranes, 
termed the trans-SNARE complex or SNAREpin (Weber et al., 1998), in general consists 
of three Q- and one R-SNARE (Fig. 1.18 A). Once the bilayers have fused and all 
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SNAREs are located within the same membrane, the still-assembled SNARE-complex is 
termed a cis-SNARE complex. SNAREs are recycled for further rounds of fusion by 
disassembly of the cis-SNARE complex by NSF/Sec18 and ?-SNAP/Sec17 (Söllner et 
al., 1993a; Söllner et al., 1993b) (Fig. 1.19). 
 Studies on vacuole fusion clarified the order of events leading to membrane 
fusion, when it became clear that the yeast NSF and ?-SNAP-homologs Sec18 and Sec17 
act prior to docking and not during fusion (Mayer and Wickner, 1997; Mayer et al., 1996) 
(Fig. 1.19). Later on, five SNAREs were identified on yeast vacuoles that are involved in 
the fusion reaction: three Q-SNAREs (Vam3, Vam7 and Vti1) and two R-SNAREs (Ykt6 
and Nyv1) (Darsow et al., 1997; Nichols et al., 1997; Sato et al., 1998; Ungermann et al., 
1998a; Ungermann et al., 1999). The Q-SNAREs Vam3, Vam7 and Vti1 form complexes 
either with Nyv1 or Ykt6 (Dietrich et al., 2005; Fukuda et al., 2000). Whereas the Nyv1 
complex is driving homotypic vacuole fusion, the Ykt6 complex is implicated in other 
fusion reactions at the vacuole (Dilcher et al., 2001) and palmitoylation (Dietrich et al., 
2004). 
Figure 1.18 | Structure of an assembled SNARE complex. A Upon assembly, SNAREs form a 4-helix 
bundle, which shapes into a circular cylinder of approximately 120Å length. Zippering starts for all 
components at the membrane-distal N-terminus and proceeds to the C-terminus, which is anchored to the 
membrane in most cases. B In the center of the SNARE complex (referred to as “0-layer”), the Q- and R-
residues, which are responsible for the modern classification of SNAREs, are involved in an ionic interaction. 
The surrounding layers are held together by leucine-zipper-like hydrophobic interactions, therefore shielding 
the 0-layer from the aqueous environment. Figure adapted from Sutton et al., 1998. 
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1.5.1 SNAREs during priming
*
 
Every vacuole fusion event leads to the accumulation of the SNARE-complex on the 
same membrane – the cis-SNARE complex, which is associated with Sec17 (Ungermann 
et al., 1998a; Wang et al., 2000) and the HOPS complex (Laage and Ungermann, 2001; 
Price et al., 2000a). For further rounds of fusion to occur, the cis-SNARE complex is 
disassembled by the ATPase Sec18/NSF (Ungermann et al., 1998a) (Fig. 1.19), which 
leads to the release of Sec17/?-SNAP (Mayer et al., 1996; Wang et al., 2000), and the 
HOPS complex (Price et al., 2000a) as well as the soluble SNARE Vam7 (Boeddinghaus 
et al., 2002; Ungermann et al., 2000; Ungermann and Wickner, 1998). Vam7 lacks a 
transmembrane domain, but contains a phosphatidylinositol-3-phosphate (PI(3)P) binding 
module, a PX domain, at its N-terminus, which is required for membrane binding 
                                                      
* extracted and modified from Ostrowicz et al., 2008, written by the author of this thesis. 
Figure 1.19 | General model of SNARE mediated vesicle fusion and recycling of SNAREs. Cis-SNARE 
complexes from previous fusions are disassembled by the action of Sec18/NSF and its co-factor Sec17/?-
SNAP. Free Q-SNARE form pre-complexes, which are believed to be chaperoned by Sec1/SM-proteins. 
Upon successful tethering, R- and Q-SNAREs are brought into sufficient proximity to form trans-complexes. 
The energy released during complex formation is exerted to drive lipid bilayer fusion. Figure adapted from 
Jahn and Scheller, 2006. 
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(Cheever et al., 2001; Lee et al., 2006; Song et al., 2001). Following its release, Vam7 is 
specifically recruited to the docking site (Boeddinghaus et al., 2002). Moreover, Vam7 
initiates docking of vacuoles in conjunction with Ypt7 (Ungermann et al., 2000), while 
the free Q-SNARE Vam3 engages in binding to the HOPS complex (Laage and 
Ungermann, 2001; Sato et al., 2000), which subsequently leads to the docking of 
vacuoles. It is possible that that the N-terminal domain of Vam3 has a critical role in this 
process. Mutant vacuoles carrying Vam3 without this domain show reduced trans-
SNARE pairing, HOPS binding and fusion (Laage and Ungermann, 2001). It should be 
noted, however, that another study did not find impaired fusion in a similar mutant 
(Wang et al., 2001a). 
1.5.2 SNAREs during tethering, docking and fusion
*
 
The events taking place during vacuole fusion downstream of priming can be divided into 
two steps (1) the reversible tethering of vacuoles mediated by HOPS and (2) the 
irreversible pairing of SNAREs between vacuoles in trans. Initial tethering of vacuoles 
occurs at specific sites and is mediated by the Rab Ypt7, but apparently occurs 
independent of SNARE function (Ungermann et al., 1998b; Wang et al., 2002b) (Wang et 
al., 2003b). Following this, Vam3 and Vam7 regulate each other’s enrichment at these 
initial contact sites, whereas Vti1 assembly seems to be regulated by a different 
mechanism (Wang et al., 2003b). Ypt7 is thought to orchestrate the associations between 
the Q-SNARE and HOPS thereby bridging the transient tethering with the irreversible 
step of trans-SNARE complex formation (Collins et al., 2005). Lipid rearrangements are 
important for these events to proceed (Fratti et al., 2004; Jun et al., 2004; Kato and 
Wickner, 2003; Lee et al., 2006; Wang et al., 2003b; Wang et al., 2002b). SNARE 
pairing between vacuoles can be detected using SNARE deletion strains or assays with 
tagged SNAREs (Collins and Wickner, 2007; Dietrich et al., 2005; Ungermann et al., 
1998b). Each of these assays shows a Sec17-Sec18, ATP-, and Ypt7-dependent 
accumulation of SNARE complexes, which are also detectable when fusion inhibitors are 
added to the reaction. 
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2 Rationale  
Eukaryotic cells harbor a diversity of intracellular organelles that need to function in a 
concerted manner to support cellular homeostasis. The efficient exchange of matter of 
various kinds is a crucial prerequisite to sustain communication between organelles. 
Components contained in compartments continuous with the cytosol can freely diffuse or 
be actively transported through membrane-spanning pores and channels. Luminal 
contents as well as membrane lipids and transmembrane proteins rely on active vesicular 
transport for proper trafficking between organelles. This transport system is defined by a 
number of highly complex and precisely regulated processes involving proteins, protein 
modifications, and lipids. Intracellular membrane fusion is one of the key processes 
during trafficking next to vesicle budding and transport. Mainly at this stage, specificity 
of trafficking appears to be achieved. Although numerous different SNARE proteins, 
which constitute the core fusion machinery, exist in eukaryotic cells, most of these share 
a high degree of structural homology and the process of trans-SNARE-complex 
formation or “zippering” appears to follow a general scheme. Furthermore, most 
SNAREs, if belonging to the same SNARE family (R, Qa, Qb or Qc), seem to be 
redundant in function, i.e. are able to functionally replace a different SNARE protein. 
Hence, directionality and specificity of vesicular transport and homotypic organelle 
fusion events must rely on a machinery that is different from the fusion-promoting 
SNARE complexes. The primary recognition event of apposing membranes is mediated 
by the action of Rab GTPases and tethering factors. Although most Rab GTPases are 
homologous, they appear to function in a non-promiscuous manner and interact with a 
defined tethering effector in most cases. Other than the two protein families of SNAREs 
and Rabs mentioned above, not all tethers appear to be related and, in some cases, rather 
seem to be the product of convergent evolution. Together with their molecular interaction 
partners, the Rab proteins, it is these factors that are now generally accepted to confer 
organelle and vesicle identity. The molecular complexity of many tethers and the lack of 
a common molecular scheme for tethering events have made the investigation of this 
crucial step in membrane fusion an intricate scientific challenge. Previous work on 
tethering complexes like the exocyst at the plasma membrane and the GARP-complex at 
the Golgi has revealed a sequential functioning of subunits and the existence of defined 
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subcomplexes towards the assembly of the holo complexes, which are functionally linked 
with the fusion process (see sections 1.3.2.3 and 1.3.2.4). Fusion events at the yeast 
vacuole and at the homologous lysosome of higher eukaryotes are dependent on the 
multi-subunit HOPS tethering complex. Only little data was obtained for the functioning 
of single HOPS subunits in the past and most studies were dealing with the analysis of 
the full complex’s function (see section1.3.2.5). Since nothing is known about the 
complex’s structure and possible assembly routes, and our knowledge about regulation of 
its function is limited, I was striving to answer the following questions: 
 
1. What is the molecular structure of single HOPS subunits? 
2. What is the overall quaternary structure of the HOPS complex? 
3. Which subunits interact and what is the stoichiometry of these interactions? 
4. Do stable subcomplexes exist? 
5. Do yet unidentified HOPS interactors exist? 
6. How is HOPS activity regulated? 
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3 Results 
3.1 Regulation of the HOPS tethering complex by Yck3- 
mediated phosphorylation of its subunit Vps41 
Previous studies in our lab revealed the existence of a mechanism that regulates the 
vacuolar HOPS tethering complex function during homotypic vacuole fusion (LaGrassa 
and Ungermann, 2005). Upon transfer to a medium of high osmolarity (e.g. 0.4M NaCl), 
the yeast vacuole fragments and does not fuse back unless osmotic stress is released. 
Although the mechanisms leading to fragmentation are not yet clearly elucidated, it 
appears that the massive production of phosphatidylinositol-3,5-bisphosphate (PI(3,5)P2) 
on the vacuolar membrane and massive flux of water from the vacuolar lumen to the 
cytosol are involved in this process (Ostrowicz et al., 2008). If the cells are transferred to 
medium with normal osmolarity after osmotic stress, vacuoles rapidly fuse back. This 
process relies on the bona fide vacuole fusion machinery including the HOPS complex 
and the vacuolar set of SNAREs (Vam3, Vti1, Vam7, Nyv1/Ykt6). In a screen for 
impaired fragmentation during salt stress, a strain lacking the yeast casein kinase 3 
(Yck3) was identified by our lab to exhibit premature vacuole back-fusion during 
continuous high osmolarity (LaGrassa and Ungermann, 2005). Yck3 was previously 
identified as a non-transmembrane cargo of the AP-3 pathway. The protein gets 
palmitoylated at its C-terminus and is mainly found on the vacuolar membrane facing the 
cytosol (Sun et al., 2004). In contrast to this, possible targets or cellular functions of Yck3 
beyond its activity as a casein kinase were not described. In further experiments 
employing the in vitro vacuole fusion assay, it could be shown that Yck3 exerts its 
function during tethering, since vacuoles with surplus Yck3 cannot dock and vacuoles 
lacking Yck3 are not susceptible to two classical fusion inhibitors, Gdi1 and Gyp7-47, 
known to act at the tethering stage of the fusion reaction. Furthermore, the HOPS subunit 
Vps41 was identified as a phosphorylation target, since a GFP-fusion protein changed 
localization in a yck3? strain, whereas other fusion factors did not. Moreover, Vps41 was 
observed previously to change its mobility in SDS-PAGE if vacuole containing fractions 
were incubated with ATP (Price et al., 2000a); this effect could now be shown to rely on 
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the existence of Yck3 in the vacuole preparation: Vps41 from yck3? vacuoles did not 
exhibit the “up-shift”, which was observed for wt vacuoles (LaGrassa and Ungermann, 
2005). After the elucidation of this crucial layer of regulation during vacuole tethering, it 
was critical to identify the phosphorylation target sequence in Vps41. This appeared to be 
especially important, since Yck3, a as a casein kinase, is believed to possibly act on a 
number of target proteins, which makes it difficult to clearly assign effects of 
manipulations on Yck3 solely to its action on Vps41. To substantiate the findings about 
Yck3 and to gain further insight into the molecular processes underlying our 
observations, it would be useful to perform further studies with variants of Vps41, which 
are unable to get phosphorylated or contain acidic amino acids at the phosphorylation 
site, mimicking a constitutive phosphorylation.  
3.1.1 Identification of phosphorylation sites in Vps41 
The most straightforward approach to determine the sites of phosphorylation in Vps41 
seemed to perform mass spectrometry with the up-shifted fraction of Vps41 in 
comparison to non-phosphorylated protein. For this approach, subcellular fractionation of 
a yeast strain overexpressing Vps41 was performed. In this procedure, cells are subjected 
to cell wall digestion and subsequent mild rupture of the resulting spheroblasts. Hence, 
cellular organelles are released into the lysis buffer and can be separated by differential 
centrifugation. The P13 fraction, which is the resulting pellet from a centrifugation of 
13,000xg and contains vacuoles to a high extent, is then incubated with ATP to allow for 
in vitro phosphorylation of Vps41 by the Yck3 kinase. This approach was also used for 
the experiments in which Vps41 phosphorylation was assayed analytically. In the case of 
mass spectrometry sample preparation, a much higher amount of cell material was used 
(approx. 2000 OD-Units vs. 60 OD-Units for standard subcellular fractionation), to allow 
for the subsequent purification of Vps41 with ?-Vps41 antibody coupled sepharose and 
for visualization by Coomassie staining on an SDS-PAGE gel (Fig. 3.1). The resulting 
gel was sent for further mass spectrometry analysis (MALDI-TOF and ESI-MS/MS) to 
Christian Preisinger, a protein phosphorylation specialist in the collaborating group of 
Francis Barr (at that time: Max-Planck-Institute, Martinsried, Germany). 
                                                                                                                       RESULTS 
 45 
Unfortunately, the results of the mass spectrometry analysis did not lead to clear results. 
One major drawback was the low amount of phosphorylated specimen, which could also 
not be raised in subsequent experiments. Furthermore, the results from Munich revealed 
that Vps41 is constitutively phosphorylated independent of Yck3 activity at several serine 
residues at its amino terminus, complicating a clear identification of transiently 
phosphorylated residues.  
 To circumvent the shortcomings of the mass spectrometric approach, we decided 
to single out the most promising phosphorylation sites in Vps41 by in silico prediction 
using the web-based NetPhos service (http://www.cbs.dtu.dk/services/NetPhos/). Since 
Vps41 is a large protein of 992 amino acids and contains a substantial amount of serine 
and threonine residues, 87 and 53, respectively, the incidence for a predicted 
phosphorylation site was relatively high. We employed a score threshold of 0.5 with 1 
being the highest and 0 being the lowest score. Netphos predicted 40 serine residues and 
9 threonine residues to be possible phosphorylation targets (Fig. 3.2). 
Figure 3.1 | Purified Vps41 samples after ATP incubation used for mass spectrometry analysis. A P13 
fractions of a wild-type yeast strain and of a yck3? mutant were incubated with ATP and Vps41 was 
subsequently purified using an anti-Vps41 affinity column. B Western blot of the wt samples decorated 
against Vps41. Note the small percentage of upshifted protein. 
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Following the most promising predictions, we prepared mutants of the VPS41 coding 
sequence by the use of site-directed mutagenesis. Several neighboring potential 
phosphorylation sites were simultaneously altered to narrow down the search for potential 
sites in a first approach, therefore decreasing the number of constructs that would have to 
be prepared (Table 3.1). 
 
 
 
Due to the results obtained from the mass spectrometric approach, we decided to 
disregard the most amino terminal residues in our future experiments and focused on the 
Figure 3.2 | Prediction of Vps41 phosphorylation sites by the NetPhos algorithm. 
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four potential phosphorylation sites listed in Table 3.1. The mutated sequences were 
cloned into genomically integrative vectors under the control of the constitutive NOP1 
promoter and transformed into a vps41 deletion strain. The resulting mutants were 
subjected to cell lysis and the P13 fraction was incubated with or without ATP (Fig. 3.3). 
Two potential sites yielded a change in SDS-PAGE mobility compared to the wild type if 
mutated into alanine. During further analysis of the two phosphorylation-impaired 
mutants, fluorescence microscopy of FM 4-64-stained cells revealed, that the S118-120-
121A mutant had strongly fragmented vacuoles, reminiscent of the phenotype observed 
upon deletion of the vps41 gene. In contrast to this, the S364-367-368-371-372-T376A 
mutant exhibited normal vacuolar morphology. A GFP-tagged version of this Vps41 
variant specifically localized to one or few punctate structures adjacent to the vacuolar 
membrane. Strikingly, this resembled the exact phenotype observed in a yck3 deletion 
background (Fig. 3.4). 
Figure 3.3 | Analysis of putative phosphorylation sites in Vps41. A P13 fractions of 
the indicated strains were incubated with and without ATP, subjected to SDS-PAGE 
and Western blotting. B Scheme of the analyzed Phosphorylation sites. Adapted from 
Cabrera et al., 2009. Experiment conducted by the author of this thesis. 
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We therefore concluded that we identified the correct phosphorylation site. Further 
experiments with single and dual amino acid residue alterations (Fig. 3.5) revealed that 
the minimal mutation needed to diminish SDS-PAGE up-shift as well as a change in 
intracellular localization of the GFP-tagged Vps41 protein, is the mutation of the 
sequence coding for amino acid residues S367, S368, S371 and S372.  
Figure 3.5 | Analysis of single and dual amino acid alterations to assess the minimal 
phosphorylation site. Indicated mutants were subjected to up-shift analysis as described above. Adapted 
from Cabrera et al., 2009. Experiment performed by Dr. Margarita Cabrera. 
Figure 3.4 | Microscopic analysis of the two putative phosphorylation mutants that showed impaired 
upshift. Log-phase cells were subjected to FM 4-64 staining and analyzed by fluorescence microscopy. 
Size bar: 10?m 
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This finding was the basis for several additional experiments performed by Dr. Margarita 
Cabrera in our lab, which elucidated the major effects of Vps41 phosphorylation in the 
endolysosomal system (Cabrera et al., 2009). Furthermore, in silico analysis of the Vps41 
sequence revealed that this protein harbors a putative ALPS motif (Drin et al., 2007), 
which could form an amphipathic helix that inserts into lipid bilayers. Intriguingly, this 
motif is located exactly at the phosphorylation site. Further studies currently under way in 
our lab aim at the elucidation of the effect of Yck3 mediated phosphorylation on the 
integrity of the ALPS motif. Possibly, this connection is only one example of a general 
scheme of controlling the association of proteins to intracellular membranes (see 
discussion). 
3.1.2 The vacuolar fusion factor Mon1 is a substrate of Yck3 
Next to Vps41, there was no substrate known to be phosphorylated by the Yck3 kinase, 
contradictory to our knowledge about casein kinases as promiscuous kinases with usually 
several possible target substrates. However, in several studies by the lab of Dan Klionsky, 
it has been reported that the prevacuolar/vacuolar fusion factor Mon1, which is known to 
interact with another factor, Ccz1, exhibits a change in SDS-PAGE mobility upon 
incubation of vacuole containing fractions with ATP (Wang et al., 2003a; Wang et al., 
2002a). Since this phenotype is reminiscent of the effect we observed for Vps41, we 
sought to elucidate if the observed up-shift is dependent on Yck3 activity. To test this, 
P13 fractions from wild type and yck3? cells were incubated with and without ATP. To 
facilitate detection of Mon1 and Ccz1, a TAP tag was fused to the C-terminus of both 
proteins in the respective strain backgrounds. Indeed, I was able to observe a clear change 
of SDS-PAGE mobility for a fraction of the Mon1 protein upon ATP incubation. This up-
shift was not visible in the yck3 deletion background. In contrast to this, no change in 
SDS-PAGE mobility could be detected for the Mon1 binding partner Ccz1 under any 
circumstances (Fig. 3.6 A) 
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This data suggests that Mon1 is another substrate of Yck3, which exhibits a 
biochemically well-detectable effect upon phosphorylation. Furthermore, I was able to 
purify the Mon1-Ccz1 complex from a strain harboring a TAP-tagged version of Ccz1 
(Fig. 3.6 B). No unknown interactors could be identified using mass spectrometry.  
Recent work by Alexey Merz and colleagues (Brett et al., 2008) suggests that the 
vacuolar Q-SNARE Vam3 is another phosphorylation target of Yck3, with a putative 
function of Yck3 in controlling the vacuolar SNARE machinery next to its effect on the 
HOPS tethering complex (Brett et al., 2008). However, further studies on the effect of 
Yck3-mediated phosphorylation of Mon1 performed by Dr. Margarita Cabrera and a 
diploma student in our lab did not yield any further advances on the subject yet. 
3.2 Purification of HOPS complex and its subunits for 
crystallization and electron microscopy analysis 
One aim of my thesis was the production of sufficient amounts of single HOPS subunits 
so that crystallization trials and subsequent X-ray analysis could be carried out. The 
elucidation of protein structures can provide substantial help in understanding the 
functioning of proteins and protein complexes on a molecular level. In several studies it 
was shown that the HOPS complex at the yeast vacuole fulfills a major function in the 
process of tethering. The complex was demonstrated to interact with the activated form of 
the vacuolar Rab GTPase Ypt7 and to be able to interact with SNARE complexes 
Figure 3.6 | Probing for Yck3-dependence of the Mon1 upshift. A Indicated strains were subjected to 
the up-shift assay as described above. B The Mon1-Ccz1-complex was successfully purified from a Ccz1-
TAP strain. A full TAP experiment was performed and eluates were analyzed by SDS-PAGE and 
Coomassie staining. 
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(Collins et al., 2005; Price et al., 2000a; Seals et al., 2000); yet the precise molecular 
events taking place during tethering and subsequent docking remained obscure. I sought 
to disclose the mechanism of tethering by providing information about the molecular 
details of the involved factors. 
3.2.1 Recombinant expression of HOPS subunits 
The smallest subunit of the HOPS complex is the Sec1/Munc18-homolog Vps33 with an 
apparent molecular weight of 79kDa. The other subunits’ molecular weights range from 
93kDa (Vps16) to 123kDa (Vam6). Hence, it becomes clear that recombinant expression 
of these proteins in standard expression systems like Escherichia coli is not an easy task. 
Moreover, HOPS subunits might not be very soluble proteins, since they appear to act as 
peripheral membrane proteins in vivo. Although the production of small quantities of 
some proteins was reported on (Darsow et al., 2001), the amounts and the quality of a 
protein needed for crystallization trials exceeds everything yet obtained from recombinant 
expression systems. To succeed in the production of these complicated proteins, different 
approaches were employed to find the most appropriate method of production as well as 
purification of HOPS proteins. 
3.2.1.1 Bicistronic expression 
In a study by Lutzmann et al. (Lutzmann et al., 2002) it was reported that the expression 
of nuclear pore complex subunits could be greatly improved by bicistronic co-expression 
of several proteins in one E. coli cell. Moreover, the assembly of nuclear pore 
subcomplexes could be followed by these means in the recombinant expression system. 
To adopt this elegant system for the HOPS subunits, I constructed a bicistronic plasmid 
based on the pET24d-system. The background plasmid was a kind gift from Professor Ed 
Hurt. It contained the sequence for an N-terminal GST-fusion protein tag combined with 
a TEV protease cleavage site for the first gene to be introduced. For bicistronic 
expression, an additional ribosomal binding site had to be introduced into the primers 
employed for the cloning of the second gene of interest (Lutzmann et al., 2002). The 
bicistronic co-overexpression of recombinant proteins that form subcomplexes has 
several advantages: (i) if the proteins are well interacting, they might aid in the process of 
protein folding in the cell, by specifically chaperoning already folded domains, (ii) the 
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two proteins should be expressed to roughly the same concentration in the cell, since they 
are translated from the same mRNA molecule and (iii) only one protein must harbor an 
affinity purification tag, since the second protein will be co-purified as long as native 
purification conditions are employed. Since our knowledge of the HOPS subunits and the 
interactions taking place between these were very limited and partially wrong at this stage 
of my studies, I chose the two subunits Vps41 and Vam6 to be co-expressed in E. coli 
(Nakamura et al., 1997; Price et al., 2000b). These two subunits were reported to act 
together in the “Vps41/Vam6” complex and reasoned to transiently interact with the class 
C-VPS proteins. Unfortunately, the co-overexpression of these two proteins did not lead 
to an increase in expression or purification efficiency of Vps41 or Vam6. Furthermore, 
induction could only be monitored on Western blot level, so that this approach was not 
followed on. During further work in this study on the interactions taking place between 
the HOPS complex subunits and the subcomplexes that stably form, it turned out that 
Vps41 and Vam6 do not directly interact, clearly explaining the above-mentioned results. 
3.2.2 Purification of HOPS proteins from yeast 
The Tandem Affinity Purification technique allows for the efficient native purification of 
proteins and their interactors from cell lysate. Two different affinity tags are fused in 
tandem to either the N- or C-terminus of the protein of interest. Both tags are separated 
by a protease cleavage site, which allows for the native elution from the first affinity 
column (compare methods section 5.3.12.1). The classical TAP tag consists of a 
calmodulin-binding-peptide (CbP) a TEV-protease cleavage site and an additional protein 
A tag, derived from Staphylococcus aureus, which binds to the constant region of IgG 
antibodies. One advantage of the TAP method over other, classical purification 
procedures is that the proteins can be purified to a high degree of purity because 
background impurities are diminished due to two different affinity matrices. Another 
improvement over some other methods for analytical protein purification is that the 
proteins of interest are generally eluted natively, so that downstream analysis can be 
performed with functional proteins. During my studies dealing with the architecture of 
the HOPS complex, I employed the TAP method, using a protocol that had been adapted 
from the original method for the work with membrane-associated proteins by the group of 
Prof. Ed Hurt (see methods section 5.3.12.1). The TAP technique proved useful for 
answering many questions about the interactions taking place between the different 
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HOPS subunits and was especially powerful in combination with the gelfiltration method, 
which allows for the sizing of protein complexes and the separation of proteins and 
complexes by molecular weight. As depicted in Fig. 3.7, the TAP method allowed me to 
efficiently purify the full native HOPS complex. For this experiment, I used TEV eluate 
from a purification employing a strain harboring a TAP-tagged version of Vps41. The 
eluate was applied to a Superose 6 column (GE healthcare, Munich, Germany) and 
isocratic gelfiltration was performed. Since I employed the same buffer for the elution as 
for protein purification, the UV absorption that was monitored during the column run was 
strongly quenched due to the contained detergent. Therefore, no useful UV-absorption 
pattern for the column elution can be presented. The complex containing fractions 10-12 
approximately correspond to a molecular weight of 700 kDa, as it was determined using 
calibrating protein complexes of that size. The single Vps41 protein elutes shortly after in 
fraction 13-14, which corresponds to a molecular weight of approximately 150-100 kDa.  
All other bands that can be observed on the SDS-PAGE gel in Fig. 3.7, most likely 
represent impurities resulting from unspecific binding to the IgG-sepharose matrix. 
Single subunits that could have dissociated off the complex are hard to detect (besides 
Figure 3.7 | Purification of the HOPS tethering complex. TAPurification was performed with a strain 
harboring a TAP-tagged version of Vps41. The TEV eluate was used to perform a size exclusion 
chromatography (gelfiltration). 100% of the elution fractions were TCA-precipitated and loaded onto a 
precast 4-12% SDS-PAGE gel (Invitrogen, Karlsruhe, Germany) that was subsequently stained with 
Coomassie. 
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Vps41, which was specifically pulled down in this experiment), suggesting a very stable 
interaction of the HOPS subunits. Interestingly, no other major bands can be detected in 
the complex fraction, indicating that all other HOPS-interactors, which were described 
before, are only transiently binding. The one additional band that can be seen in fraction 
12 at a size of approximately 70kDa represents a chaperone, which was only sometimes 
detected in the HOPS purifications and most likely represents an artifact of the 
purification procedure. Further results from these experiments are presented in the 
following sections. Next to the usefulness of the TAP method for analytical protein 
complex purification, I utilized this procedure for the purification of overproduced 
proteins from S. cerevisiae, for which recombinant expression in E. coli proved 
unsuccessful before (see section 3.2.1). 
3.2.2.1 Purification of Vps41 for crystallographic trials 
Overproduction in S. cerevisiae can be performed by several methods. Transformation 
with multi-copy plasmids like the 2? plasmids leads the occurrence of several copies of 
the gene of interest in a single cell, which consequently results in increased expression 
levels due to a higher number of mRNA transcripts. Unfortunately, these plasmids are 
normally not retained in the cell unless selectivity pressure is applied, making the use of 
selective minimal media unavoidable, which very often leads to slow growth and 
reduction of cell mass yield. Another possibility is the genomic integration of a highly 
active promoter upstream of the gene of interest. The advantage of this method is the 
robustness of the genomic DNA alteration and the possibility to use complex media, 
which results in higher viability of cells, leading to faster cell growth and higher cell 
densities. Due to these benefits, I decided to utilize the GAL1 gene promoter. This 
promoter is induced upon addition of galactose to the growth medium in the absence of 
glucose, which represses transcription of genes, which are under the control of the GAL1 
promoter.  
 Since the Vps41 protein is of major interest for our understanding of the 
functioning of the HOPS complex and vacuole tethering per se, it was chosen as the main 
target to be tested for overproduction in yeast. Indeed, the protein proved to be well-
expressed and soluble after purification with detergent-containing buffer. As observed in 
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Fig. 3.8, galactose induced overexpression of Vps41 led to a substantial increase in 
protein yield with the standard purification procedure. 
3.2.2.2 Screening for optimal purification conditions for Vps41 
Although the first results from the galactose overproduction of Vps41 appeared to be 
promising in that the acquired protein amounts could be suitable for crystallographic 
trials, further experiments were necessary, to optimize the purification conditions. The 
amount of obtained protein should be maximized and at the same time, buffer conditions, 
Figure 3.8 | Effect of Gal-overproduction on the protein yield in a Vps41-TAP purification from 
yeast. Same amounts of TEV eluate were applied to a Superose 6 column in A (compare Fig. 3.7) and B. 
The amount of purified complex is equal in both cases, whereas Vps41 is highly enriched in B due to 
GAL1pr overproduction. 
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such as detergent type and concentration, and salt strength should be as close as possible 
to the optimal starting conditions for crystallographic trials. For this purpose, small-scale 
TAP experiments (Mini-TAPs, see section 5.3.12.2) with cells from the GAL1pr-VPS41 
strain were performed until the TEV elution step. Several different conditions could be 
tested in parallel by this approach, allowing for a more rapid determination of optimal 
buffer conditions. 
Different detergents that were especially suitable for protein crystallographic 
experiments were screened for best performance during lysis and purification. In all 
cases, the end concentration of the detergent was at least two times the critical micelle 
concentration (CMC). One first experiment, in which the standard nonionic detergent 
IGEPAL-630 was exchanged for the zwitterionic detergent CHAPS, revealed that this 
detergent was suitable for lysis and IgG-sepharose binding of Vps41-TAP. Unfortunately, 
CHAPS inhibited the TEV protease that was used to elute the protein natively from the 
IgG-beads. This example shows that a detailed examination of all purification steps has to 
be carried out, before a single component can be deliberately altered. 
 To determine the optimal detergent for Vps41 purification, I screened a number 
of different substances (Table 3.2), which had been used in crystallization trials before  
and had proven to be compatible with this procedure. Interestingly, the different 
detergents that were used for this screen revealed partially striking differences in their 
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ability to support the solubility of the target protein and, even more noticeably, to allow 
for efficient TEV cleavage (Fig. 3.9). 
Even though NDDM and UDDM do only slightly differ in the length of their carbon 
chain (compare Table 3.2), they solubilize Vps41 differently and show a stark difference 
in supporting the TEV cleavage reaction. The detergent LDAO, which has proven useful 
for solubilizing and crystallizing transmembrane proteins, does apparently not support 
solubilization of the membrane associated Vps41. The sugar-based detergent UDDM 
matched the good solubilization properties as well as the good support of the TEV 
protease activity of IGEPAL-630 and was chosen as the detergent of choice for 
subsequent purifications for crystallization trials. 
 Another crucial property of the purification buffer is its salt strength. For 
crystallization, it is useful to have a low starting concentration of salts to allow for facile 
Figure 3.9 | Analysis of different detergents during cell lysis and protein purification. The Mini TAP 
protocol was performed with buffer containing the indicated detergents in A and B. The indicated 
amounts were subjected to SDS-PAGE and Western blotting. The membrane was decorated with anti-
Vps41 antibody afterwards. 
Figure 3.10 | Influence of the NaCl concentration on the 
efficiency of the Mini-TAP protocol. The experiment was 
performed as in Fig. 3.8, but with different NaCl concentrations.  
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screening of the right crystallization conditions. Originally, the TAP procedure was 
conducted using 300mM NaCl in all buffers. Since this is a rather high concentration 
above the physiological salt strength, I tested different NaCl concentrations for the 
effectiveness of Vps41 solubilization and efficiency of TEV cleavage (Fig. 3.10). 
Evidently, the salt strength has profound influence on the Vps41 solubilization 
properties of the buffer. 500mM NaCl extracts the protein best from the membrane 
fraction (Fig. 3.10 lane 5 compared to 1-4), although only slightly better than 300mM 
NaCl. The TEV elution, on the other hand, is strongly inhibited by the high salt 
concentration (lane 10), whereas 300mM NaCl seem to be tolerated by the TEV protease 
(lane 9). The beneficial effects of a low salt concentration on the TEV cleavage reaction 
become clear by the comparison of lanes 7-9 with lanes 2-4 (note the change in loading 
order). Even though the cleared lysate, which was used for loading the IgG sepharose, 
contained much less protein in the case of lanes 2 and 3, the protein amounts eluted by 
the TEV treatment do not reflect these strong differences but appear relatively similar 
(compare lanes 7 and 8 to lane 9). 
Although a substantial amount of work was invested on the investigation and 
optimization of the purification conditions of Vps41 from yeast, crystallization of the 
protein was not yet possible. Purified samples were sent to the group of Professor Roger 
Goody (Max-Planck-Institute, Dortmund, Germany) and different crystallization 
conditions were tested without success. Future crystallization trials could be more 
successful, since only a limited number of conditions were tested in this first approach. 
The purification routine that I established for Vps41 could also be applied for other 
subunits to successively determine the HOPS complex subunits’ structures.  
3.2.2.3 Purification of HOPS complex for electron microscopy 
The impressive advances on the protein yield that became possible by genomic 
integration of the GAL1 promoter in front of the Vps41 coding region led me to generate 
a strain harboring all six HOPS subunit genes under the control of the GAL1 promoter. 
Since each of these genomic alterations is dependent on the use of an antibiotic or 
auxotrophy marker, we decided to generate two parent strains with each containing three 
subunits’ genes under the GAL1 promoter control. For the creation of the “all-GAL-
HOPS” strain, these two parent strains would have to be mated, which would result in a 
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diploid strain containing all six genomic alterations. Indeed, I was successful in the 
production of both parent strains and, consequently, the all-GAL-HOPS strain. First 
purification trials showed that the resulting yield of purified HOPS complex was at least 
ten- to fifteen-fold increased compared to the wild-type purification (Fig. 3.11). Despite 
Figure 3.11 | Effect of Gal-overproduction of all HOPS subunits on the protein yield in a TAP 
purification from yeast. Same amounts of TEV eluate were applied to a Superose 6 column in A and B. 
The amount of purified complex is highly enriched in B due to GAL1pr overproduction of all subunits. Note 
that in the main complex fractions, only 10% of the fractions were loaded on the gel compared to 100% in 
A. The complex proteins observed in B in fractions 6-9 and 16-19 most likely occur due to the column’s 
inability to efficiently separate higher protein amounts of the complete complex.  
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this multiplication of purified protein amounts, crystallization of the whole complex did 
not appear feasible until now, since the total amounts do still not compare to the yields 
accomplished for the single subunit Vps41 (compare section 3.2.2.1). Nonetheless, 
analysis of the HOPS complex structure by electron microscopy is under way. My 
successor colleague Cornelia Bröcker is currently performing several experiments in 
collaboration with Dr. Stefan Raunser at the Max-Planck-Institute in Dortmund. First 
negative stain results were just recently obtained and are depicted in Fig. 3.12. 
 
 
 
 
 
Figure 3.12 | Preliminary negative stain EM-data of the 
HOPS complex. Provided with kind permission by Cornelia 
Bröcker. EM analysis was performed by Dr. Stefan Raunser. 
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3.3 Identification and characterization of the novel 
CORVET tethering complex and intermediate 
complexes 
3.3.1 Vps3 interacts with the class C Vps proteins 
The establishment of methods needed to tackle the challenges of protein overproduction 
and complex purification mentioned above served as powerful tools for further 
characterization of the HOPS tethering complex. One incidental finding of a former co-
worker of mine, Dr. Karolina Peplowska (now Max-Planck-Institute, Martinsried, 
Germany), gave rise to a number of experiments that finally led to the identification of 
three novel protein complexes with homology to the HOPS tethering complex 
(Peplowska et al., 2007). Together with me, she performed a tandem affinity purification 
of the class D protein Vps3, that had been previously described by our lab to be involved 
Figure 3.13 | Vps3 binds to the class C-Vps proteins and Vps8. A standard TAPurification was 
performed with a strain harboring a TAP-tagged version of Vps3. Adopted from (Peplowska et 
al., 2007). Experiment was conducted by this thesis’ author together with Dr. Karolina 
Peplowska. 
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in the process of vacuole fragmentation upon osmotic stress (LaGrassa and Ungermann, 
2005). Intriguingly, we found that Vps3 does interact with the class C Vps proteins 
Vps11, Vps16, Vps18 and Vps33, all of which are main components of the HOPS 
complex (Fig. 3.13). Additionally to the class C Vps proteins, the class D protein Vps8 
was identified to interact with Vps3. Vps8 had been previously identified to bind to the 
class C Vps proteins by Elizabeth Jones and co-workers (Subramanian et al., 2004), a 
finding that I could confirm with my own TAP experiments before (Fig. 3.14). 
3.3.2 Vps3 is a subunit of a novel HOPS homologous complex 
Based on our findings of the interaction of Vps3 with Vps11, -16, -18, and -33, we 
decided to investigate to which extent these proteins act together. For this purpose, I 
performed IgG-sepharose pull-downs and subsequent TEV protease cleavage with cell 
lysates from strains harboring a TAP-tagged version of Vps3 or Vps8. The eluates where 
applied to a Superose 6 size exclusion column (compare section 3.2.2.1) to determine the 
size of putative protein complexes and the stoichiometry of the involved proteins. Indeed, 
I was able to show that Vps3 and Vps8 are both part of a protein complex of an 
approximate molecular weight of 700kDa, comparable to the HOPS tethering complex 
(Fig. 3.15). Interestingly, Vps3 is not found in equal amounts as the other subunits in the 
complex containing fractions, as judged by the strength of the Coomassie stained bands 
(Fig. 3.15, compare fractions 10-12 in A and B). Yet in both the Vps3- as well as the 
Vps8-TAP gelfiltration, Vps3 is observed in a peak of higher retention, resembling lower 
molecular weight fractions of 100-150kDa. In the case of the Vps8 purification, the 
amount of Vps3 eluting in this second peak corresponded well with the amount of the 
other subunits still present in the complex (Fig. 3.15, compare fractions 10-12 with 13-14 
Figure 3.14 | Vps8 is contained in Vps11-TAP TEV eluate. Gelfiltration analysis of a Vps11-TAP TEV 
eluate. Vps8 was identified via mass spectrometry. Vps3 is most likely present on the gel together with 
Vps41 and Vam6 but could not be detected by the mass spectrometric analysis. 
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in B), indicating that it was part of the complex during the purification procedure but 
dissociated either during TEV elution at 16°C or upon injection on the gel filtration 
column due to the strong dilution effect. In the case of the Vps3-TAP size exclusion, 
more Vps3 is found in the single protein fractions 13 and 14 than the other proteins in the 
complex fractions 10-12, most likely because not all of the Vps3 molecules are included 
in the complex in vivo, resulting in non-equimolar amounts on the SDS-PAGE gel. 
 Beside this very specific characteristic, comparison with the results of the 
gelfiltration experiments obtained for the HOPS complex reveals that the observed 
complexes show a strong similarity in their biochemical properties in vitro (Fig. 3.15, 
compare A and B to C). Both Vps3 and Vps8 have previously been shown to act at the 
level of endosomes (Subramanian et al., 2004), and are needed for proper sorting of cargo 
to the vacuole (Rothman et al., 1989). Owing to these facts and the involvement of the 
Figure 3.15 | Identification of the Vps3-Vps8-Class C complex. TEV eluates from TAPurifications of 
the indicated strains were subjected to SDS-PAGE and subsequent Coomassie staining. Note that all 
complexes elute in fractions corresponding to approx. 700kDa and show equal elution patterns. 
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Class C Vps proteins, we decided to term this novel complex CORVET (class C core 
vacuole/endosome tethering). 
3.3.3 Identification of intermediate complexes 
The striking similarity between the CORVET and the HOPS complex led us to analyze 
the sequence similarities between the four subunits that are specific for each of the two 
complexes. Although all of these proteins share a certain similarity, the strongest 
similarity was found between Vps3 and Vam6 as well as Vps41 and Vps8 (Peplowska et 
al., 2007). This indicated that the respective subunits could fulfill comparable functions 
and might be involved in interactions with similar subunits. We therefore wondered, if 
next to the CORVET and HOPS complex, mixed complexes could exist and if we were 
Figure 3.16 | Identification of two intermediate complexes. A-B The Vps8-Vam6 intermediate complex 
could not be identified on Coomassie levels. Therefore, I employed an HA-tagged version of Vps8. B 20% of 
the gelfiltration elution fractions were subjected to SDS-PAGE and Western blotting and subsequently 
decorated with anti-HA antibody (mouse, red) and anti-Vps41 antibody (rabbit, green). Antibodies were 
visualized using fluorescent secondary antibodies and a LiCor Odyssey scanner. C The Vps3-Vps41 
intermediate complex is readily detectable in a vps8? strain. 
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able to detect those. Indeed, I was able to show that an HA-tagged version of Vps8 is 
specifically co-eluting with the complex purified with Vam6-TAP from an otherwise 
unaltered strain background (Fig. 3.16 A). Since the HOPS complex is primarily purified 
under these conditions, Vps8-3HA is not detectable on a Coomassie-stained SDS-PAGE 
gel, but can be identified on Western blot level using a specific anti-HA antibody (Fig. 
3.16 B). In order to probe for the existence of the other putative mixed complex, I chose a 
vps8? strain with a TAP-tagged version of Vps3 and performed an IgG-sepharose 
affinity purification with TEV elution and subsequent gelfiltration. In this case, the 
purified complex could be well observed on a Coomassie stained SDS-PAGE gel (Fig. 
3.16 C) and proteins were identified via mass spectrometry. Together with Vps3, Vps41 
and the class C Vps proteins were retained on the IgG-sepharose matrix and eluted 
together from the gelfiltration column in a single peak. Again, Vps3 dissociates partially 
from the complex as it has been observed in section 3.3.2.  
3.4 Identification of stable HOPS subcomplexes  
3.4.1 Deletion of single HOPS subunits reveals the existence of 
stable subcomplexes 
In my efforts to unravel the interactions and transformations taking place in the course of 
tethering complex conversion from the endosomal CORVET to the vacuolar HOPS 
complex (Peplowska et al., 2007), I was confronted with several interesting findings. My 
first observation was the existence of a stable subcomplex comprised of Vam6, Vps11 
and substoichiometric amounts of Vps18 in a deletion mutant of the HOPS subunit Vps41 
(Fig. 3.17 compare A and B (wild-type condition) to C (vps41?)). In order to uncover 
additional stable subcomplexes and to address the question of the HOPS complex 
architecture I asked which subunit interactions would survive the single gene deletion of 
other subunits. I found that only subunits Vam6 and Vps33 could be removed without 
subsequent loss of other subunits from the core complex (Fig. 3.18). In the case of Vam6, 
this finding can be explained at least partially by its replacement by Vps3, which leads to 
the formation of the previously identified intermediate complex (Peplowska et al., 2007). 
In support of previous findings (Rieder and Emr, 1997), I observed that deletion of 
VPS16 caused Vps33 to vanish from the complex 
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(Fig. 3.19), suggesting that Vps33 binding to the HOPS complex is solely dependent on 
its interaction with Vps16 and that Vps33 is not needed to maintain a stable core 
complex. The resulting tetrameric subcomplex consists of the two class C Vps proteins 
Vps11 and Vps18 as well as Vam6 and Vps41, indicating that Vps16 and Vps33 are  
Figure 3.17 | Identification of stable HOPS subcomplexes by deletion mutant analysis. As described in 
previous experiments, TEV eluates from TAPurifications of the indicated strains were applied onto a 
Superose 6 column and elution fractions were put on an 4-12% SDS-PAGE gel and subsequently stained 
with Coomassie. 
Figure 3.18 | Vps33 and Vam6 are the most peripheral subunits and their absence only slightly 
impairs complex stability. TEV eluates from TAPurifications of the indicated strains were applied onto 
a Superose 6 column and elution fractions were put on an 4-12% SDS-PAGE gel and subsequently 
stained with Coomassie. Note that complexes elute slightly different due to the employment of two 
different Superose 6 columns.
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dispensable for the remaining interactions to occur. Single deletion of the remaining 
Class C-Vps genes (i.e. vps11 or vps18) resulted in hardly or no detectable residual 
subcomplexes except for the dimeric subcomplex Vps11-Vam6 in vps18? (Fig. 3.17 D). 
This data led to a basic model of HOPS subunit interactions (see discussion section 4.4). 
This model gained refinement due to additional co-overexpression studies (see below). 
3.4.2 Overexpression of apposite subunits allows formation of 
stable subcomplexes 
The intriguing findings about the existence of stable subcomplexes in single HOPS 
subunit deletion strains led me to survey the possibilities to express and overproduce 
those in cells with wild type background. My aim was to confirm our previous results, to 
gain further insight into the organization of HOPS and its corresponding subcomplexes, 
and to be able to produce larger amounts for further biochemical characterization. 
Therefore, I tested the ability of the HOPS subunits to form stable subcomplexes in the 
relative absence of other HOPS subunits. Indeed, upon expression of specific doublets, 
one triplet and one quadruplet of HOPS subunits under the strong, inducible GAL1 
Promoter, I observed formation of stable subcomplexes (Fig. 3.20, summarized in Table 
3.3). In the case of the two doublets Vps11-Vam6 and Vps16-Vps33 (Fig.  3.20, lane 2 
and 3), a near 1:1 stoichiometry of the purified proteins is observed, indicating that these 
proteins do form very stable interactions. 
Figure 3.195 | Vps33 binds to the HOPS complex via Vps16. TEV eluates from TAPurifications of the 
indicated strains were applied onto a Superose 6 column and elution fractions were put on an 4-12% 
SDS-PAGE gel and subsequently stained with Coomassie. 
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 Furthermore, it seems most likely that the two proteins of each pair represent at least one 
of their respective primary interaction partners in the assembled HOPS complex. If 
Figure 3.20 | Co-overexpression of cognate subunits allows for purification of highly pure subcomplexes. 
Strains harboring the indicated genomic alterations (compare Table 3.3) were purified using the Mini TAP 
protocol. Both purification steps were employed and the resulting final EGTA eluates were TCA-precipitated. 
Different amounts were loaded on a 7% SDS-PAGE gel to achieve comparable signals. The  gel was stained 
using the linear Sypro Orange stain to allow for better comparison of signal strengths for different proteins. 
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Vps18 is co-overexpressed with Vam6 and Vps11 (Fig.  3.20, lane 4), a similar picture as 
in the vps41 deletion background is observed (compare section 3.4.1), indicative of a 
mixed population, where only part of the Vps11-Vam6 complex binds Vps18. Also 
Vps41 only associates with a fraction of the total Vps11-Vam6 complex (Fig.  3.20, lane 
5). Its co-overexpression does not alter the amount of bound Vps18 significantly and it 
appears that the two proteins interact in a similar ratio with the Vp11-Vam6 subcomplex. 
This finding either indicates that Vps41 binding to the HOPS complex is mediated by 
interactions with Vps18 alone or that its binding site is comprised of Vps18 and Vps11 
together. Since no direct interaction between Vps41 and Vam6 was detectable in any of 
our essays before, we could exclude that Vam6 contributes substantially to Vps41 
binding to the complex (see also discussion section 4.4). To further elucidate this, we 
assayed for Vps41 interactors in different overexpression backgrounds. Vps41 
overproduction in the GAL1pr-VAM6-VPS11 background did not lead to a trimeric 
subcomplex and co-overexpression of Vps18 and Vps41 did not yield a dimeric 
subcomplex, indicating that Vps41 does not exclusively bind to either C-Vps subunit.  
The additional co-overexpression of Vps16 (Fig.  3.20, lane 6) does not lead to 
the formation of a pentameric subcomplex as it was observed for the vps33 deletion strain 
(compare section 3.4.1). A possible explanation for this obvious difference could be that 
Vps16, if overproduced without its binding partner Vps33, forms aggregates that do not 
participate in the generic subcomplex assembly. One indication that further substantiates 
this idea is that a very small portion of Vps33 and Vps16 does associate to the Vps11-
Vps18-Vam6-Vps41 subcomplex, which means that binding of Vps16 is restricted to the 
amount of available Vps33. If Vps16 is not overexpressed, it does not seem to be 
dependent on Vps33, most likely because its cytosolic concentration is much lower, 
which would prohibit its presumed aggregation. The Vps33 dependence of overexpressed 
Vps16 becomes even more apparent in the purification made from a strain co-
overexpressing all six subunits of the HOPS complex. Here, all subunits are pulled down 
to a similar extent (Fig.  3.20, lane 7). Also the association of Vps18 and Vps41 are 
increased in this expression background. Hence, Vps16 and Vps33 seem to stabilize 
interactions of Vps18 and Vps41 with the complex. This notion is well supported by the 
deletion experiments, where the overall ratio of complex to single protein is reduced in 
the vps33? and vps16? strains (compare section 3.4.1 Fig. 3.18 and 3.19 fractions 10/11 
versus 13/14). 
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A substantial amount of information about the architecture of the HOPS complex 
could be obtained using the deletion and co-overexpression approach. To further 
strengthen the data and to rule out that secondary unspecific effects led to the observed 
results, I decided to further substantiate the data with Yeast-2-Hybrid analysis of selected 
binding partners (Fig. 3.21) 
The Yeast-2-Hybrid experiment yielded several interesting results. Vps41 does only show 
an interaction with Vps18 and no other HOPS subunit probed for. This finding does only 
partially match the results from my co-overexpression experiments, where Vps41 only 
interacted with subcomplexes containing both Vps11 and Vps18, just as if it depends on a 
binding platform, which consists of Vps11 and Vps18. Furthermore, in a strain 
overexpression both Vps41 and Vps18, no stable subcomplex was observed. However, 
considering the overexpression results from Fig. 3.20, it appears that Vps41 is only 
binding to the Vam6-Vps11-Vps18 subcomplex to the same extent as Vps18, indicating a 
that Vps41 might be able to bind Vps18 alone. The interaction between these two 
Figure 3.21 | Yeast-2-Hybrid analysis of HOPS subunits ineractions. Indicated protein sequences were 
cloned into the corresponding Yeast-2-Hybrid vector and yeast cell were transformed with two constructs 
each. Selection on a double drop-out (DDO) plate is employed to screen for positive transformants. Growth 
on a quadruple drop-out (QDO) plate can only be observed, if the proteins of interest interact. 
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proteins without Vps11 is most likely too weak to withstand the co-purification 
conditions and therfore becomes only visible in the Yeast-2-Hybrid approach.  
Vps11 binds Vam6, Vps18 and itself. The Vam6 as well as the Vps18 binding is 
in good agreement with my previous results. The observed weak interaction of Vps18 
with Vam6 could be due to small amounts of Vps11 entering the nucleus in complex with 
the prey Vam6, therefore bridging the two otherwise not interacting proteins. No 
interaction of Vps16 with any of the assayed HOPS subunits can be detected. This could 
indicate a similar binding characteristic to the proposed Vps11-Vps18 platform or be due 
to a false-negative result. 
3.4.3 HOPS related subcomplexes are naturally occurring in vivo 
The knowledge gained from the combined deletion and overproduction TAPurifications 
yielded intriguing insights into the architecture of the HOPS/CORVET complex. 
However, by these means, we were not able to answer, if these subcomplexes do also 
naturally occur in wild type cells. To address this crucial question and to substantiate my 
previous findings, I employed a TAP strategy called “subtraction method” (Puig et al., 
2001). For this, I TAP-tagged Vam6 and additionally tagged Vps16 with a Protein A tag 
lacking a TEV-protease cleavage site in a wild type strain background. This allowed me 
to bind both proteins as well as their attached binding partners to IgG-Sepharose. The 
Vam6-TAP containing complexes that do not harbor Vps16-ProtA should be efficiently 
eluted off the column by TEV-protease treatment, whilst most of the Vps16-ProtA 
containing complexes (like the HOPS complex) were supposed to stick to the beads. If 
the Vps11-Vps18-Vam6 subcomplex was naturally occurring in the cell lysate, an 
enrichment of this subcomplex should be observed, whereas the full HOPS complex, 
which yields a dominant majority in the standard Vam6-TAP setup (compare Fig. 3.17 
B), would be diminished. Indeed, we detected an enrichment of the three proteins both 
visible by the linear fluorescent Sypro Orange stain (Fig. 3.22) as well as Coomassie 
staining. It has to be noted that all six HOPS subunits are eluted off the column in this 
experiment. This most likely indicates, that either Vps16-ProtA binding to the IgG beads 
is not complete and/or that a part of the Vps16-ProtA-containing complex is co-eluting 
due to secondary effects like the increase in incubation temperature during TEV elution. 
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3.4.4 In vivo localization of overexpressed HOPS subunits 
To further address the functionality of the subcomplexes, which formed by co-
overexpression of cognate HOPS subunits, I tagged several subunits with a fluorescent 
GFP-tag in the respective strain backgrounds. The HOPS subunits usually localize to the 
vacuolar limiting membrane and especially the class C Vps proteins, which are also part 
of the CORVET complex are additionally found in dots close to the vacuole, most likely 
representing late endosomes (Fig. 3.23, Vps18pr-VPS18-GFP as an example for the other 
HOPS subunits). Upon overexpression of single subunits, I observed a striking 
accumulation of the protein in dot-like structures of different sizes and numbers that did 
not clearly co-localize with the vacuole as monitored using the membrane dye FM 4-64. 
Overexpressed Vps11-GFP localized for example primarily to a single or few large dots 
that were only in some cases observed close to the vacuole, whereas overproduced 
Vps18-GFP localized to several small dots that appeared to be located closer to the 
slightly fragmented vacuole (Fig. 3.23). Interestingly, Vps11-GFP is not accumulated 
anymore, if co-overexpressed with Vps18 (Fig. 3.23 fourth panel from top). 
Overexpression of Vps11-GFP together with Vam6 leads to a high concentration of the 
Figure 3.22 | The Vam6-Vps11-Vps18 subcomplex naturally occurs in vivo. A A full standard TAP 
experiment was performed with yeast cells harboring a Tap tagged version of Vam6 as well as a Protein 
A tagged version of Vps16. Note the different intensities measured for the fluorescence of the Sypro 
Orange stain, which reflects different amounts of the HOPS subunits in the gel (right side). B Control 
purification of Vam6-TAP without additional subunit tagging. Note that only Coomassie staining is 
shown here, but the difference in band intensities in A were also observed using Coomassie staining. 
                                                                                                                       RESULTS 
 73 
GFP signal especially at vacuole-vacuole junctions as monitored with FM 4-64. 
Intriguingly, this phenotype is altered, if Vps18 is co-overexpressed on top. Vps11-GFP 
now localizes to the boundaries of compartments that are not dot-like, but appear like 
small vacuoles. As monitored by FM 4-64 staining, endocytic transport seems to be 
impaired, since the dye accumulates in small vesicles that are not overlapping with the 
Figure 3.23 | Localization of selected overexpressed HOPS subunits in different co-overexpression 
backgrounds. In the top panel, an example of wild type localization of a HOPS subunit is depicted. Note 
the different localizations and vacuole fragmentation phenotypes dependent on the overexpression of 
different subunit combinations. Size bar: 10?m 
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GFP-stained structures, most likely representing earlier endocytic compartments that are 
delayed in maturation. Although these results are not simply explained, I suggest that 
depending on the co-overexpression and therefore accumulation of single HOPS subunits 
or, more strikingly, HOPS subcomplexes, endocytic transport is delayed or maybe even 
stuck at different stages towards the vacuole. 
3.4.5 In vitro reconstitution of HOPS complex assembly 
The co-overexpression approach used above proved to be a powerful tool to identify and 
characterize stable subcomplexes. Since I was able to purify decent amounts of highly 
purified subcomplexes, I sought to re-capitulate HOPS complex assembly from 
subcomplexes, as I expected it to happen inside the cell as part of intracellular membrane 
trafficking (see discussion 4.4). However, all experiments in which I tried to assemble the 
holo-complex from purified subcomplexes failed. In these experiments, I employed the 
Mini-TAP protocol to produce EGTA eluates from a GAL1pr-VPS41-TAP and a GAL1pr-
3HA-VPS16-TAP GAL1pr-VPS33 strain. The eluates were then added to IgG-sepharose 
beads, which were previously incubated with a lysates from a GAL1pr-VPS11 GAL1pr-
VPS18 GAL1pr-VAM6-TAP strain and washed afterwards. After incubation for 1-4 hours 
at different temperatures, the beads were washed and bound protein was eluted using 
TEV protease. Interestingly, I was not able to recover the HOPS complex, indicating that 
in vitro assembly was not feasible in this reaction setup. I consider three possible 
explanations for this unexpected finding. First, the EGTA contained in the Mini-TAP 
eluates does impair HOPS subunit interaction; this could be explained for example by the 
chelating activity of the EGTA towards the zinc ions, which are supposed to be bound to 
the RING domains of Vps11 and Vps18 (compare introduction, section 1.3.2.5). Second, 
it is possible that the subcomplexes need further factors to correctly assemble, which are 
not contained in the purified sample or, third and most unlikely, the subcomplexes are not 
capable of assembling in vivo and consequently do not do so in vitro, which would 
contradict my findings in section 3.4.3. Since the first possible reason could only be 
challenged by generating further differently tagged strains and the third possible reason 
did not appear very likely to me, I tried to assemble the complex in a more native, yet an 
in vitro environment first. I decided to bring the overexpressed subcomplexes together as 
early during the purification procedure as possible. In this experiment, I mixed intact cells 
of the different subunit/subcomplex overexpressing strains as indicated in Fig. 3.24 
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before glass bead mediated cell lysis and performed an IgG pull-down with the lysate 
(Fig. 3.24 lanes C and C’). As controls, pull-downs using the lysates of unmixed cells 
were performed (Fig. 3.24 lanes 1-3 and 4-6). Furthermore, to address the question, when 
the subcomplexes loose their ability to assemble, I carried out a pull-down with a lysate 
mixture that was produced by mixing lysates from the three employed strains directly 
after the first pre-clearing step of the single lysates after a 20,000xg centrifugation step 
(Fig. 3.24 lanes L and L’).  
 Indeed, the TEV eluate from the Vam6-TAP bound IgG beads does contain the 
HA-tagged Version of Vps16, which was contributed from the cell pool that did not 
contain a TAP tag. This indicates that the observed interaction formed during cell lysis or 
the incubation (Fig. 3.24 a-HA decoration, upper panel C’). Intriguingly, the amount of 
3HA-Vps16 that was co-eluting in the lysates mixture sample (Fig. 3.24 a-HA 
decoration, upper panel L’) was strongly reduced compared to the cell mixture eluate and 
did almost match the weak signal of the background of 3HA-Vps16 that bound to the 
beads without Vam6-TAP (Fig. 3.24 lane 5), although similar amounts of Vam6-CbP 
were eluted from the column (Fig. 3.24 a-TAP decoration, lowest panel compare C’ and 
L’). I concluded that the whole complex assembles in the reaction setup, since also the 
Figure 3.24 | In vitro HOPS complex assembly. HOPS subcomplexes do only efficiently assemble into the 
holo complex, if they are mixed during cell lysis and not upon mixture of pre-cleared lysates. IgG-sepharose 
pull-downs were performed as in the Mini-TAP protocol and the TEV eluate was loaded onto an SDS-
PAGE gel. Western blotting was carried out and the membrane was decorated with the indicated antibodies. 
Detected protein bands were visualized using fluorescently labeled secondary antibodies and the Odyssey 
system. 
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amount of Vps41 is enhanced in the cell mixture pull-down compared to the lysates 
mixing approach (Fig. 3.24 lanes L and L’, a-Vam2, lower panel). Unfortunately, Vps41 
unspecifically binds to the IgG-sepharose without a TAP tag (Fig. 3.24 lane 4) and is also 
existent in low quantities in the Vam6-TAP eluate, since trace amounts of HOPS 
complex are co-purified (Fig. 3.24 lane 6). However, the signal observed for Vps41 in the 
cell mixture eluate is higher than in the lysates mixture approach or in the controls 
(compare Fig. 3.24 lane C’ with L’ and lanes 4 and 6).  
These results strongly suggest, that a factor, which is either inactivated or not 
extracted from membranes during cell lysis with the detergent containing lysis buffer 
promotes the assembly of the subcomplexes into the HOPS complex. Alternatively, 
intracellular membranes themselves or a lipid factor are needed for efficient assembly, 
but get separated from subcomplexes during prolonged lysis and centrifugation. Further 
experiments are currently underway to determine the nature of this proposed factor. A 
first experiment, where recombinant GST-Ypt7 was added to a HOPS reconstitution 
mixture did not suggest an involvement of the vacuolar Rab protein in this process. 
3.5 Functional characterization of HOPS subunits and 
subcomplexes 
3.5.1 Vps41 and Vam6 differentially interact with the vacuolar 
Rab GTPase Ypt7 
In a previous publication (Wurmser et al., 2000), the HOPS subunit Vam6 has been 
shown to act as a guanyl nucleotide exchange factor (GEF) for the yeast late 
endosomal/vacuolar Rab protein Ypt7. Moreover, Vps41 as the second HOPS specific 
subunit (i.e. not being part of the CORVET complex) has very recently been shown to 
interact with Ypt7 in a different manner than Vam6 (Brett et al., 2008). We therefore 
asked, if Vps41 is the only Ypt7 interacting subunit beside Vam6 and if it could be 
assigned to functioning as the subunit, which is mediating Rab-effector properties to the 
assembled HOPS complex.  
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Considering our results from section 3.4.1, we were most cautious in interpreting 
experimental data retrieved from HOPS subunit deletion strains. Therefore, I employed 
different overproduced and purified HOPS subunits to perform pull-down experiments 
with recombinantly produced GST-tagged Rab proteins to assess their Rab binding 
properties. The GTPases were stripped of all nucleotides and either kept nucleotide free 
or loaded with GDP or the non-hydrolyzable GTP analog GTP?S to mimic the inactive or 
active state of the Rab protein, respectively. GST-Vps21 or GST-Ypt1, as indicated, were 
used as controls and were treated just as GST-Ypt7. First, we performed a Rab pull-down 
experiment with Vam6-CbP from a GAL1-overexpression strain, lacking stoichiometric 
amounts of the other HOPS subunits (Fig. 3.25). Indeed, we can report on a protein 
specific interaction of Ypt7 with Vam6-CbP alone. In our Rab-pull-down experiment, we 
observe relatively equal binding of single Vam6 to all three nucleotide-binding states of 
Ypt7. This is in agreement with Y2H data from previous publications (Wurmser et al., 
2000) and my own Yeast-2-Hybrid experiments (Fig. 3.26). In contrast to this, our 
finding differs from one pull-down experiment previously published, showing interaction 
only with the GDP-form of Ypt7 (Wurmser et al., 2000). Nevertheless, my results are in 
accord with several previous studies concerning the interaction of other GEFs with their 
respective GTPase (Bos et al., 2007). Moreover, for two other described Rab-GEFs the 
observed binding pattern appears to be differing from each other, indicating that the Rab-
Figure 3.25 | Rab pull-down of purified Vam6 reveals its affinity for Ypt7. Purified Vam6-CbP was 
subjected to a Rab pull-down experiment using Ypt7 and Vps21 as a control. Vam6 specifically binds Ypt7 
and exhibits a promiscuous binding pattern to all nucleotide states. L=load, NF=nucleotide free. 
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GEF proteins can function in a variety of binding modes (Hama et al., 1999; Walch-
Solimena et al., 1997). 
 A different result was obtained in the Vps41 Rab-pull-down experiment. In this 
case, Vps41-CbP was mainly pulled down by GST-Ypt7 in the GTP?S bound form 
whereas a weak signal was detected for the nucleotide-free form of GST-Ypt7 (Fig. 
Figure 3.27 | Vps41 preferentially interacts with the active, GTP-form of Ypt7. Purified Vps41-CbP was 
subjected to a Rab pull-down experiment using Ypt7 and Vps21 as a control. Vps41-CbP specifically binds to 
GTP-Ypt7, suggesting that it functions as the Rab-effector subunit in the HOPS complex. L=load, 
NF=nucleotide free. 
Figure 3.26 | Vam6 interacts with all Ypt7 variants in the Yeast-2-Hybrid system. 
Indicated protein sequences were cloned into the corresponding Yeast-2-Hybrid vector and 
yeast cell were transformed with two constructs each. Selection on a double drop-out (DDO) 
plate is employed to screen for positive transformants. Growth on a quadruple drop-out 
(QDO) plate can only be observed, if the proteins of interest interact.  
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3.27). The interaction of Vps41 with the GDP-bound form of Ypt7 was as low as the 
background levels, which were detected for the interaction with the other unspecific Rab 
GTPases. This finding clearly designates Vps41 as a Rab GTPase effector for Ypt7, 
which is supposed to specifically interact with the activated form, and to exhibit a 
markedly low affinity for the GDP-bound, inactive form of the Rab protein. 
3.5.2 The HOPS complex interacts with Ypt7 via Vps41 alone 
I wondered, if the reported interaction of the vacuolar Rab Ypt7 with the HOPS complex 
was reflecting the same way of interaction that I observed for Vam6 and Vps41. For this 
purpose, nucleotide specific Rab pull-downs with purified HOPS complex were 
conducted (Fig. 3.28). Intriguingly, I detected strong HOPS interaction with the GTP-
form and a weaker interaction with the nucleotide free form of Ypt7, which exactly 
reflects my findings for Vps41 alone (compare Fig. 3.25). 
I wondered, why no interaction with the GDP-bound form was detectable, as it has been 
observed for Vam6 (compare Fig. 3.25). I reasoned that either Vam6 binding to Ypt7 was 
too weak to be detected, compared to the strong Vps41-Ypt7 interaction, or that Vam6 
loses its capability to bind Ypt7 in the assembled HOPS complex. To test this, I took 
advantage of our knowledge of stable subcomplexes and subjected purified Vam6-Vps11 
complex to the Rab pull-down assay. Indeed, Vam6-Vps11 binding to any form of Ypt7 
was strongly reduced down to background levels (Fig. 3.29). Moreover, if I purified 
Figure 3.28 | Purified HOPS complex exhibits the same Ypt7 variant specificity as Vps41. The HOPS 
complex exhibits the same binding pattern to Rab proteins as its subunit Vps41. No interaction could be 
measured to the control Rabs Vps21 or Ypt1. L=load, NF=nucleotide free. 
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HOPS complex via Vam6-TAP instead of Vps41-TAP and subjected the complex to a 
Rab pull-down experiment, Vam6-CbP as a member of the complex exhibits the exact 
binding characteristics of Vps41 (Fig. 3.30). This clearly indicates, that Vam6, if bound 
to the HOPS complex, is not capable of interacting with Ypt7 by itself any more. In the 
study by Wurmser et al. (Wurmser et al., 2000) it was demonstrated that Vam6 exhibits 
GEF activity in a vps11? background. Therefore, I conclude that Vam6 functions as a 
GEF as a single protein only and is attenuated in its activity, as soon as it is incorporated 
into a complex with Vps11 at any level of complexity (i.e. in the Vps11-Vam6, Vps18-
Figure 3.30 | Vam6 loses its affinity for Ypt7 also if part of the HOPS complex. Vam6 that is part of the 
HOPS complex interacts with Ypt7 in the same way as Vps41, suggesting that its ability to act as a GEF for 
this Rab is abolished as soon as it gets incorporated into the complex. L=load, NF=nucleotide free. 
Figure 3.29 | Vam6 does not bind to Ypt7, if it is in a complex with Vps11. Binding to Ypt7 of Vam6 that 
is in complex with Vps11 is reduced to background levels. L=load, NF=nucleotide free. 
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Vps11-Vam6- or the HOPS complex). Our pull-down experiments reveal that the binding 
of the HOPS complex to Ypt7 is exclusively based on its activity as an effector for this 
Rab protein. Furthermore, I could now show that this activity entirely depends on its 
subunit Vps41.  
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4 Discussion 
The results of my thesis work give new substantial insights into the regulation of the 
HOPS complex by Vps41 phosphorylation, the architecture of the HOPS tethering 
complex and its subcomplexes. The identification of the novel CORVET tethering 
complex and the corresponding intermediate complexes filled a gap in our knowledge 
about endolysosomal tethering and supports previous reports on the mechanism of 
endosomal maturation upstream of fusion with the vacuole.  
4.1 Regulation of the HOPS tethering complex by Vps41 
phosphorylation 
In a study by Tracy LaGrassa in our lab, it was demonstrated that Vps41 is a substrate for 
the vacuolar casein kinase Yck3. She was able to show that Vps41 phosphorylation has 
an influence on the tethering activity of the HOPS complex by employing a hyperosmotic 
stress experiment (LaGrassa and Ungermann, 2005). To rule out secondary effects of 
other Yck3 targets in this process and to be able to investigate the effects of Vps41 
phosphorylation on the activity of the HOPS complex in more detail, I identified the 
phosphorylation sites within the protein’s sequence (see section 3.1.1). Further 
experiments that were conducted by my colleague Dr. Margarita Cabrera revealed that an 
unphosphorylated mutant of Vps41 (Vps41 S-A) concentrates together with the other 
HOPS subunits at endosome-vacuole fusion sites. Moreover, endosomal structures 
accumulate at this site, suggesting that fusion activity is altered due to impaired 
phosphorylation of Vps41 S-A. A phosphomimetic Vps41 mutant (Vps41 S-D) exhibited 
a contrasting phenotype with a more cytosolic distribution of Vps41 S-D and no sites of 
accumulation on the vacuolar rim of Vps41 S-D or the other HOPS subunits. 
Interestingly, the HOPS complex was still assembled in both the unphosphorylated and 
the phosphomimetic mutant strains (Cabrera et al., 2009). Furthermore, the 
phosphorylation-independent binding of Vps41 to the active form of the vacuolar Rab 
GTPase, which I was able to characterize in my studies, allows for a partial rescue of 
Vps41 S-D localization and enhances the phenotype observed for the unphosphorylated 
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mutant if high levels of Ypt7 are provided (Cabrera et al., 2009). This suggests, that 
Vps41 and hence HOPS complex localization and activity are dependent on both Ypt7 
and Yck3 phosphorylation activity. 
 Since Vps41 is needed for AP-3 vesicle formation at the trans Golgi (Darsow et 
al., 2001; Rehling et al., 1999), the influence of Vps41 phosphorylation on this specific 
step was investigated. We found that AP-3 cargo transport is impaired in the Vps41 S-A 
mutant background, which is in good agreement with a reduced mobility of this Vps41 
variant (Cabrera et al., 2009). Moreover, this finding implies a positive feedback 
regulation: Yck3 is transported via the AP-3 pathway and releases Vps41 after it reached 
the vacuole, therefore allowing it to fulfill its function during AP-3 vesicle formation. 
 An interesting finding of Bruno Antonny and co-workers sheds light on a 
possible mechanism of how Vps41 phosphorylation alters its membrane association. In a 
previous study (Drin et al., 2007), Vps41 was found among other proteins to contain an 
ALPS-like motif, which can form amphipathic helices that can dip into membranes in a 
reversible manner and preferentially expose Serine and Threonine residues on the polar 
surface of the helix. Intriguingly, the ALPS-like motif was predicted to be exactly located 
at the phosphorylation site identified by me. These findings imply that the mode by which 
unphosphorylated Vps41 binds to the membrane is by the insertion of an amphipathic 
helix into the lipid bilayer, a feature that seems to be inhibited by the phosphorylation of 
the hydrophilic face of the amphipathic helix (Cabrera et al., in preparation).  
 It is possible that the above-mentioned findings could serve as a general model of 
how reversible membrane association of proteins can be achieved by site-specific 
phosphorylation. Since the ALPS motif identified by the Antonny lab always contains 
Serine and Threonine residues on the polar surface of the amphipathic helix, it appears 
likely that membrane binding of several other proteins that have been found to contain 
such a motif could be regulated by yet unidentified phosphorylation events. Our lab is 
currently following up on this idea by investigating the properties of an ALPS-like 
sequence in the Vps41 homolog CORVET subunit Vps8. Also the fusion factor Mon1, 
which I identified as another target of Yck3 activity could be regulated in a similar way, 
although no ALPS-like motif was yet identified in its amino acid sequence. 
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4.2 Structural analysis of the HOPS complex 
The HOPS complex remained the structurally least characterized tethering complex in the 
past. Recombinant expression of the subunits was in most cases not feasible due to their 
high molecular weight and the tendency to aggregate (Dr. Alexey Rak, now Sanofi-
Aventis, Paris, personal communication; my own observations). However, these are only 
some of the features that make the HOPS complex appear quite unique among tethering 
complexes, and that raised my interest in identifying the structural properties of this very 
complex.  
A substantial amount of time and effort during my thesis work was spent on 
experiments aiming for the crystallization of single HOPS subunits and the electron 
microscopic analysis with the complete complex. In preparing the overexpression strains, 
establishing the purification routine and screening the optimal purification conditions, I 
was able to pave the ground for current EM experiments with promising results (see 
section 3.2.2.3). First negative stain electron microscopy pictures are available and the 
next experiments employing electron tomography should yield even better data, which 
could finally serve for a refined modeling of the overall complex structure. This structure 
might give insights into a possible working mode of the complex during tethering. The 
structures of other tethering factors have been analyzed before (Kim et al., 2006; Kümmel 
and Heinemann, 2008; Tripathi et al., 2009) (see section 1.3.2) and it will be most 
interesting, if the HOPS complex structure is in line with these or if it might exhibit a yet 
unique architecture.  
 First crystallization trials conducted with the purified HOPS subunit Vps41 were 
not successful. However, additional crystallization conditions will be tested in further 
trials to succeed in the analysis of subunits of the HOPS complex. Next to the purification 
from yeast, fragments of the different subunits are currently recombinantly produced in 
E. coli by my successor colleague Cornelia Bröcker. Together with the knowledge 
obtained about the interactions between different HOPS subunits in this thesis work, it 
appears feasible to also co-overexpress cognate subunits or interacting fragments in a 
bicistronic approach in E. coli (see section 3.2.1.1), which might allow for an enhanced 
purification yield.  
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4.3 Identification of the novel CORVET complex and 
intermediate complexes 
Together with my colleague Dr. Karolina Peplowska, I was able to identify a novel 
protein complex with homology to the vacuolar HOPS tethering complex. The existence 
of this complex and its functioning at the later endosomal compartments is in good 
agreement with previous studies. The complex interacts with the endosomal Rab GTPase 
Vps21 (Rab5 homolog) and the Vam6 homolog Vps3 is proposed to act as a guanyl 
nucleotide exchange factor for Vps21, two findings that stress the similarity also to the 
functional characteristics of the HOPS complex (Peplowska et al., 2007) (see below).  
 Interestingly, next to these two complexes, we could identify two additional 
“intermediate” complexes, that contain one of the complex specific subunits (i.e. Vps3 
and Vps8 for CORVET, Vam6 and Vps41 for HOPS) together with one specific subunit 
of the other complex (Fig. 4.1). 
Previous results by Rink et al. (Rink et al., 2005) showed that maturation of 
single endosomes in mammalian cells from an earlier to the late stage was accompanied 
by an exchange of the Rab GTPase Rab5 for the Ypt7 homolog Rab7 on the endosomal 
surface. Together with our new data, these findings imply that this Rab exchange depends 
on or promotes the conversion of tethering complexes during endosomal maturation (Fig. 
4.2). 
 
Figure 4.1 | The different novel complexes identified in this study. 
Adapted from Ref. (Peplowska et al., 2007). 
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However, the identification of stable HOPS subcomplexes and the finding that a vps41 
deletion leads to a trimeric complex consisting of Vam6, Vps11 and Vps18 and not to the 
formation of the iHOPS complex challenge this model. Although the experiments that 
identified the iHOPS complex are solid and show the existence of small amounts of this 
intermediate complex (see section 3.3.3) in wild type cells, the question arises, to which 
extent such a complex could be involved in the turnover of physiological amounts of 
tethering complexes (as proposed in Fig. 4.2). Especially the fact that the conversion 
from CORVET on endosomes to HOPS on very late endosomes, a process that should be 
vigorously happening during endosomal maturation, would rely on this very low 
abundant intermediate complex raises further doubt. In this regard, my results can be best 
interpreted, if one would assume that this conversion is happening extremely rapid. Still, 
iHOPS would have to be very instable to explain, why it could not be detected in a vps41 
deletion background. In fact, my findings about stable subcomplexes suggest a much 
more dynamic model, were tethering could be mediated by assembling cognate 
subcomplexes into the HOPS complex, a mode of function that was shown for the 
exocyst tethering complex (Boyd et al., 2004) and that would as well apply for the 
CORVET complex. I will further discuss these ideas in the next section. 
Figure 4.2 | A possible mode of tethering complex conversion linked to 
endolysosomal maturation. Since the endosomal CORVET complex and the vacuolar 
HOPS complex appear to be linked by the intermediate complexes, it appears likely that 
they are converted into each other upon endolysosomal maturation events. Figure 
extracted from Ref. (Peplowska et al., 2007). 
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Considering the model of tether conversion (Fig. 4.2), one of the major questions 
for future experiments is the identification of factors that regulate the maturation events. 
Since endosomes harbor ubiquitinylated cargo on their surface, which is destined for 
invagination by the action of ESCRT complexes at the stage of MVB formation, it could 
be that the enrichment of such cargo on the surface membrane could serve as a trigger for 
endosomal maturation events.  
4.4 Identification of stable subcomplexes and functional 
characterization of HOPS subunits 
Although single HOPS subunits have been show to act upstream of the vacuole in the 
AP-3 pathway (Vps41) and the CPY pathway (class C-Vps proteins), the finding that the 
four class-C-Vps proteins function together with Vam6 and Vps41 in the HOPS complex 
somehow halted the investigation of single subunits in the scientific community. The 
HOPS tethering complex has therefore been looked upon as a rather static entity residing 
on the vacuolar membrane to allow for homo- and heterotypic fusion events at the 
vacuole (Collins et al., 2005; Starai et al., 2008; Stroupe et al., 2006). One aim of my 
thesis work was to investigate the interactions taking place between different HOPS 
subunits, which allows the assembly into the holo complex. The striking finding that the 
deletion of vps41 leads to the disassembly of the complex into stable subcomplexes, led 
me to perform additional experiments to reveal further stable subcomplexes. Due to these 
experiments, I was able to draw a picture of the subunits’ interactions taking place in the 
fully assembled complex (Fig. 4.3). In employing a special variant of the TAP technique, 
I was furthermore able to provide evidence that at least one of the identified 
subcomplexes (Vam6-Vps11-Vps18) naturally occurs in vivo (see section 3.4.3). 
 These results next to the above-mentioned insights into the connectivity of the 
CORVET and the HOPS tethering complexes lead me to propose a more dynamic 
functioning of these two tethers. The exocyst complex, which tethers exocytic vesicles to 
the plasma membrane, has been shown in several studies to be sequentially assembled 
during the process of vesicle tethering (Boyd et al., 2004; Munson and Novick, 2006). 
Similar to the mechanism of trans-SNARE formation, the assembled complex only marks 
the end point of a series of events that are all needed to perform the task of membrane 
fusion. Our exciting finding about the mechanism of HOPS regulation via the Yck3-
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dependent phosphorylation of Vps41 could help to understand how the complexes 
subunits could be made available again after complete assembly. 
The idea of a sequential functioning of the HOPS subunits and their subcomplexes 
is further supported by my finding, that the Ypt7-GEF Vam6 loses its ability to interact 
with this Rab protein upon binding to its sole binding partner in the HOPS complex, 
Figure 4.3 | Interactions between different HOPS subunit as reported in this study. A interactions that 
were observed in this thesis work are depicted by double lines. Interactions that were confirmed by Yeast-2-
Hybrid analysis are depicted by bold lines. Note that the two subunits Vps16 and Vps41 appear to bind to a 
platform made of Vps11 and Vps18 together, not to the single proteins. B Model of how the subunits could 
be arranged in the fully assembled HOPS complex base on this thesis work. 
Figure 4.4 | A Possible mode of sequential assembly of the HOPS tethering complex. Vam6* is active as 
a GEF for Ypt7, most likely at the late endosomal membrane, but loses this activity upon binding of Vps11. 
The other subunits/subcomplexes that might be involved in yet unidentified reactions bind sequentially. 
Vps41 is recruited to Ypt7-GTP positive membranes and could serve as a dock for the other subcomplexes 
(compare to Sec3 function in the exocyst, section 1.3.2.4) thereby spatially limiting sites of HOPS complex 
formation.  
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Vps11. Hence, the assembled HOPS complex cannot act as GEF for Ypt7 as it has been 
taken for granted in the past. The subunit Vps41, which I could identify as the only Rab 
effector subunit of the HOPS complex, could serve as an adaptor, which would bind to 
Ypt7-GTP-positive membranes, while assembling into the complete HOPS complex 
during the tethering event (Fig. 4.4). By these means, the site of assembly and thereby 
tethering could be spatially restricted, since only membranes harboring Ypt7-GTP on 
their surface would be recognized. To substantiate this idea, several future experiments 
have to be performed, which address the functionality and site of action of the HOPS 
subcomplexes in vivo and identify the factor that promotes HOPS complex assembly 
during cell lysis in vitro (compare section 3.4.5).  
4.5 Conclusion 
In sum, the data provided in my thesis work provide valuable data for expanding our 
knowledge about tethering in the endolysosomal system and the architecture and 
dynamics of the complexes, which are involved in this process. Based on my work on the 
overexpression and efficient purification of the HOPS complex and its subunits, further 
structural information will hopefully be accessible in the near future. In combination with 
my results on the interaction network of HOPS subunits, these data could help clarifying 
our picture of tethering at the yeast vacuole and yield substantial insights into the process 
of tethering per se. 
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5 Materials and Methods 
5.1 Chemicals and Reagents 
Chemicals were purchased from the Sigma-Aldrich Chemie GmbH (Munich, Germany) 
and Carl Roth (Karlsruhe, Germany) if not differently indicated. All Products used for 
Molecular cloning, i.e. polymerases, restriction enzymes and accessory products were 
obtained from Fermentas (St. Leon-Rot, Germany) and NEB (Frankfurt a.M., Germany). 
Primers were ordered from Thermo-Fisher Scientific (Ulm, Germany). Reagents used for 
production of media and plates were obtained from MP-Biomedicals (Heidelberg, 
Germany) and Applichem (Darmstadt, Germany). All plasticware as reaction tubes and 
pipette tips were acquired from Sarsted (Nümbrecht, Germany). Cultivation flasks and 
other glassware was provided by VWR (Darmstadt, Germany). 
5.2 Yeast and bacteria culture 
5.2.1 Media 
For yeast cultures, the following media were utilized: 
5.2.1.1 Complex media  
Yeast Extract Peptone Dextrose (D-Glucose) (YPD) for standard yeast culture. For 1l 
medium, 10g yeast extract, 20g peptone and 20g D-Glucose were dissolved in 1l 
ultrapure water and the pH was adjusted to 5.5 using 1M HCl.  
Yeast Extract Peptone Galactose (YPG) for yeast culture of Gal1pr-overexpressor strains. 
For 1l medium, 10g yeast extract, 20g peptone and 20g D-Galactose were dissolved in 1l 
ultrapure water and the pH was adjusted to 5.5 using 1M HCl.  
For the production of plates, 15g Agar were added per liter medium before autoclaving. 
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YPD and YPG were supplemented with antibiotics, if necessary. For a list of antibiotics 
and working concentrations, see below. 
5.2.1.2 Synthetic media 
Synthetic Dextrose complete drop-out medium (SDC-X) for selecting strains harboring a 
plasmid- or genomically encoded auxotrophy marker (e.g. after transformation). For 1l 
medium, 6.75g yeast nitrogen base w/o amino acids, 20g D-Glucose and ca. 0,75 
complete supplement media lacking the specific marker metabolite (CSM, exact amount 
depends on the drop-out medium used) were dissolved in 1l ultrapure water and the pH 
was adjusted to 5.5 using 1M NaOH 
For E. coli cultures, lysogeny broth (LB) (BERTANI, 1951) medium was used, 
supplemented with the antibiotic of choice. For 1l medium, 5g yeast extract, 10g tryptone 
and 10g NaCl were dissolved in 1l ultrapure water and the pH was adjusted to 7 using 1M 
HCl.  
5.2.2 Antibiotics 
The following antibiotics were used in yeast or bacterial cultures in the indicated 
concentrations: 
Ampicillin   100?g/ml 
Chloramphenicol  30?g/ml 
Geneticin (G418)  200?g/ml 
Hygromycin B   300?g/ml 
Kanamycin   35?g/ml 
Nourseothricin (ClonNat) 100?g/ml 
5.2.3 Yeast and bacteria culture 
Yeast and bacteria liquid cultures were incubated at 30°C or 37°C, respectively. In both 
cases, the cultivation flasks or tubes were put on an Innova shaker (New Brunswick 
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Scientific, Edison, NJ, U.S.A.) set to a rotation of 180rpm. For cultures up to 2ml 
volume, a benchtop Thermo-Shaker (Eppendorf, Hamburg, Germany) was employed. 
5.2.4 Generation of strains 
Genetic manipulation of strains was performed genomically by homologous 
recombination of PCR products, if not indicated differently. C-terminal TAP tagging 
(Rigaut et al., 1999) was performed with the use of three different template plasmids 
using either the URA3-, TRP1- (Puig et al., 2001) or KanMX4- (Janke et al., 2004) 
resistance marker. Primers were designed according to the respective references.  
Yeast-2-Hybrid analyses were performed using plasmid pACT2 and pFBT9 (derived 
from pGBT9, both Clontech labs, Mountain View, CA, U.S.A.; provided by Dr. Francis 
Barr, University of Liverpool, UK). Open reading frames were amplified from purified 
genomic DNA from strain BY4741 and ligated into pACT2 or pFBT9 after restriction 
digest with BamHI and XhoI or BamHI and SalI, respectively. Mutated versions of Rab 
genes were generated using a site-directed-mutagenesis kit (Quick-Change kit, 
Stratagene, La Jolla, CA, U.S.A.).  
5.3 Biochemical assays 
5.3.1 TCA precipitation 
For denaturing precipitation of proteins, samples were supplemented with 100% TCA 
solution to a final concentration of 13%, mixed and incubated for 10 minutes on ice. 
Samples containing no detergent were supplemented with 10% NP-40 to a final 
concentration of 0,1% beforehand. Samples were incubated for 10 minutes on ice and 
centrifuged for 10 minutes at 20,000xg. TCA-containing supernatant was discarded and 
the pellet was washed once with 1ml 100% Aceton at -20°C. After additional 
centrifugation at 20,000g for 10 minutes, the pellet was dried at 55°C for several minutes. 
SDS-sample buffer (Laemmli, 1970) was added after drying was completed.  
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5.3.2 Total protein extraction from yeast 
To assess the protein content of yeast cells both quantitatively and qualitatively, the 
equivalent of cells contained in 1ml of a cell culture with an optical density (OD) at 
600nm wavelength of 1AU (1OD-unit) was subjected to alkaline lysis. The cell 
suspension was treated with lysis solution containing 0.25M NaOH, 140mM ?-ME and 
3mM PMSF and lysis was allowed to continue for 10 minutes on ice. Afterwards, TCA 
precipitation of the lysate was performed. If not otherwise denoted, the equivalent of ? 
OD-unit was applied to an SDS-PAGE gel and subsequent Western-blotting was 
performed. 
5.3.3 SDS-PAGE 
Gelelectrophoresis was performed using either the HOEFER Mini vertical units from 
Amersham-Biosciences (GE-Healthcare, Munich Germany) or the Mini-PROTEAN II 
system (Biorad, Munich, Germany). NuPAGE pre-cast gels (Invitrogen, Karlsruhe, 
Germany) were employed for 4-12% gradient gel electrophoresis. Pre-cast gels were run 
according to the manufacturer’s protocol, whereas all other gels were run following the 
Laemmli system (Laemmli, 1970).  
5.3.4 Coomassie staining of SDS-PAGE gels 
For the staining of proteins separated on an SDS-PAGE gel, the colloidal Coomassie 
System (Roth, St. Leon-Rot, Germany) was employed according to the manufacturer’s 
description unless denoted otherwise. In brief, 5x Coomassie suspension was diluted in 
25% Methanol/ddH20 solution. Gels were incubated overnight together with 100ml of 1x 
Coomassie suspension per gel. Destaining was performed with 25% Methanol/ddH20 
solution. Stained gels were scanned on an EPSON (Meerbusch, Germany) flatbed scanner 
and pictures were processed using Adobe Illustrator CS software (Adobe, San Jose, CA, 
U.S.A.). 
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5.3.5 Sypro Orange staining of SDS-PAGE gels 
For the quantitative analysis of proteins separated on an SDS-PAGE gel, the protein dye 
Sypro Orange (Invitrogen, Karlsruhe, Germany) was employed. Sypro Orange allows for 
the fluorescence-based detection of proteins, yielding linear signals for a broad range of 
protein concentrations. Since the dye molecule interacts with the SDS bound to the 
polypeptide chains, the signal strength is independent of the amino acid sequence to a 
great extent compared to other staining methods like Coomassie staining. Gels were 
washed for 30 minutes in SDS-running buffer containing 0,5% SDS compared to 1% 
normal concentration. After brief rinsing with water, the gels were incubated in 7,5% 
acetic acid containing SyproOrange dye in 1:5000 dilution for 30 minutes at room 
temperature. After staining, the gels were briefly rinsed in 7,5% acetic acid and analyzed 
on a Versadoc fluorescence detection system (Bio-Rad, Munich, Germany) using 
QuantityOne software by the same manufacturer. 
5.3.6 Production of recombinant proteins in E.coli 
BL21 DE3 Rosetta cells were freshly transformed with the plasmid coding for the protein 
of interest and plated onto LB agar plates containing the appropriate antibiotics. Single 
colonies were picked from the transformation plate and the cells were directly suspended 
in 1l of LB medium containing the appropriate antibiotics. The culture was grown in an 
Innova Shaker at 37°C, 180rpm for several hours until the OD at 600nm was between 0.4 
and 0.8. The cultures were then cooled down to 16-25°C depending on the plasmid 
encoded protein. Expression was induced with 0.5mM IPTG and cells were grown at 16-
25°C, 180rpm overnight or at least additional 4 hours.  
5.3.7 Purification of recombinant proteins from E. coli 
After growth of bacterial culture and expression induction, the cell suspension was 
harvested by centrifugation in a JLA 8.000 rotor in an Avanti J26 XP centrifuge (both 
Beckman, Krefeld, Germany) at 5000rpm for 10 minutes. Cells were then washed once 
with 20ml/l culture ice-cold purification buffer (100mM NaCl, 50mM Hepes/NaOH 
pH=7.4, 1mM MgCl2) and centrifuged once more as above. The pelleted cells were then 
carefully resuspended in 10ml/lculture lysis buffer containing 2mM PMSF and 0.2x PIC 
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avoiding cell aggregates. The cells were then lysed using a Microfluidizer (Microfluidics, 
Newton, MA, U.S.A.) 
5.3.8 Western Blotting 
For the detection of proteins by antibody decoration after the transfer of proteins to 
nitrocellulose membrane from SDS-PAGE gels, the Western blotting technique was 
employed. The protein containing samples were first subjected to SDS-PAGE for size-
dependent separation. Afterwards, a nitrocellulose membrane of similar size as the gel 
was soaked in Western transfer buffer and put on a wet filter paper. The SDS-PAGE gel 
was then put on the membrane directly after the electrophoresis run. The gel was overlaid 
with another sheet of filter paper, turned once by 180 degrees and then put into the 
blotting chamber (Idea Scientific, Minneapolis, MN, U.S.A.) between several layers of 
thin cloth sponges. The chamber was then filled with transfer buffer and the transfer was 
carried out at 400mA, 12-15V for 90minutes. Afterwards, the protein bands were 
visualized by short incubation of the membrane with 0,3% PonceauS dye in 3% TCA 
solution and subsequent wash in distilled water. The protein bands of the molecular 
weight marker were marked with a black pen and free protein binding sites on the 
membrane were blocked by incubation with 5% milk in PBS buffer for 30 minutes. For 
protein detection, the blot membrane was then incubated with primary antibody directed 
against the antigen of interest. In most cases, the primary antibodies were obtained from 
rabbit serum and diluted 1:3000 to 1:6000 in 5% milk. If affinity purified antibodies were 
used, the dilution ranged from 1:100 to 1:500. The antibody directed against the HA tag 
was obtained mouse hybridoma cells and was diluted 1:1000 in 5% BSA. Blots were 
decorated with primary antibodies generally for 1 hour at room temperatur and washed 
three times with PBS afterwards. Secondary antibodies were obtained from goat serum 
and were directed against rabbit or mouse antibodies dependent on the first antibody that 
was used. These antibodies were coupled to fluorescent dyes; either Alexafluor 680 
(Invitrogen, Karlsruhe, Germany) or IRDye800 (LiCor, Bad Homburg, Germany) were 
used and could be detected on a LiCor Odyssey scanner (LiCor). Incubation of blot 
membranes with secondary antibody (1:10000 dilution in 5%milk in PBS) was performed 
for 30 minutes at room temperature. Before detection, the membrane was washed four 
times for five minutes with PBS. 
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5.3.9 Subcellular fractionation 
This protocol was employed to determine the localization of proteins in the 
endomemembrane system of yeast cells or to crudely separate vacuoles or endosomes 
from slower sedimenting organelles. Subcellular fractionating was for example employed 
to prepare Vps41 and Yck3 containing fractions for a subsequent up-shift assay. The 
protocol was performed as described in (LaGrassa and Ungermann, 2005). In brief, yeast 
spheroblasts were prepared and mildly lysed to release the cell content in to the lysis 
buffer. By subsequent centrifugation at 13,000xg a P13 (pellet at 13,000xg) and an S13 
(supernatant at 13,000xg) were generated. If indicated, the S13 fraction was further 
centrifuged for 1 hour at 100,000xg to generate the P100 and S100 fractions, which 
contain slower sedimenting organelles as ER Golgi, and plasma membrane fragments and 
soluble proteins, respectively. The obtained fractions were either directly diluted in 1x 
Laemmli SDS sample buffer or TCA precipitated. Subsequent SDS-PAGE and Western 
blotting allowed for the analysis of the samples.  
5.3.10   Vps41 upshift assay 
P13 fractions obtained via subcellular fractionation (see 5.3.8) were subjected to 
incubation with ATP and ATP-regenerating system to allow for efficient phosphorylation 
of Vps41 by Yck3. The samples were incubated for 45 minutes at 26°C for the 
phosphorylation reaction. Afterwards, samples were centrifuged at 20,000xg for 5 
minutes and the resulting pellet was dissolved in 1x Laemmli SDS sample buffer and 
loaded onto 7,5% SDS-PAGE gels without prior boiling. 
5.3.11   Rab GTPase pull-down 
GST-Rab fusion proteins (300-350μg per sample) were incubated in 500μl nucleotide 
loading buffer containing 20mM Hepes/NaOH (pH=7.4), 20mM EDTA and 1mM GDP, 
GTP?S or no nucleotide for 15 min at 30°C. The GDP and GTP?S samples were adjusted 
to 25 mM MgCl2, and loaded onto 50μl of washed GSH-sepharose, whereas no MgCl2 
was added to the nucleotide free sample prior to loading onto the same amount of GSH-
sepharose. After incubation for 1h at 4°C, the GSH-bound nucleotide free form was 
washed once with 20mM Hepes/NaOH (pH=7.4), 20mM EDTA and the matrix was then 
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resuspended in 200μl buffer containing 20mM Hepes/NaOH (pH=7.4) 100mM NaCl, 
1mM MgCl2. The GDP and GTP?S loaded samples were resuspended in 200μl of the 
same buffer containing additional 2.5mM GDP or GTP?S, respectively. These nucleotide 
loaded Rab GTPases bound to GSH-sepharose were then immediately used for pull-down 
experiments. Protein samples to be applied to Rab GTPase pull-down where prepared in 
parallel using the Mini-TAP protocol. TEV eluates were directly applied to the 
immobilized GST-Rab proteins and the bead suspension was incubated for 1h at 4°C on a 
turning wheel. After the binding reaction, the beads were carefully pelleted by 
centrifugation and washed three times with 1ml ice-cold buffer (20mM Hepes/NaOH 
(pH=7.4), 100mM NaCl, 1mM MgCl2 and 0.1% IGEPAL-630 (NP-40 substitute)). 
Bound proteins were then eluted by incubation with 600?l elution buffer containing 
20mM Hepes/NaOH (pH=7.4), 20mM EDTA, 200mM NaCl, 1mM MgCl2 and 0.1% 
IGEPAL-630 for 20 min at room temperature on a turning wheel. A second elution step 
was performed with 300?l elution buffer for 10 minutes to elute residual protein. Eluates 
were then pooled, subjected to TCA precipitation and analyzed by SDS-PAGE and 
Western blotting. 
5.3.12   Tandem affinity purification (TAP) 
5.3.12.1 Standard TAP 
For native purification of proteins together with non-covalently bound interactors from 
yeast cells was performed essentially following the protocol of Seraphin and co-workers 
(Puig et al., 2001). 2 to 4 liters culture of yeast cells harboring the TAP-tagged fusion 
protein of interest were grown overnight and harvested at an OD600 of 2-5. Cells were 
washed once with ddH20 once with lysis buffer (150mM NaCl, 50mM Hepes pH=7.4, 
2mM MgCl2, 0,15% NP-40 (IGEPAL-630), 1xFY protease inhibitor mix (Serva, 
Heidelberg, Germany) and 2mM PMSF) and finally centrifuged at 4000xg to pellet the 
cells. Cell pellets were frozen in liquid nitrogen and stored at -80° C until usage. For 
lysis, cell pellets were thawed and suspended in lysis buffer additionally containing 1mM 
DTT in a total volume of 25ml. The cell suspension was transferred to milling buckets 
and 25ml glass beads with a diameter of 0.4-0.6?m were added. The buckets were closed 
and fastened in a Pulverisette Mono-planet-mill located in a 4° C cold-room (Fritsch, 
Idar-Oberstein, Germany). The milling settings were 3 x 500rpm for 4 minutes with 1 
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minute breaks to allow for sample cooling. Glass beads were separated from the cell 
lysate by pressing through a standard 50ml syringe. Retained beads were washed with 
10ml lysis buffer containing all additives. The lysate was subsequently centrifuged at 
4000xg 4° C for 10 minutes to remove unlysed cells and coarse cell debris. The resulting 
pre-cleared supernatant was then transferred to high-speed ultracentrifugation tubes 
(Eppendorf, Hamburg, Germany) and centrifuged for 1 hour at 100,000xg in a Ti 50.2 
rotor (Beckman, Krefeld, Germany). Before removing the 100,000xg supernantant, the 
fatty top-phase was removed from the centrifugation tubes using a water-jet vacuum 
pump. The remaining supernatant was poured off the pellet into a fresh 50ml tube. IgG-
spharose beads (GE-Healthcare, Munich, Germany) were washed three times with lysis 
buffer containing no additives for equilibration. 250-500?l of bead slurry was added to 
each lysate of approx. 20ml volume. The mixture was incubated one hour at 4°C on a 
nutator. Afterwards, beads were transferred to small MoBiCol columns (MoBiTec, 
Göttingen, Germany), drained by gravity flow and washed once with 15ml lysate buffer 
containing only 0.5mM DTT as additive. The beads were drained, the column closed at 
the bottom and 150?l lysate buffer (+0.5mM DTT) containing 4?l of a 1mg/ml TEV-
protease preparation were added. For the cleavage reaction, the mixture was incubated for 
1 hour at 16°C on a turning wheel. Elution from the beads was performed by centrifuging 
the column in a 1.5ml tube in a tabletop centrifuge at 2000xg for 20 seconds. To raise the 
elution efficiency, the beads were incubated with additional 100?l of lysis buffer 
(+0.5mM DTT) briefly mixed and centrifuged as above. Elution fractions were pooled. 
The TEV eluate was then either used for Gelfiltration analysis, TCA precipitated and 
used for SDS-PAGE analysis or subjected to an additional purification step as described 
below: 
1M CaCl2 solution was added to the lysate to a final concentration of 2mM CaCl2. 
Calmodulin sepharose beads were washed 3 times in lysis buffer containing 2mM CaCl2. 
TEV eluate and 250-350?l of bead slurry per sample were mixed in a new MoBiCol 
column. The mixture was incubated 1 hour at 4°C on a turning wheel. After the binding 
reaction, beads were drained by gravity flow and subsequently washed with 10ml lysis 
buffer containing 1mM DTT and 2mM CaCl2. For the elution, 600?l of EGTA-elution 
buffer (lysis buffer containing 20mM EGTA) were added per sample and incubated at 
30°C for 20 minutes to allow for efficient chelating of Ca2+ ions. Eluates were collected 
as for the TEV elution. A second elution reaction was performed using 300?l of EGTA-
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elution buffer and incubation for 10 minutes at 30°C. Both eluates were pooled and used 
for SDS-PAGE and Western blot analysis after TCA precipitation or other subsequent 
experiments. 
5.3.12.2 Mini TAP 
The Mini-TAP was essentially carried out as the standard TAP protocol (see 5.3.12.1). 
For one purification sample, cell material from 250ml culture at an OD600 of approx. 2 
was used (ca. 1/20 of a standard TAP sample) and resuspended the same volume of TAP 
lysis buffer containing all additives. Lysis was performed on a Disruptor-Genie 
(Scientific Industries, Bohemia, NY, U.S.A.) in a 2ml reaction tube containing cell 
suspension and the same volume of glass beads. The following incubation steps are 
perfomed in 1.5ml reaction tubes instead of MoBiCol columns due to the decreased 
reaction volume. Wash steps were performed with 3x 1ml with the respective buffers. 
Incubation conditions were the same as for the standard TAP protocol. Purified proteins 
were used for Rab GTPase pull-downs or analysis with SDS-PAGE. 
5.3.13   Gelfiltration 
For the separation of proteins/protein complexes dependent on their molecular weight and 
for purifying complexes from smaller proteins and metabolites, size exclusion 
chromatography, or gelfiltration, was employed. Generally, a Superose 6 10/300 GL 
column (GE Healthcare, Munich, Germany) with a volume of 24ml was used for this 
procedure if not indicated otherwise. The column was attached to an ÄKTA FPLC 
system, which was operated from a PC using the Unicorn 5.01 software (both GE 
Healthcare). The standard flow rate during the gelfiltration run was 0.3ml/minute and up 
to 0.5ml/minute for washing and equilibration. Since TEV eluate from a TAP experiment 
was usually applied to the column, TEV-elution buffer (see 5.3.12.1, TAP procedure) 
containing 4mM DTT was used for the isocratic elution of the sample from the 
gelfiltration matrix, to avoid the danger of protein precipitation due to a buffer change. 
Buffers where generally filtered through a 0.22?m filter and subsequently degassed by 
application of vacuum to prevent damage of the column bed packing by particles or air 
bubbles. All samples where centrifuged at 20,000xg for 10 minutes prior to loading into 
the sample loop to pellet insoluble material. Fractions where collected for 0.9 column 
MATERIALS AND METHODS 
 100 
volumes i.e. for approx. 21.6ml. The fraction size was 1ml if not indicated differently. All 
gelfiltration experiments where carried out at 4°C to avoid sample degradation and 
disintegration of protein complexes. Collected fractions where TCA precipitated 
afterwards and analyzed by SDS-PAGE alone and/or additional Western blotting.  
5.3.14   FM 4-64 staining of live cells 
To visualize the yeast vacuole for fluorescence microscopy analysis, the lipophilic styryl 
dye FM4-64 (N-(3-triethylammoniumpropyl)-4-(6-(4-(diethylamino)phenyl)hexatrienyl) 
pyrid-inium dibromide, Invitrogen, Karlsruhe, Germany) was employed. Yeast cells were 
grown in an overnight culture and diluted in the morning with fresh medium to an OD600 
of approx. 0.25. These cultures were then grown at least 3-4 hours to an OD of 0.5 to 1. 
The cells were then pelleted by centrifugation at 3000xg for 5 minutes and resuspended in 
50?l of fresh medium. 3?l of a 0.3mM FM4-64 solution was added and the cell 
suspension was incubated in the dark for 30 minutes at 30°C while shaking in a tabletop 
thermo-shaker (Eppendorf, Hamburg, Germany) (“pulse”). As a crude washing step, 1ml 
medium was then added, cells briefly centrifuged for pelleting and the supernatant 
discarded. The cells where then resuspended in 500?l of fresh medium and incubated for 
45 minutes in the dark at 30°C while shaking (“chase”). Afterwards, the cells were again 
pelleted, washed one time with 1ml PBS and finally resuspended in 10-30?l of PBS prior 
to microscopy.  
5.4 Molecular biology  
5.4.1 PCR  
Primer design and amplification of nucleic acid sequences destined for the integration 
into the yeast genome after transformation was carried out using a PeqLab PCR machine 
(PeqLab, Erlangen, Germany) as described in (Janke et al., 2004).  
5.4.2 Agarose gelelectrophoresis 
To assess the efficiency of PCRs or to monitor restriction enzyme digests, DNA 
containing samples were subjected to agarose gel electrophoresis. To prepare 1% gels. 
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0,5g of agarose were mixed with 50ml 1xTAE buffer (20mM Tris, 1mM EDTA, 20mM 
acetic acid) and heated in a microwave oven at 160Watts for 3-5 minutes. After te 
agarose was dissolved completely, the solution was cooled down for 1 minute at room 
temperature and 3?l of a 1% ethidium bromide solution was added. After careful mixing, 
the mixture was poured into a agarose gel cast stand equipped with a gel slide and the 
appropriate comb (Hoefer Mini sub system provided by Pharmacia Biotech, now GE-
healthcare, Munich, Germany). After cooling for 20-30 minutes, the combs were 
removed and gels were loaded into the mini sub horizontal gel electrophoresis chamber, 
which was filled with 1x TAE buffer. Samples were applied into the gel wells and the 
electrophoretic run was performed at 120V, 30-40mA for 25 minutes. After the run, gels 
were put into a UV gel documentation system (Peqlab, Erlangen, Germany) and the 
ethidium bromide stained nucleic acids were visualized. 
5.4.3 Bacteria transformation 
Standard bacteria strains for cloning procedures (DH5?) or recombinant protein 
expression (BL21 DE3 Rosetta) were provided as frozen competent cells (competence 
chemically induced by CaCl2). DNA was added to freshly thawed 50?l bacteria 
suspension and gently mixed. The mixture was kept on ice for 20 minutes and subjected 
to a heat shock for 30 seconds at 42°C afterwards. After placing the cell suspension back 
on ice for additional two minutes, 750?l LB medium without antibiotics was added and 
the resulting culture was incubated for one hour at 37°C. After the incubation, cells were 
pelleted by centrifugation at 5000xg for two minutes, resuspended in 150?l sterile water 
and directly plated onto LB agar plates containing the appropriate antibiotics. 
5.4.4 Yeast transformation 
Yeast cells were transformed with PCR products or plasmids using Polyethylenglykol 
(PEG) and Lithium Acetate (LiAc). In brief, overnight yeast cell cultures were diluted in 
the morning and grown for additional four to five hours. The cells were then harvested by 
centrifugation, washed once with water and once with 0.1M LiAc solution. Afterwards, 
appropriate amounts of cells were pelleted by centrifugation and overlaid with a solution 
containing 50% PEG, 0.1M LiAc and salmon sperm DNA acting as carrier DNA to 
facilitate the uptake of the DNA of interest. For plasmids, 100-300ng DNA were 
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employed per transformation. For transformation of PCR products, 15?l of a standard 
50?l PCR reaction was used.  
5.5 Microscopy 
For fluorescence microscopy of cells carrying GFP- and RFP-tagged proteins, cells were 
grown to logarithmic phase in 5ml complex or selective medium, dependent on the strain 
background. The cells were harvested by centrifugation and washed once with 1 ml of 
PBS buffer and resuspended in 10-30?l PBS or stained with FM4-64. Images were 
acquired using a Leica DM5500 microscope (Leica, Wetzlar, Germany) and a SPOT 
Pursuit-XS camera (Visitron, Puchheim, Germany) using filters for GFP, FM4-64 and 
RFP. The pictures were processed using Adobe Photoshop CS3. 
5.6 Strains used in this study 
Table 5.1 Strains used in this study 
strain   genotype   reference 
     
CUY100  BY4727 MATalpha his3?200 leu2?0 lys2?0 
met15?0 trp1?63 ura3?0 
 Brachman et al., 
1998 
CUY105  BY4732 MATa his3?200 leu2?0 met15?0 trp1?63 
ura3?0  
 Brachman et al., 
1998 
CUY490  MATa his3? leu2? met15? ura3?  vps41?::kanMX  Euroscarf library 
CUY516  MATa his3? leu2? met15? ura3?  vam6?::kanMX  Euroscarf library 
CUY520  MATa his3? leu2? met15? ura3?  vps33?::kanMX  Euroscarf library 
CUY521  MATa his3? leu2? met15? ura3?  vps16?::kanMX  Euroscarf library 
CUY523  MATa his3? leu2? met15? ura3?  vps18?::kanMX  Euroscarf library 
CUY552  MATa pep4::HIS3 prb1-?1.6R HIS3 lys2-208 
trp1?101 ura3-52 gal2 can vps41?::KANMX6 
ura3::pRS406-NOP1pr-VPS41 
 LaGrassa and 
Ungermann, 2005 
CUY592  MATa his3? leu2? met15? ura3?  yck3?::kanMX 
ura3::pRS406-NOP1pr-GFP-VPS41 
 LaGrassa and 
Ungermann, 2005 
CUY764  MATa his3?1 leu2?0 met15?0 ura3?0  Euroscarf library 
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CUY785  MATa pep4::HIS3 prb1-?1.6R HIS3 lys2-208 
trp1?101 ura3-52 gal2 can yck3?::kanMX 
 LaGrassa and 
Ungermann, 2005 
CUY830  MATa pep4::HIS3 prb1-?1.6R HIS3 lys2-208 
trp1?101 ura3-52 gal2 can yck3?::kanMX4 
pRS406-NOP1pr-eGFP-VPS41 
 LaGrassa and 
Ungermann, 2005 
CUY856  MATa pep4::HIS3 prb1-?1.6R HIS3 lys2-208 
trp1?101 ura3-52 gal2 can VPS11::TAP-kanMX 
 this study 
CUY857  MATa pep4::HIS3 prb1-?1.6R HIS3 lys2-208 
trp1?101 ura3-52 gal2 can VPS16::TAP-kanMX 
 this study 
CUY858  MATa pep4::HIS3 prb1-?1.6R HIS3 lys2-208 
trp1?101 ura3-52 gal2 can VPS18::TAP-kanMX 
 this study 
CUY859  MATa pep4::HIS3 prb1-?1.6R HIS3 lys2-208 
trp1?101 ura3-52 gal2 can VPS33::TAP-kanMX 
 this study 
CUY860  MATa pep4::HIS3 prb1-?1.6R HIS3 lys2-208 
trp1?101 ura3-52 gal2 can VPS41::TAP-kanMX 
 this study 
CUY866  MATa pep4::HIS3 prb1-?1.6R HIS3 lys2-208 
trp1?101 ura3-52 gal2 can VAM6::TAP-kanMX 
 this study 
CUY927  MATa pep4::HIS3 prb1-?1.6R HIS3 lys2-208 
trp1?101 ura3-52 gal2 can ura3::pRS406-NOP1pr-
VPS41 
 LaGrassa and 
Ungermann, 2005 
CUY928  MATa pep4::HIS3 prb1-?1.6R HIS3 lys2-208 
trp1?101 ura3-52 gal2 can ura3::pRS406-NOP1pr-
VPS41 yck3?::kanMX 
 LaGrassa and 
Ungermann, 2005 
CUY981  MATa his3?1 leu2?0 met15?0 ura3?0 
yck3pr::HIS3-GAL1pr 
 LaGrassa and 
Ungermann, 2005 
CUY983  MATa pep4::HIS3 prb1-?1.6R HIS3 lys2-208 
trp1?101 ura3-52 gal2 can yck3pr::TRP1-GAL1pr 
 LaGrassa and 
Ungermann, 2005 
CUY1014  MATa his3? leu2? met15? ura3?  vps3?::kanMX  LaGrassa and 
Ungermann, 2005 
CUY1048  MATa his3? leu2? met15? ura3? vpr1?::kanMX 
vps41pr::HIS5-PHO5pr-GFP-Myc 
 LaGrassa and 
Ungermann, 2005 
CUY1326  MATa pep4::HIS3 prb1-?1.6R HIS3 lys2-208 
trp1?101 ura3-52 gal2 can vps41?::KANMX6 
ura3::pRS406-NOP1pr-VPS41 yck3?::hphNT 
 LaGrassa and 
Ungermann, 2005 
CUY1331  MATa pep4::HIS3 prb1-?1.6R HIS3 lys2-208 
trp1?101 ura3-52 gal2 can vps41?::KANMX6 
ura3::pRS406-NOP1pr-VPS41 nop1pr::TRP1-
PHO5pr-GFP-Myc 
 LaGrassa and 
Ungermann, 2005 
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CUY1335  MATa pep4::HIS3 prb1-?1.6R HIS3 lys2-208 
trp1?101 ura3-52 gal2 can yck3?::TRP1 
 LaGrassa and 
Ungermann, 2005 
CUY1344  MATa pep4::HIS3 prb1-?1.6R HIS3 lys2-208 
trp1?101 ura3-52 gal2 can yck3?::TRP1 
VPS41::TAP-KanMX4 
 this study 
CUY1381  MATa his3? leu2? met15? ura3?  VPS18::GFP-
hphNT 
 this study 
CUY1534  MATa pep4::HIS3 prb1-?1.6R HIS3 lys2-208 
trp1?101 ura3-52 gal2 can CCZ1::TAP-kanMX4 
 this study 
CUY1535  MATa pep4::HIS3 prb1-?1.6R HIS3 lys2-208 
trp1?101 ura3-52 gal2 can MON1::TAP-KanMX4 
 this study 
CUY1601  MATa pep4::HIS3 prb1-?1.6R HIS3 lys2-208 
trp1?101 ura3-52 gal2 can yck3?::TRP1 
CCZ1::TAP-KanMX4 
 this study 
CUY1602  MATa pep4::HIS3 prb1-?1.6R HIS3 lys2-208 
trp1?101 ura3-52 gal2 can yck3?::TRP1 
MON1::TAP-KanMX4 
 this study 
CUY1761  MATalpha his3?200 leu2?0 lys2?0 met15?0 
trp1?63 ura3?0 vps11pr::HIS3-GAL1pr 
 this study 
CUY1768  MATalpha his3?200 leu2?0 lys2?0 met15?0 
trp1?63 ura3?0 vps11pr::HIS3-GAL1pr 
 this study 
CUY1772  MATalpha his3?200 leu2?0 met15?0 trp1?63 
ura3?0 vps33pr::HIS3-GAL1pr 
 this study 
CUY1776  MATalpha his3?200 leu2?0 lys2?0 met15?0 
trp1?63 ura3?0 vps11pr::HIS3-GAL1pr 
vps16pr::TRP1-GAL1pr vps18pr::kanMX-GAL1pr 
 this study 
CUY1792  MATa his3?1 leu2?0 met15?0 ura3?0 VPS8::TAP-
kanMX 
 Peplowska et al., 
2007 
CUY1795  MATa his3?1 leu2?0 met15?0 ura3?0 VPS3::TAP-
URA3 
 Peplowska et al., 
2007 
CUY1796  MATa his3? leu2? met15? ura3?  vam2?::kanMX 
VPS3::TAP-URA3 
 Peplowska et al., 
2007 
CUY1797  MATa his3?1 leu2?0 met15?0 ura3?0 
vps8?::kanMX VPS3::TAP-URA3 
 Peplowska et al., 
2007 
CUY1798  MATa his3?1 leu2?0 met15?0 ura3?0 
vam6?::kanMX VPS3::TAP-URA3 
 Peplowska et al., 
2007 
CUY1799  MATa his3? leu2? met15? ura3?  vps33?::kanMX  
VPS3::TAP-URA3 
 Peplowska et al., 
2007 
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CUY1800  MATa his3?1 leu2?0 met15?0 ura3?0 
VPS41::TAP-URA3 
 Peplowska et al., 
2007 
CUY1801  MATa his3?1 leu2?0 met15?0 ura3?0 
vam6?::kanMX VAM2::TAP-URA3 
 Peplowska et al., 
2007 
CUY1802  MATa his3?1 leu2?0 met15?0 ura3?0 
vps3?::kanMX VAM2::TAP-URA3 
 Peplowska et al., 
2007 
CUY1803  MATa his3?1 leu2?0 met15?0 ura3?0 
vps8?::kanMX VAM2::TAP-URA3 
 Peplowska et al., 
2007 
CUY1804  MATa his3? leu2? met15? ura3?  vps33?::kanMX 
VPS41::TAP-URA3 
 Peplowska et al., 
2007 
CUY1846  MATa his3? leu2? met15? ura3? VPS3::TAP-
URA3 VPS3::HIS3-GAL1pr 
 this study 
CUY1847  MATa his3? leu2? met15? ura3? VPS41::TAP-
URA3 vps3pr::HIS3-GAL1pr 
 Peplowska et al., 
2007 
CUY1874  MATa his3? leu2? met15? ura3? VPS8::TAP-
kanMX vps8pr::HIS3-GAL1pr 
 this study 
CUY1875  MATa his3? leu2? met15? ura3? VPS8::TAP-
kanMX vps3pr::HIS3-GAL1pr 
 Peplowska et al., 
2007 
CUY1876  MATalpha his3?200 leu2?0 met15?0 trp1?63 
ura3?0 VAM6::TAP-kanMX4 VAM6pr::TRP1-
GAL1pr vps11?::URA3 
 this study 
CUY1877  MATa his3? leu2? met15? ura3? VPS8::TAP-
kanMX vps3?::URA3 
 Peplowska et al., 
2007 
CUY1878  MATa his3? leu2? met15? ura3? VPS3::TAP-
URA3 vps11?::kanMX 
 Peplowska et al., 
2007 
CUY1896  MATa his3?200 leu2?0 met15?0 trp1?63 ura3?0 
vps41pr::TRP1-GAL1pr 
 this study 
CUY1903  MATa his3?200 met15?0 trp1?63 ura3?0 
vps41pr::TRP1-GAL1pr vam6pr::KanMX-GAL1pr 
 this study 
CUY1906  MATa his3? leu2? met15? ura3?  vps11?::URA3  this study 
CUY1908  MATa his3?200 met15?0 trp1?63 ura3?0 
vps41pr::TRP1-GAL1pr vam6pr::KanMX-GAL1pr 
vps33pr::HIS3-Gal1pr 
 this study 
CUY1915  MATa his3?1 leu2?0 met15?0 ura3?0 
vps3pr::kanMX-Gal1pr 
 Peplowska et al., 
2007 
CUY1916  MATa his3?1 leu2?0 met15?0 ura3?0 VPS8::TAP-
kanMX vps41pr::HIS3-GAL1pr 
 Peplowska et al., 
2007 
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CUY1918  MATa pep4::HIS3 prb1-?1.6R HIS3 lys2-208 
trp1?101 ura3-52 gal2 can vps41?::kanMX 
URA3::pRS406-NOP1pr-VPS41-(F124A, F128A) 
 Cabrera et al., 
2009 
CUY1919  MATa pep4::HIS3 prb1-?1.6R HIS3 lys2-208 
trp1?101 ura3-52 gal2 can vps41?::kanMX 
URA3::pRS406-NOP1pr-VPS41-
(S663,664,669A,T662,665A) 
 Cabrera et al., 
2009 
CUY1920  MATa pep4::HIS3 prb1-?1.6R HIS3 lys2-208 
trp1?101 ura3-52 gal2 can vps41?::kanMX 
URA3::pRS406-NOP1pr-VPS41-(S794A, S798A) 
 Cabrera et al., 
2009 
CUY1921  MATa pep4::HIS3 prb1-?1.6R HIS3 lys2-208 
trp1?101 ura3-52 gal2 can vps41?::kanMX 
URA3::pRS406-NOP1pr-VPS41-
(S364,367,368,371,372A,T376A) 
 Cabrera et al., 
2009 
CUY1922  MATa pep4::HIS3 prb1-?1.6R HIS3 lys2-208 
trp1?101 ura3-52 gal2 can vps41?::kanMX 
URA3::pRS406-NOP1pr-VPS41-(S117,119,120A) 
 Cabrera et al., 
2009 
CUY1923  MATa pep4::HIS3 prb1-?1.6R HIS3 lys2-208 
trp1?101 ura3-52 gal2 can vps41?::kanMX 
URA3::pRS406-NOP1pr-VPS41-(F329A,F333A) 
 Cabrera et al., 
2009 
CUY1924  MATa pep4::HIS3 prb1-?1.6R HIS3 lys2-208 
trp1?101 ura3-52 gal2 can vps41?::kanMX 
URA3::pRS406-NOP1pr-VPS41 
 Cabrera et al., 
2009 
CUY1953  MATa his3?200 met15?0 trp1?63 ura3?0 
VAM2::TRP1-GAL1pr VPS41::TAP-URA3 
vam6pr::KanMX-GAL1pr vps33pr::HIS3-GAL1pr 
 this study 
CUY1954  MATalpha his3?200 leu2?0 lys2?0 met15?0 
trp1?63 ura3?0 vps11pr::HIS3-GAL1Pr 
vps16pr::TRP1-GAL1Pr vps18pr::kanMX-GAL1Pr 
pRS411 MET15 
 this study 
CUY1980  MATa his3? leu2? met15? ura3? vps33?::kanMX 
VAM6::TAP-URA3 
 this study 
CUY1982  MATa his3? leu2? met15? ura3? vps18?::kanMX 
VAM6::TAP-URA3 
 this study 
CUY1983  MATa his3? leu2? met15? ura3? vps41?::kanMX 
VPS33::TAP-URA3 
 this study 
CUY1984  MATa his3? leu2? met15? ura3? vam6?::kanMX 
VPS33::TAP-URA3 
 this study 
CUY1985  MATa his3? leu2? met15? ura3? vps16?::kanMX 
VPS33::TAP-URA3 
 this study 
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CUY1986  MATa his3? leu2? met15? ura3? vps18?::kanMX 
VPS33::TAP-URA3 
 this study 
CUY1987  MATalpha his3?200 leu2?0 met15?0 trp1?63 
ura3?0 VAM6::TAP-kanMX4 vps8pr::HIS3-
GAL1pr-3HA 
 Peplowska et al., 
2007 
CUY1989  MATa his3? leu2? met15? ura3? vam2?::kanMX 
VAM6::TAP-Ura3 
 this study 
CUY1998  MATalpha his3?200 leu2?0 met15?0 trp1?63 
ura3?0 VAM6::TAP-kanMX4 VPS8::3HA-HIS3 
 Peplowska et al., 
2007 
CUY2029  MATalpha his3?200 leu2?0 met15?0 trp1?63 
ura3?0 vam6pr::kanMX-GAL1pr VAM6::TAP-Trp 
 this study 
CUY2032  MATa pep4::HIS3 prb1-?1.6R HIS3 lys2-208 
trp1?101 ura3-52 gal2 can vps41?::kanMX 
URA3::pRS406-NOP1pr-VPS41-(F124A, F128A) 
TRP1::pRS406-NOP1pr-VPS41-(F124A, F128A)-
GFP 
 Cabrera et al., 
2009 
CUY2033  MATa pep4::HIS3 prb1-?1.6R HIS3 lys2-208 
trp1?101 ura3-52 gal2 can vps41?::kanMX 
URA3::pRS406-NOP1pr-PS41-(S364,367,368,371, 
372A,T376A) TRP1::pRS406-NOP1pr-VPS41-
(S364,367,368,371,372A,T376A)-GFP 
 Cabrera et al., 
2009 
CUY2034  MATa pep4::HIS3 prb1-?1.6R HIS3 lys2-208 
trp1?101 ura3-52 gal2 can vps41?::kanMX 
URA3::pRS406-NOP1pr-VPS41-(S117,119,120A) 
URA3::pRS406-NOP1pr-VPS41-(S117,119,120A)-
GFP 
 Cabrera et al., 
2009 
CUY2035  MATa pep4::HIS3 prb1-?1.6R HIS3 lys2-208 
trp1?101 ura3-52 gal2 can vps41?::kanMX 
URA3::pRS406-NOP1pr-VPS41 TRP1::pRS406-
NOP1pr-VPS41-GFP 
 Cabrera et al., 
2009 
CUY2104  MATa his3? leu2? met15? ura3?  vps41?::kanMX 
VPS11::TAP-URA3 
 this study 
CUY2105  MATa his3? leu2? met15? ura3?  vps41?::kanMX 
VPS18::TAP-URA3 
 this study 
CUY2106  MATa his3? leu2? met15? ura3?  vps41?::kanMX 
VPS16::TAP-URA3 
 this study 
CUY2107  MATa his3? leu2? met15? ura3? vam6?::kanMX 
VPS11::TAP-URA3 
 this study 
CUY2108  MATa his3? leu2? met15? ura3? vam6?::kanMX 
VPS18::TAP-URA3 
 this study 
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CUY2109  MATa his3? leu2? met15? ura3? vam6?::kanMX 
VPS16::TAP-URA3 
 this study 
CUY2110  MATa his3? leu2? met15? ura3? vps33?::kanMX 
VPS11::TAP-URA3 
 this study 
CUY2111  MATa his3? leu2? met15? ura3? vps33?::kanMX 
VPS18::TAP-URA3 
 this study 
CUY2112  MATa his3? leu2? met15? ura3? vps33?::kanMX 
VPS16::TAP-URA3 
 this study 
CUY2113  MATa his3? leu2? met15? ura3? vps16?::kanMX 
VPS11::TAP-URA3 
 this study 
CUY2114  MATa his3? leu2? met15? ura3? vps18?::kanMX 
VPS11::TAP-URA3 
 this study 
CUY2116  MATa his3? leu2? met15? ura3? vam6?::kanMX 
vps8pr::HIS3-GAL1pr-3HA VPS3::TAP-URA3 
 Peplowska et al., 
2007 
CUY2117  MATalpha his3?200 leu2?0 met15?0 trp1?63 
ura3?0 vam6pr::kanMX-GAL1pr VAM6::TAP-
Trp1 VPS8::3HA-HIS3 
 Peplowska et al., 
2007 
CUY2152  MATa his3?200 met5?0 trp1?63 ura3?0 
vps41pr::TRP1-GAL1pr VPS41::TAP-URA3 
 this study 
CUY2153  MATa his3?200 met15?0 trp1?63 ura3?0 
vps41pr::TRP1-GAL1pr vam6pr::KanMX-GAL1pr 
VPS41::TAP-URA3 
 this study 
CUY2154  MATa his3? leu2? met15? ura3?  vps16?::kanMX 
VPS41::TAP-URA3 
 this study 
CUY2155  MATa his3? leu2? met15? ura3?  vps18?::kanMX 
VPS41::TAP-URA3 
 this study 
CUY2156  MATa his3? leu2? met15? ura3?  vps18?::kanMX 
VPS16::TAP-URA3 
 this study 
CUY2226  MATa his3? leu2? met15? ura3?  vps11?::URA3 
VPS41::TAP-kanMX 
 this study 
CUY2227  MATa his3? leu2? met15? ura3?  vps11?::URA3 
VAM6::TAP-kanMX 
 this study 
CUY2228  MATa his3? leu2? met15? ura3?  vps11?::URA3 
VPS16::TAP-kanMX 
 this study 
CUY2229  MATa his3? leu2? met15? ura3?  vps11?::URA3 
VPS18::TAP-kanMX 
 this study 
CUY2230  MATa his3? leu2? met15? ura3?  vps11?::URA3 
VpS33::TAP-kanMX 
 this study 
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CUY2231  MATa his3?1 leu2?0 met15?0 ura3?0 VPS8::TAP-
kanMX vam6pr::HIS3-GAL1pr-3HA 
 this study 
CUY2368  MATa pep4::HIS3 prb1-?1.6R HIS3 lys2-208 
trp1?101 ura3-52 gal2 can vps41?::kanMX 
URA3::pRS406-NOP1pr-VPS41 S367,368D 
 Cabrera et al., 
2009 
CUY2369  MATa pep4::HIS3 prb1-?1.6R HIS3 lys2-208 
trp1?101 ura3-52 gal2 can vps41?::kanMX 
URA3::pRS406-NOP1pr-VPS41 S367,368A ::GFP-
TRP1 
 Cabrera et al., 
2009 
CUY2370  MATa pep4::HIS3 prb1-?1.6R HIS3 lys2-208 
trp1?101 ura3-52 gal2 can vps41?::kanMX 
URA3::pRS406-NOP1pr-VPS41 S371,372A ::GFP-
TRP1 
 Cabrera et al., 
2009 
CUY2379  MATa pep4::HIS3 prb1-?1.6R HIS3 lys2-208 
trp1?101 ura3-52 gal2 can vps41?::kanMX 
URA3::pRS406-NOP1pr-VPS41 S371A 
 Cabrera et al., 
2009 
CUY2380  MATa pep4::HIS3 prb1-?1.6R HIS3 lys2-208 
trp1?101 ura3-52 gal2 can vps41?::kanMX 
URA3::pRS406-NOP1pr-VPS41S371A 
 Cabrera et al., 
2009 
CUY2381  MATa pep4::HIS3 prb1-?1.6R HIS3 lys2-208 
trp1?101 ura3-52 gal2 can vps41?::kanMX 
URA3::pRS406-NOP1pr-VPS41 S371,372D 
 Cabrera et al., 
2009 
CUY2483  MATa his3? leu2? met15? ura3? vam6?::kanMX 
VPS11::TAP-URA3 vam6pr::HIS3-GAL1pr 
 this study 
CUY2488  MATalpha his3?200 leu2?0 lys2?0 met15?0 
trp1?63 ura3? vps18pr::KanMX-GAL1Pr-3HA 
 this study 
CUY2489  MATalpha his3?200 leu2?0 lys2?0 met15?0 
trp1?63 ura3?0 vps11pr::HIS3-GAL1Pr 
vps16pr::natNT2-GAL1Pr vps18pr::kanMX-
GAL1Pr-3HA 
 this study 
CUY2530  MATa his3?200 met15?0 trp1?63 ura3?0 
vps33pr::TRP1-GAL1pr 
 this study 
CUY2531  MATalpha his3?200 leu2?0 lys2?0 met15?0 
trp1?63 ura3?0  vps16pr::kanMX-GAL1Pr-3HA 
 this study 
CUY2567  MATalpha his3?200 leu2?0 lys2?0 met15?0 
ura3?0 vps11pr::HIS3-GAL1Pr vps18pr::kanMX-
GAL1Pr-3HA VPS11::TAP-URA3 
 this study 
CUY2568  MATalpha his3?200 leu2?0 lys2?0 met15?0 
trp1?63 ura3?0 VPS16::TAP-URA3 
 this study 
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CUY2569  MATalpha his3?200 leu2?0 lys2?0 met15?0 
trp1?63 ura3?0 VPS18::TAP-URA3 
 this study 
CUY2570  MATalpha his3?200 leu2?0 lys2?0 met15?0 
trp1?63 ura3?0 VPS33::TAP-URA3 
 this study 
CUY2571  MATalpha his3?200 leu2?0 lys2?0 met15?0 
trp1?63 ura3?0 VPS41::TAP-URA3 
 this study 
CUY2572  MATalpha his3?200 leu2?0 lys2?0 met15?0 
trp1?63 ura3?0 VAM6::TAP-URA3 
 this study 
CUY2659  MATa his3?200 leu2?0 met15?0 trp1?63 ura3?0 
vps11pr::KanMX-GAL1Pr 
 this study 
CUY2660  MATa his3?200 leu2?0 met15?0 trp1?63 ura3?0 
vps16pr::KanMX-GAL1Pr 
 this study 
CUY2661  MATa his3?200 leu2?0 met15?0 trp1?63 ura3?0 
vps18pr::KanMX-GAL1Pr 
 this study 
CUY2673  MATalpha his3?200 leu2?0 lys2?0 met15?0 
trp1?63 ura3?0 vps11pt::HIS3-GAL1Pr 
vps16pr::natNT2-GAL1Pr 
 this study 
CUY2674  MATalpha his3?200 leu2?0 lys2?0 met15?0 
trp1?63 ura3?0 vps11pr::HIS3-GAL1Pr 
vam6pr::natNT2-GAL1Pr 
 this study 
CUY2675  MATa/alpha his3?200/his3?200 met15?0/met15?0 
trp1?63/TRP1 ura3?0/ura3?0 LEU2/leu2?0 
LYS2/lys2?0 vps41pr::TRP1-GAL1pr VPS41::TAP-
URA3 vam6pr::KanMX-GAL1pr vps33pr::HIS3-
GAL1pr vps11pr::HIS3-GAL1Pr vps16pr::natNT2-
GAL1Pr vps18pr::kanMX-GAL1Pr-3HA  
 this study 
CUY2721  MATa his3?200 leu2?0 met15?0 trp1?63 ura3?0 
vam6pr::KanMX- GAL1Pr 
 this study 
CUY2723  MATalpha his3?200 leu2?0 lys2?0 met15?0 
trp1?63 ura3?0 vps11pr::HIS3-GAL1pr 
vam6pr::natNT2-GAL1pr VPS11::TAP-kanMX 
 this study 
CUY2724  MATalpha his3?200 leu2?0 lys2?0 met15?0 
trp1?63 ura3?0 vps11::HIS3-GAL1pr 
vam6pr::natNT2-GAL1pr VAM6::TAP-URA3 
 this study 
CUY2725  MATalpha his3?200 leu2?0 lys2?0 met15?0 
trp1?63 ura3?0 vps11pr::HIS3-GAL1pr 
vam6pr::natNT2-GAL1pr VAM6::TAP-TRP1 
 this study 
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CUY2741  MATalpha his3?200 leu2?0 lys2?0 met15?0 
trp1?63 ura3?0 vps11pr::HIS3-GAL1pr 
vam6pr::natNT2-GAL1pr VPS11::?Ring-TAP-
URA3 
 this study 
CUY2836  MATalpha his3?200 leu2?0 lys2?0 met15?0 
ura3?0 vps11pr::HIS3-GAL1pr vps16pr::natNT2-
GAL1pr vps18pr::kanMX-GAL1pr-3HA 
VPS11::TAP-Ura3 
 this study 
CUY2837  MATalpha his3?200 leu2?0 lys2?0 met15?0 
ura3?0 vps11pr::HIS3-GAL1pr vps16pr::natNT2-
GAL1pr vps18pr::kanMX-GAL1pr-3HA 
VPS16::TAP-Ura3 
 this study 
CUY2838  MATalpha his3?200 leu2?0 lys2?0 met15?0 
ura3?0 vps11pr::HIS3-GAL1pr vps16pr::natNT2-
GAL1pr vps18pr::kanMX-GAL1-3HA VPS18::TAP-
Ura3 
 this study 
CUY2839  MATa his3?200 met15?0 trp1?63 ura3?0 
vps33pr::TRP1-GAL1pr VPS33::TAP-Ura3 
 this study 
CUY2841  MATalpha his3?200 leu2?0 lys2?0 met15?0 
trp1?63 ura3?0 vps11pr::HIS3-GAL1pr 
vam6pr::natNT2-GAL1pr VPS11::TAP-kanMX 
vps41?::URA3 
 this study 
CUY2858  MATa his3?200 leu2?0 met15?0 trp1?63 ura3?0 
vps16pr::KanMX-Gal1Pr VPS16::TAP-Ura3 
 this study 
CUY2872  MATalpha his3?200 leu2?0 lys2?0 met15?0 
trp1?63 ura3?0 vps11pr::HIS3-GAL1pr 
vam6pr::natNT2-GAL1pr VAM6::TAP-URA3 
vps41?::KanMX 
 this study 
CUY2873  MATa his3?200 leu2?0 met15?0 trp1?63 ura3?0 
vam6pr::KanMX-GAL1Pr VAM6::URA3-TAP 
 this study 
CUY2874  MATa his3?200 leu2?0 met15?0 trp1?63 ura3?0 
VPS11::?RING-TAP-Ura3 
 this study 
CUY2875  MATa his3?200 leu2?0 met15?0 trp1?63 ura3?0 
VPS18::?RING-TAP-Ura3 
 this study 
CUY2876  MATa/alpha his3?200/his3?200 met15?0/met15?0 
trp1?63/TRP1 ura3?0/ura3?0 LEU2/leu2?0 
LYS2/lys2?0 vps11pr::HIS3-GAL1Pr 
vps16pr::natNT2 GAL1Pr vps18pr::kanMX-
GAL1Pr-3HA vps33pr::TRP1-GAL1pr 
VPS33::TAP-Ura3 
 this study 
CUY2916  MATalpha his3?200 leu2?0 lys2?0 met15?0 
trp1?63 ura3?0 vps11pr::HIS3-GAL1pr 
VPS3::KanMX-GAL 
 this study 
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CUY2952  MATalpha his3?200 leu2?0 lys2?0 met15?0 
trp1?63 ura3?0 vps11pr::HIS3-GAL1pr 
vps3pr::KanMX-GAL1pr VPS3::TAP-Ura3 
 this study 
CUY2975  MATalpha his3?200 leu2?0 met15?0 trp1?63 
ura3?0 vam6pr::TRP1-GAL1pr-TAP 
 this study 
CUY2989  MATalpha his3?200 leu2?0 lys2?0 met15?0 
ura3?0 vps11pr::HIS3-GAL1pr vps16pr::natNT2-
GAL1pr vps18pr::kanMX-GAL1pr-3HA 
VPS33::TAP-URA 
 this study 
CUY3021  MATa/alpha his3?200/his3?200 met15?0/met15?0 
trp1?63 ura3?0/ura3?0 lys2?0 leu2?0  
vps33pr::TRP1-GAL1pr vps11pr::HIS3-GAL1pr 
vps16pr::natNT2-GAL1pr vps18pr::kanMX-
GAL1pr-3HA VPS11::TAP-Ura3 
 this study 
CUY3022  MATa/alpha his3?200/his3?200 met15?0/met15?0 
trp1?63 ura3?0/ura3?0 leu2?0 lys2?0 
vps33pr::TRP1-GAL1pr vps11pr::HIS3-GAL1pr 
vps16pr::natNT2-GAL1pr vps18pr::kanMX-
GAL1pr-3HA VPS16::TAP-Ura3 
 this study 
CUY3023  MATa/alpha his3?200/his3?200 met15?0/met15?0 
trp1?63 ura3?0/ura3?0 leu2?0 lys2?0 
vps33pr::TRP1-GAL1pr  vps11pr::HIS3-GAL1pr 
vps16pr::natNT2-GAL1pr vps18pr::kanMX-
GAL1pr-3HA VPS18::TAP-Ura3 
 this study 
CUY3028  MATa/alpha his3?200/his3?200 met15?0/met15?0 
leu2?0 lys2?0  trp1?63 ura3?0/ura3?0 
vps41pr::TRP1-GAL1pr vam6pr::KanMX-GAL1pr 
vps33pr::HIS3-Gal1pr vps11pr::HIS3-GAL1pr 
vps16pr::natNT2-GAL1pr vps18pr::kanMX-
GAL1pr-3HA 
 this study 
CUY3050  MATalpha his3?200 leu2?0 lys2?0 met15?0 
ura3?0 vps11pr::HIS3-GAL1pr vps18pr::kanMX-
GAL1pr-3HA 
 this study 
CUY3067  MATalpha his3?200 leu2?0 met15?0 trp1?63 
ura3?0 vam6pr::TRP1-GAL1pr-TAP 
vps11?::URA3 
 this study 
CUY3070  MATa/alpha lys2?0 met15?0 ura3?0  this study 
CUY3095  MATalpha his3?200 leu2?0 lys2?0 met15?0 
trp1?63 ura3?0 vps11pr::HIS3-GAL1pr 
vam6pr::natNT2-GAL1pr VAM6::TAP-URA3 
VPS11?RING::TRP1 
 this study 
CUY3210  MATa his3?200 leu2?0 met15?0 trp1?63 ura3?0 
vps18pr::KanMX-GAL1Pr VPS18::TAP-URA3 
 this study 
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CUY3238  MATalpha/a his3?200/his3?200 leu2?0/leu2?0 
met15?0/met15?0 trp1?63/trp1?63 
ura3?0/ura3?0 vps33pr::HIS3-GAL1pr 
vps16pr::KanMX-Gal1Pr VPS16::TAP-Ura3 
 this study 
CUY3246  MATa/alpha his3?200/his3?200 leu2?0 lys2?0 
met15?/met15?0 trp1?63 ura3?0/ura3?0 
vps11pr::HIS3-GAL1pr vps16pr::natNT2-GAL1pr 
vps18pr::kanMX-GAL1pr-3HA VPS11::?Ring-
TAP-URA3 vps33pr::TRP1-GALpr 
 this study 
CUY3247  MATa/alpha his3?200/his3?200 trp1?63 leu2?0 
lys2?0 met15?0/met15?0 ura3?0/ura3?0 
vps11pr::HIS3-GAL1pr vps16pr::natNT2-GAL1pr 
vps18pr::kanMX-GAL1pr-3HA VPS18::?RING-
TAP-URA3 vps33pr::TRP1-GAL1pr 
 this study 
CUY3248  MATa/alpha his3?200/his3?200 leu2?0 lys2?0 
met15?0/met15?0 ura3?0/ura3?0 vps11pr::HIS3-
GAL1pr vps16pr::natNT2-GAL1pr 
vps18pr::kanMX-GAL1pr-3HA VPS11::?Ring-
TAP-URA3 vps41pr::TRP1-GAL1pr 
vam6pr::KanMX-GAL1pr vps33pr::HIS3-Gal1pr 
 this study 
CUY3249  MATa/alpha his3?200/his3?200 leu2?0 lys2?0 
met15?0/met15?0 ura3?0/ura3?0 trp1?63 
vps11pr::HIS3-GAL1pr vps16pr::natNT2-GAL1pr 
vps18pr::kanMX-GAL1pr-3HA VPS18::?RING-
TAP-URA3 vps41pr::TRP1-GAL1pr 
vam6pr::KanMX-GAL1pr vps33pr::HIS3-GAL1pr 
 this study 
CUY3250  MATalpha his3?200/his3?200 leu2?0 lys2?0 
met15?0/met15?0 ura3?0/ura3?0 trp1?63 
vps11pr::HIS3-GAL1pr vps16pr::natNT2-GAL1pr 
vps18pr::kanMX-GAL1pr-3HA VPS11::?Ring-
TAP-URA3 vps33pr::TRP1-GAL1pr 
vps3pr::KanMX-GAL1pr vps8pr::NatNT2-GAL1pr-
3HA 
 this study 
CUY3251  MATalpha his3?200/his3?200 leu2?0 lys2?0 
met15?0/met15?0 ura3?0/ura3?0 trp1?63 
vps11pr::HIS3-GAL1pr vps16pr::natNT2-GAL1pr 
vps18pr::kanMX-GAL1pr-3HA VPS18::?RING-
TAP-URA3 vps33pr::TRP1-GAL1pr 
vps3pr::KanMX-GAL1pr vps8pr::NatNT2-Gal1pr-
3HA 
 this study 
CUY3297  MATalpha his3?200 leu2?0 met15?0 trp1?63 
ura3?0 VAM6::TAP-kanMX4 vps41pr::NatNT2-
GALLpr 
 this study 
MATERIALS AND METHODS 
 114 
CUY3298  MATalpha his3?200 leu2?0 met15?0 trp1?63 
ura3?0 VAM6::TAP-kanMX4 vps41pr::NatNT2-
GALSpr 
 this study 
CUY3323  MATalpha his3?200 leu2?0 lys2?0 met15?0 
trp1?63 ura3?0 vps11pr::HIS3-GAL1pr 
vps3pr::KanMX-GAL1pr VPS11::?RING-TAP-
URA 
 this study 
CUY3335  MATa/alpha his3?200/his3?200 leu2?0/leu2?0 
lys2?0 met15?0/met15?0 trp1?63 ura3?0/ura3?0  
vam6pr::KanMX- GAL1Pr vps11pr::HIS3-GAL1Pr 
vps18pr::kanMX-GAL1Pr-3HA VPS11::TAP-URA3 
 this study 
CUY3336  MATalpha/a his3?200/his3?200 leu2?0 lys2?0 
met15?0/met5?0 trp1?63/trp1?63 ura3?/ura3?0 
vps18pr::KanMX-GAL1Pr-3HA  vps41pr::TRP1-
GAL1pr VPS41::TAP-URA3 
 this study 
CUY3347  MATa his3?200 met15?0 trp1?63 ura3?0 
vps33pr::TRP1-GAL1pr VPS33::TAP-Ura3 
vps16pr::KanMX-GAL1pr 
 this study 
CUY3361  MATalpha/a his3?200/his3?200  leu2?0/leu2?0 
lys2?0 met15?0/met15?0 trp1?63/trp1?63 
ura3?0/ura3?0 vps11pr::HIS3-GAL1pr 
vps18pr::kanMX-GAL1pr-3HA vam6pr::KanMX-
GAL1Pr VAM6::URA3-TAP 
 this study 
CUY3362  MATalpha/a his3?200/his3?200 leu2?0 lys2?0 
met15?0/met15?0 trp1?63/trp1?63 
ura3?0/ura3?0 vps11pr::HIS3-GAL1pr 
vps18pr::kanMX-GAL1pr-3HA vps41pr::TRP1-
GAL1pr vam6pr::KanMX-GAL1pr VPS41::TAP-
URA3 
 this study 
CUY3363  MATalpha/a his3?200/his3?200 leu2?0 lys2?0 
met15?0/met5?0 trp1?63/trp1?63 ura3?0/ura3?0 
vps11pr::HIS3-GAL1pr vps18pr::kanMX-GAL1pr-
3HA vps41pr::TRP1-GAL1pr VPS41::TAP-URA3 
 this study 
CUY3364  MATa/alpha his3?200/his3?200 leu2?0 lys2?0 
met15?0/met15?0 trp1?63 ura3?0/ura3?0  
vps41pr::TRP1-GAL1pr vam6pr::KanMX-GAL1pr  
vps11pr::HIS3-GAL1Pr vps18pr::kanMX-GAL1Pr-
3HA VPS11::TAP-URA3 
 this study 
CUY3396  MATalpha his3?200 leu2?0 lys2?0 met15?0 
trp1?63 ura3?0 VPS11::HIS3-GAL 
vam6pr::natNT2-GAL1pr VAM6::TAP-URA3 
vps18pr::TRP1-GAL1 
 this study 
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CUY3407  MATalpha his3?200 leu2?0 lys2?0 met15?0 
trp1?63 ura3?0 vps41pr::TRP1-GAL1pr 
 this study 
CUY3408  MATa his3?200 leu2?0 met15?0 trp1?63 ura3?0 
vam6pr::KanMX-GAL1Pr VAM2::URA3-PHO5-
GFP 
 this study 
CUY3435  MATa his3?200 met15?0 trp1?63 ura3?0 
vps41pr::TRP1-GAL1pr vam6pr::KanMX-GAL1pr 
VAM6::TAP-URA3 
 this study 
CUY3436  MATa his3?200 met15?0 trp1?63 ura3?0 
vps41pr::TRP1-GAL1pr vam66pr::KanMX-GAL1pr 
ypt7pr::PHO5pr-GFP 
 this study 
CUY3446  MATalpha/a his3?200/his3?200 leu2?0/leu2?0 
lys2?0 met15?0/met15?0 trp1?63 ura3?0/ura3?0 
vps11pr::HIS3-GAL1Pr vps16pr::natNT2-GAL1Pr 
vps18pr::kanMX-GAL1Pr-3HA vam6pr::KanMX- 
GAL1Pr 
 this study 
CUY3447  MATalpha/a his3?200/his3?200 leu2?0 lys2?0 
met15?0/met15?0 trp1?63/trp1?63 
ura3?0/ura3?0 vps11pr::HIS3-GAL1pr 
vps18pr::kanMX-GAL1pr-3HA vps41pr::TRP1-
GAL1pr vam66pr::KanMX-GAL1pr VAM6::TAP-
URA3 
 this study 
CUY3448  MATalpha/a his3?200/his3?200 leu2?0 lys2?0 
met15?0/met15?0  trp1?63 ura3?0/ura3?0 
vps11pr::HIS3-GAL1Pr vps16pr::natNT2-GAL1Pr 
vps18pr::kanMX-GAL1Pr-3HA vps41pr::TRP1-
GAL1pr vam6pr::KanMX-GAL1pr VAM6::TAP-
URA3 
 this study 
CUY3491  MATa his3?200 leu2?0 met15?0 trp1?63 ura3?0 
vps11pr::KanMX-GAL1Pr VPS11::TAP-URA3 
 this study 
CUY3492  MATa his3?200 leu2?0 met15?0 trp1?63 ura3?0 
vps11pr::KanMX-GAL1Pr VPS11::?RING-TAP-
URA3 
 this study 
CUY3493  MATa his3?200 met5?0 trp1?63 ura3?0 
vps41pr::TRP1-GAL1pr VPS41::TAP-URA3 
vps18pr::HIS-GAL1pr vam66pr::natNT2-GAL1pr 
 this study 
CUY3588  MATa/alpha his3?200 leu2?0  lys2?0 met15?0 
trp1?63/trp1?63 ura3?0/ura3?0 vam6pr::KanMX- 
GAL1Pr VAM6::URA3-TAP  
 this study 
CUY3590  MATa/alpha his3?200 lys2?0 met15?0 
trp1?63/trp1?63 ura3?0/ura3?0 vps33pr::TRP1-
GAL1pr VPS33::TAP-Ura3 
 this study 
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CUY3645  MATa/alpha his3?200/his3?200  leu2?0 lys2?0 
met15?0/met15?0 trp1?63 ura3?0/ura3?0 
vps11pr::HIS3-GAL1Pr vps16pr::natNT2-GAL1Pr 
vps18pr::kanMX-GAL1Pr-3HA vps41pr::TRP1-
GAL1pr vam6pr::KanMX-GAL1pr vps33pr::HIS3-
GAL1pr VAM6::TAP-URA3 
 this study 
CUY3738  MATalpha his3?200 leu2?0 met15?0 trp1?63 
ura3?0 VPS11::GFP-hphNT1 vps11pr::TRP-
GAL1pr 
 this study 
CUY3740  MATa his3?200 leu2?0 met15?0 trp1?63 ura3?0 
VPS18::GFP-hphNT1 vps18pr::TRP-GAL1pr 
 this study 
CUY3742  MATa his3?1 leu2?0 met15?0 ura3?0 
VAM6::GFP-HIS3 vam6pr::kanMX-GAL1pr 
 this study 
CUY3770  MATa/alpha his3?200/his3?200 leu2?0/leu2?0 
lys2?0 met15?0/met15?0 trp1?63/trp1?63 
ura3?0/ura3?0 vps11pr::HIS3-GAL1Pr 
vam6pr::natNT2-GAL1Pr VPS18::GFP-hphNT1 
vps18pr::TRP-GAL1pr 
 this study 
CUY3772  MATa/alpha his3?200/his3?200 leu2?0/leu2?0 
met15?0/met15?0 trp1?63/trp1?63 
ura3?0/ura3?0 vps18pr::KanMX-GAL1Pr 
VPS11::GFP-hphNT1 vps11pr::TRP-GAL1pr 
 this study 
CUY3773  MATa/alpha his3?200/his3?200 leu2?0/leu2?0 
met15?0/met15?0 trp1?63/trp1?63 
ura3?0/ura3?0 vam6pr::KanMX-GAL1Pr 
VPS11::GFP-hphNT1 vps11pr::TRP-GAL1pr 
 this study 
CUY3775  MATa/alpha his3?200/his3?200 leu2?0/leu2?0 
lys2?0 met15?0/met15?0 trp1?63/trp1?63 
ura3?0/ura3?0 vps11pr::HIS3-GAL1pr 
VPS18::GFP-hphNT1 vps18pr::TRP-GAL1pr 
 this study 
CUY3789  MATa/alpha his3?200/his3?200 leu2?0/leu20 
lys2?0 met15?0/met15?0 trp1?63/trp1?63 
ura3?0/ura3?0 vps11pr::HIS3-GAL1pr 
vam6pr::kanMX-GAL1pr VAM6::GFP-TRP1 
 this study 
CUY3834  MATalpha his3?200 leu2?0 lys2?0 met15?0 
ura3?0 vps11pr::HIS3-GAL1pr vps18pr::kanMX-
GAL1-3HA VPS18::TAP-URA3 
 this study 
CUY3916  MATa/alpha his3?200/his3?200 leu2?0 lys2?0 
met15?0/met15?0 trp1?63/trp1?63 
ura3?0/ura3?0 vps33pr::TRP1-GAL1pr  
vps16pr::kanMX-GAL1Pr-3HA 
 this study 
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